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Abstract 
 
 
Nucleotide flipping is the phenomenon whereby a nucleotide in DNA is rotated 180° out of the 
double helix into an extrahelical position. This event is critical to many biological processes in 
which enzymes need access to a specific nucleotide, but the mechanism remains poorly 
understood. Human alkyladenine DNA glycosylase (AAG) is one of many enzymes that use 
nucleotide flipping to engage substrates. AAG initiates the base excision repair pathway by 
locating sites of damage and catalyzing the hydrolysis of the N-glycosidic bond to release the 
damaged base. Previous crystal structures of AAG in complex with DNA revealed the DNA is 
bent where a tyrosine (Y162) intercalates into the space left by the flipped-out damaged 
nucleotide. The kinetic mechanism of binding, nucleotide flipping, and base excision for wild-
type and mutant forms of AAG was determined. Mutation of active site tyrosines to 
tryptophans revealed a new intermediate that provides selectivity between damaged and 
undamaged sites prior to nucleotide flipping. Additionally, the functional contributions of the 
intercalating residue (Y162) to each of the steps in the AAG catalytic mechanism were 
determined. This residue acts as a selectivity filter and slows nucleotide flipping. Mutating the 
intercalating tyrosine to tryptophan revealed that intercalation occurs early in the search for 
damage. Similar intercalating interactions are observed in all nucleotide flipping enzymes, but 
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the identity of this residue varies. Therefore, a structure/function study of AAG was performed 
in which the intercalating tyrosine was mutated to numerous amino acids of varying sizes. The 
results showed that the rate constants for nucleotide flipping and unflipping are faster for non-
aromatic mutants, and an aromatic residue is required to stabilize the initial recognition 
complex and the stable recognition complex. Together, these results provide new insight into 
the mechanism of AAG, and have implications for other enzymes that use nucleotide flipping 
for DNA repair or epigenetic DNA modification. 
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CHAPTER 1 
Introduction 
 
Nucleotide Flipping 
To recognize and repair DNA, enzymes must overcome the problem of gaining access to bases 
that are normally embedded in the duplex. One solution to this problem is a process called base 
or nucleotide flipping that involves the complete 180° rotation of a damaged base into an 
enzyme active site where its repair can begin (Figure 1.1; (1)). Nucleotide flipping was 
discovered in 1995 when the co-crystal structure of cytosine-5 DNA methyltransferase, HhaI, 
bound to DNA was determined (3). In this ternary structure of M. HhaI in complex with the DNA 
substrate and the reaction product, S-adenosyl-L-homocysteine, the target cytosine had rotated 
180° out of the helix and into the enzyme active site. Due to overall similarities in the primary 
sequences of all cytosine-5 DNA methyltransferases (4), it seemed reasonable that M. HhaI was 
not an isolated example of nucleotide flipping. It was reassuring when additional structures of 
different methyltransferases showed the same phenomenon. Since then, nucleotide flipping 
has been shown for a variety of other enzymes including: DNA glycosylases (2), endonucleases 
(5, 6), non-catalytic transcription factors (7), and 5-methylcytosine recognition domains (8, 9). 
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Not surprisingly, this process is not limited to DNA; as RNA nucleotide flipping has also been 
observed (10-13). In one specific example, RNA nucleotide flipping occurs when aminoglycoside 
antibiotics bind to the 16S ribosomal RNA (rRNA) A site. Upon drug binding, two conserved 
adenine residues (at positions 1492 and 1493 in Escherichia coli 16S rRNA) flip out of the helical 
stack toward the minor groove, where they interact with and stabilize the minihelix that is 
formed by the mRNA codon and the tRNA anticodon during translation (14-17). 
Overall, three forms of nucleotide flipping have been observed in crystal structures:  (1) 
only the target nucleotide is flipped from the DNA duplex (18), (2) only the nucleotide across 
from the target nucleotide is flipped (19), or (3) double flipping in which both the target 
nucleotide and the opposing nucleotide are flipped from the duplex (20). In all of these cases, 
 
Figure 1.1. Nucleotide flipping. Many enzymes use nucleotide flipping to access nucleobases in 
duplex DNA. During this process, a nucleotide is rotated 180° into the enzyme active site. Watson-
Crick hydrogen bonds are broken, aromatic stacking is disrupted, and the DNA is bent. Enzymes must 
pay for these unfavorable energetic costs through the use of favorable binding energy. Figure 
adapted from (2).  
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Watson-Crick hydrogen bonds are broken, aromatic stacking interactions between DNA bases 
are disrupted, and the DNA is bent (1, 21). Crystal structures allow us to observe the final 
extrahelical state, and we can often determine the extent of DNA bending. However, the timing 
of DNA bending remains unknown. We would like to know whether the DNA bends prior to, 
simultaneous with, or after nucleotide flipping. Even though nucleotide flipping is a common 
feature of repair enzymes, little is known about the fundamental mechanisms by which 
nucleotide flipping is accomplished because it is difficult to observe rapid conformational 
changes that occur on the millisecond time scale.  
DNA Damage and Repair 
Although DNA is a remarkably stable molecule, it is nevertheless subject to modifications by a 
variety of reactive intracellular and environmental agents. Out of the ~12,000,000,000 
nucleotides in the genome, there are estimated to be ~10,000 lesions per cell per day (22). If 
not repaired, DNA damage can cause mutations, alter gene expression, affect epigenetic 
profiles, and even cause cell death (22, 23). Fortunately, a variety of DNA repair pathways exist 
to remove the different forms of damage from the genome. For example, the nucleotide 
excision repair (NER) pathway is responsible for removing helix distorting lesions such as bulky 
adducts and crosslinked nucleotides (24, 25). Mismatch repair (MMR) can be coupled with DNA 
replication to repair unpaired and mismatched nucleotides that result from polymerase errors 
during replication (26). Homologous recombination (HR) and non-homologous end joining 
(NHEJ) are responsible for repairing double-stranded breaks (27). Overall, each DNA repair 
pathway specializes in repairing distinct classes of DNA damage. 
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Most individual damaged nucleobases are repaired by the base excision repair (BER) 
pathway (Figure 1.2). This pathway is initiated by a DNA glycosylase, an enzyme that 
continuously searches the genome for a wide variety of damaged bases. Upon locating a site of 
damage, the glycosylase catalyzes the hydrolysis of the N-glycosidic bond to release the 
damaged base (28). The abasic-site containing DNA product is highly mutagenic and can be 
lethal if left exposed within cells. Therefore, it is critical that this intermediate is further 
processed, and the repair pathway is completed (29). An abasic-site-specific endonuclease 
 
       
Figure 1.2. Base excision repair pathway initiated by a monofunctional DNA glycosylase. DNA 
damage (red X) is recognized and removed by a DNA glycosylase. An AP Endonuclease binds to the 
abasic site, and cleaves 5’ of the deoxyribose. This leaves a nick in the DNA strand. The dRP lyase 
activity of DNA polymerase β removes the deoxyribose, and DNA polymerase fills the gap. Finally, 
DNA ligase seals the nick in the DNA, and repair is completed. 
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cleaves the phosphodiester backbone 5’ to the abasic site, leaving a 3’ OH and a 5’ 
deoxyribosephosphate (dRP) group. The dRP lyase activity of DNA polymerase β releases the 
dRP group, and uses the intact template strand to insert the correct nucleotide into the DNA. 
Finally, DNA ligase completes the pathway by sealing the nick. 
DNA Glycosylases 
Humans have eleven different glycosylases to remove the broad spectrum of damaged 
nucleotides (23). These eleven glycosylases are divided into four structural superfamilies: helix-
hairpin-helix, uracil DNA glycosylase, fapyG DNA glycosylase, and alkyladenine DNA glycosylase 
(Table 1.1). While evidence suggests the different structural families evolved independently, all 
glycosylases recognize and remove damaged bases from the genome (30). Each glycosylase is 
faced with the task of searching the genome for rare sites of damage. Upon finding a lesion, the 
DNA glycosylase uses nucleotide flipping to rotate the damaged nucleotide 180° into the 
enzyme active site. Both DNA bending and DNA intercalation are important for this step. 
Structural Family Glycosylase Selected Substrates 
Helix-hairpin-Helix Nth1 Tg, fapyA, DHU, 5-OHU, 5-OHC 
 OGG1 8-oxoG, fapyG 
 MutY A opposite 8-oxoG 
 MBD4 T and U opposite G 
Uracil DNA Glycosylase UDG Uracil 
 SMUG1 Uracil, 5-OH-meU 
 TDG T, U, εC 
FapyG DNA Glycosylase NEIL1 Tg, fapyG, DHU, 5-OHU, fapyA, 8-oxoG 
 NEIL2 Tg, fapyG, DHU, 5-OHU, fapyA, 8-oxoG 
 NEIL3 Tg, fapyG, 5-OHU, fapyA 
Alkyladenine DNA Glycosylase AAG 3MeA, 7MeG, εA, Hx 
 
Table 1.1. Humans have eleven different DNA glycosylases from four distinct structural families. 
While some DNA glycosylases, like UDG, have narrow substrate specificity (recognize one or a few 
structurally related lesions), other DNA glycosylases, like AAG, have broad substrate specificity 
(recognize a variety of structurally diverse lesions). 
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All glycosylases that use nucleotide flipping insert one or more intercalating residues into the 
space left by the flipped-out nucleotide. Once the damaged nucleotide is positioned in the 
active site, the DNA glycosylase catalyzes the hydrolysis of the N-glycosidic bond. In addition to 
hydrolysis, some glycosylase are bifunctional and have additional AP lyase activity (31). Of the 
eleven glycosylases, six are bifunctional (Nth1, OGG1, MutY, NEIL1, NEIL2, and NEIL3) (32). 
While the overall mechanism for excision of a damaged nucleotide is largely conserved 
within each glycosylase family, the substrate specificity of each glycosylase varies (Table 1.1). 
Some DNA glycosylases, like uracil DNA glycosylase (UDG), have narrow substrate specificity. 
UDG only excises uracil from DNA. This is achieved by a sterically constrained active site that 
occludes all other nucleobases (33). In comparison, alkyladenine DNA glycosylase (AAG) 
removes a diverse group of purine lesions that result from alkylation (3-methyladenine, 3-
methylguanine, and 7-methylguanine) and reactive oxygen and nitrogen species (hypoxanthine 
(Hx), 1,N6-ethenoadenine (εA), and 1,N2-ethenoguanine) (34-38). AAG uses steric clashes with 
the exocyclic amines of G and A to discriminate against the excision of undamaged bases. The 
smaller pyrimidines are too small to be excluded from the active site, but they are not excised 
because general acid catalysis is optimized for protonation of the larger purine rings (39). 
However, as a consequence of this broad specificity, AAG has reduced catalytic efficiency 
compared to UDG. Overall, DNA glycosylases can afford to sacrifice speed for increased 
selectivity, because sites of damage are rare (40).   
Human Alkyladenine DNA Glycosylase (AAG)  
AAG is a particularly attractive system to delve into the biophysical and biochemical mechanism 
of multi-step DNA recognition. Crystal structures of AAG in complex with DNA revealed this 
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enzyme uses nucleotide flipping to rotate lesioned bases out of the DNA duplex and into its 
active site (Figure 1.3; (18, 41)). The expression of AAG confers increased cell survival in the 
presence of exogenous alkylating agents (42, 43); however, its glycosylase activity has been 
shown to be responsible for retinal degeneration (apoptosis) in mice when exposed to DNA 
alkylating agents (44), and the overexpression of AAG leads to enhanced sensitivity to DNA 
alkylating agents in other contexts (45, 46). Furthermore, increased levels of AAG have been 
linked to microsatellite instability (47, 48). Thus, it is important that cells have the correct 
balance of AAG activity.  
 
Figure 1.3. Crystal structure of human alkyladenine DNA glycosylase (E125Q) bound to εA- 
containing DNA. The εA base is flipped into the active site and stacks between two tyrosine residues 
(Y127 and Y159). The intercalating residue (Y162) is shown in red. Image was rendered with Pymol 
(http://www.pymol.org) using coordinates from the PDB (1EWN).  
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One of the lesions that is most efficiently excised by AAG is the naturally fluorescent 
1,N6-ethenoadenine (εA), that is formed by lipid oxidation or exposure to exogenous alkylating 
agents (37, 49). The minimal kinetic mechanism for multi-step recognition of εA damage has 
been reported (Figure 1.4; (40, 50)). Given the excess of undamaged DNA, initial binding (kon) of 
AAG is not at the site of damage. AAG uses nonspecific binding and facilitated diffusion (51) to 
search for sites of damage (kfind). Once an εA is found, AAG forms an initial recognition complex 
that is accompanied by changes in the stacking of the lesion base (40). From this intermediate, 
AAG catalyzes nucleotide flipping (kflip) to form a more stable specific recognition complex that 
positions the substrate for N-glycosidic bond cleavage (kchem; (18)). This multi-step recognition 
provides multiple opportunities for discrimination between damaged and undamaged 
nucleotides, and similar mechanisms have been proposed for independently evolved DNA 
repair glycosylases, including 8-oxoguanine DNA glycosylases and uracil DNA glycosylases (52-
55). 
 
 
Figure 1.4. Minimal mechanism for the initiation of base excision repair. AAG (crescent) binds to 
nonspecific DNA and rapidly searches for DNA damage. This searching process is described by the 
macroscopic rate constant kfind. Once a lesion (solid rectangle) is encountered in an initial recognition 
complex, it can be flipped into the enzyme active site to form the specific recognition complex. In this 
specific complex, Y162 (red circle) intercalates into the DNA where it takes the place of the 
extrahelical lesion. AAG catalyzes hydrolysis of the N-glycosidic bond (kchem) from this complex. The 
overall equilibrium constant for nucleotide flipping (Kflip) is equal to kflip/kunflip. 
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Monitoring Nucleotide Flipping 
While much is known about nucleotide flipping of εA by AAG, the rate constants for nucleotide 
flipping of non-fluorescent substrates remain unknown. Tryptophan fluorescence has been 
shown to be an excellent tool to follow structural changes in a protein. The catalytic domain of 
AAG (residues 80-298) contains three tryptophan and six tyrosine residues. The three native 
tryptophan residues are all found on the back surface, opposite the protein active site and the 
DNA binding interface. The location of the three tryptophan residues suggested that they would 
not change their environment upon DNA binding. Five of the tyrosine residues line either the 
binding pocket or the DNA-protein interface, but the absorbance of tyrosine is very close to the 
absorbance of DNA, and it is unlikely that they would serve as useful reporters to monitor 
nucleotide flipping of non-fluorescent lesions. Therefore, in Chapter 2, tryptophan residues 
were introduced into the binding pocket of AAG, substituting either Y127 or Y159, the two 
tyrosine residues that sandwich the bound lesion in the crystal structures (18, 41). While 
substitution of tyrosine residues with tryptophan at positions 127 and 159 in the AAG active 
site had minimal effects on the excision of εA, there were much larger effects on the rate and 
equilibrium constant for nucleotide flipping. These results are consistent with the simple model 
that bulky tryptophan residues in the active site destabilize the flipped-out conformation and 
accelerate the rate constant for unflipping. In spite of these differences, stopped-flow 
fluorescence experiments show that these mutant proteins exhibit the same two-state binding 
model as was observed for wild-type AAG. These observations indicate that the εA lesion and 
tryptophan side chains located in the AAG active site both report on the initial recognition 
complex and on the specific recognition complex.  
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DNA Intercalation 
It is proposed that both DNA bending and DNA intercalation are important for nucleotide 
flipping (1, 21). Crystal structures of DNA glycosylases in complex with DNA revealed the 
lesioned base has rotated 180° out of the DNA duplex and into the enzyme active site (18, 33, 
41, 56, 57). In these structures, the DNA is bent where an intercalating or ‘wedge’ residue fills 
the space left by the flipped-out damaged nucleotide. Intercalating interactions are observed in 
almost all nucleotide flipping enzymes, but the identity of the intercalating amino acid varies 
and the function of this residue remains unknown (2, 58). For example, AAG uses Tyr-162, AlkA 
uses Leu-125, UDG uses Leu-191, OGG1 uses Asn-149, MutM uses Met-77, and TDG uses Arg-
275 (59).  
The two models for how DNA intercalation could contribute to nucleotide flipping have 
been described as “pushing” and “plugging” (60-62). In the pushing model, DNA intercalation 
destabilizes the DNA duplex to accelerate nucleotide flipping. In the plugging model, DNA 
intercalation occurs subsequent to nucleotide flipping and the intercalating residue prevents 
the nucleotide from returning to the duplex, effectively slowing the rate of unflipping. These 
two mechanisms are not mutually exclusive, and in both proposed models the DNA duplex 
undergoes localized structural perturbations. 
The functional contributions of the intercalating residue (Y162) to each of the steps in 
the AAG catalytic mechanism are addressed in Chapter 3. To determine the role of the 
intercalating tyrosine, this residue was mutated to phenylalanine (Y162F) and alanine (Y162A). 
Remarkably, the Y162A mutation increases the rate of nucleotide flipping by 50-fold relative to 
wild-type AAG. This mutant also exhibits faster unflipping, resulting in a 140-fold reduction in 
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the equilibrium constant for formation of the specific recognition complex. In contrast, the 
kinetic parameters for the Y162F and wild-type enzymes are very similar, suggesting that the 
hydroxyl of tyrosine is not necessary for function. These results establish that DNA intercalation 
contributes to the specific recognition of DNA damage by acting as a plug to stabilize the 
specific recognition complex. Tyrosine 162 slows the rate of nucleotide flipping by stabilizing 
the initial recognition complex. Therefore, our new model suggests that DNA intercalation 
contributes to the specificity of AAG, but the increased specificity comes at the cost of reduced 
speed. 
In Chapter 4, site-directed mutagenesis and transient kinetic approaches were used to 
determine the timing of tyrosine intercalation for human AAG. The intercalating tyrosine 
residue was mutated to tryptophan to use tryptophan fluorescence as a tool to follow 
structural changes in the protein upon DNA binding. Excision of the naturally fluorescent lesion 
εA by Y162W is identical to wild-type, and the equilibrium constant for flipping remains highly 
favorable. Even though the Y162W mutant has not been found in nature, the results indicate 
that Y162W is a conservative mutation. This raised the possibility that tryptophan fluorescence 
could be used to probe DNA binding and nucleotide flipping steps. Using stopped-flow 
fluorescence, changes in both εA and tryptophan fluorescence were monitored.  Surprisingly, 
the tryptophan fluorescence of Y162W does not report on nucleotide flipping. The rapid 
quenching of Y162W tryptophan fluorescence upon binding damaged or undamaged DNA 
suggests that Y162 intercalation occurs early in the search for DNA damage. 
Almost all DNA glycosylases employ nucleotide flipping to access a damaged base. Many 
glycosylases use a bulky side chain (Asn, Arg, Leu, or Tyr) to fill the space left by the flipped-out 
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nucleotide, although an exception includes 3-methyladenine DNA glycosylase III (MagIII), which 
has a Gly at this position (63). To investigate how the size of the intercalating side chain affects 
nucleotide flipping, seven Y162 variants of AAG were made and individual steps of the kinetic 
mechanism were characterized in Chapter 5. The structure/function study suggests formation 
of the initial recognition complex, and nucleotide flipping are both affected by the size of this 
residue. The rate constant for nucleotide flipping is 4-9-fold faster for non-aromatic mutants 
and Y162H compared to wild-type. The non-aromatic mutants also exhibit faster unflipping, 
resulting in an unfavorable equilibrium constant for nucleotide flipping. The Y162H mutant is 
unique because it has a fast rate constant for nucleotide flipping, however like the other 
aromatic mutants, the Y162H mutant stabilizes the specific recognition complex. Overall, AAG 
requires an aromatic intercalating residue to stabilize the initial recognition complex and the 
specific recognition complex.  
Conclusions 
Collectively, these studies provide a foundation for understanding the mechanism of nucleotide 
flipping and the functional role of the intercalating residue. AAG has been a particularly 
attractive system to delve into the biophysical and biochemical mechanism of multi-step DNA 
recognition. As many different enzymes must employ similar strategies to discriminate between 
specific and nonspecific sites, lessons from AAG may be more widely applicable. Future work is 
needed to measure bending of DNA to address the temporal relationship of bending and 
flipping. In addition, nuclear magnetic resonance (NMR) should be used to obtain information 
about the initial recognition complex to help us understand how damaged sites are recognized.   
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CHAPTER 2 
Substitution of Active Site Tyrosines with Tryptophan Alters the Free Energy for  
Nucleotide Flipping by Human Alkyladenine DNA Glycosylase1,2 
 
Human alkyladenine DNA glycosylase (AAG) recognizes a wide variety of structurally 
diverse deaminated and alkylated purine lesions. This enzyme initiates the base excision DNA 
repair pathway by catalyzing the hydrolysis of the N-glycosidic bond and releasing the lesion 
base. Subsequent action of an abasic-site specific endonuclease, a 5’-deoxyribose phosphate 
lyase, a DNA polymerase, and a DNA ligase are required to restore the correct DNA sequence, 
using the intact strand as a template. AAG is the only human glycosylase known to recognize a 
wide variety of alkylated and deaminated purines (1-4). The expression of AAG confers 
increased cell survival in the presence of exogenous alkylating agents (5, 6), however its 
glycosylase activity has been shown to be responsible for retinal degeneration (apoptosis) in 
mice (7) and the overexpression of AAG leads to enhanced sensitivity to DNA alkylating agents 
in certain contexts (8, 9). Furthermore, increased levels of AAG have been linked to 
1Reproduced with permission from Hendershot, J.M., Wolfe, A.E., and O’Brien, P.J. (2011) Substitution of 
active site tyrosines with tryptophan alters the free energy for nucleotide flipping by human alkyladenine 
DNA glycosylase, Biochemistry 50, 1864-1874. Copyright 2011 American Chemical Society. 2All authors 
participated in planning the experiments. AEW developed the fluorescence-based assays for εA and 
tryptophan, JMH collected all of the data and analyzed the experiments, PJO and JMH wrote the 
manuscript.  
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microsatellite instability (10, 11). Thus, it is important that cells have the correct balance of AAG 
activity. 
Crystal structures of AAG in complex with DNA revealed that this enzyme uses nucleotide 
flipping to gain access to the N-glycosidic bond of a damaged nucleotide (12, 13). We previously 
used the intrinsic fluorescence of εA to characterize the minimal kinetic mechanism for the 
recognition, flipping, and excision of this lesion by wild-type AAG (Scheme 2.1; (14)). 
Rapid mixing experiments indicated that an initial recognition complex rapidly and reversibly 
formed in which the εA lesion is partially unstacked. We hypothesized that the further change 
in the fluorescence of the εA lesion is indicative of the capture of the lesion in the active site of 
AAG. In order to test this hypothesis we sought to observe conformational changes in the 
protein directly, as similar approaches have been informative for other DNA glycosylases (15-
18). 
The catalytic domain of AAG (residues 80-298) contains six tyrosine and three 
tryptophan residues. The three native tryptophan residues are all found near the surface on the 
opposite side of the protein from the active site and the DNA binding interface, suggesting that 
they would not change their environment upon DNA binding. Five of the tyrosine residues line 
 
Scheme 2.1 
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either the binding pocket or the DNA-protein interface, but the absorbance of tyrosine is very 
close to the absorbance of DNA and it is unlikely that they would serve as useful reporters. 
Therefore, we took the approach of introducing tryptophan residues into the binding pocket of 
AAG, substituting either Y127 or Y159, the two tyrosine residues that sandwich the bound 
lesion in the crystal structures (12, 13). The Y127 side chain stacks on top of the εA lesion, 
whereas the Y159 side chain makes a T-shaped interaction with the lesion (Figure 2.1). 
Comprehensive analysis of aromatic interactions in protein structures suggests that T-type 
interactions are common and presumably contribute similar binding energy as stacked 
interactions (19). It has been suggested that tyrosine to tryptophan mutations are relatively 
conservative (20), but these two positions in AAG are invariably found to be tyrosine in 
organisms ranging from bacteria to vertebrates (21). 
 
 
Figure 2.1. Active site contacts with the flipped-out εA from the published crystal structure of AAG 
bound to εA-DNA. The coordinates are from 1EWN (13) and the image was rendered with Pymol 
(http://www.pymol.org). Only the immediate residues surrounding the εA base are shown.  
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We found that substitution of tyrosine residues with tryptophan at position 127 and 159 
in the AAG active site had minimal effects on the excision of εA, however, there were much 
larger effects on the rate and equilibrium constant for nucleotide flipping. These results are 
consistent with the simple model that bulky tryptophan residues in the active site destabilize 
the flipped-out conformation and accelerate the rate constant for unflipping. However, it is 
surprising that the Y159W mutation resulted in a 5-fold faster rate constant for εA flipping. 
Although flipping is perturbed in these mutants, they follow the same mechanism as the wild-
type enzyme with formation of two distinct intermediates prior to N-glycosidic bond cleavage. 
The observation of identical rate constants for time-dependent changes in either εA or 
tryptophan fluorescence, demonstrates that there are already changes in the active site 
environment prior to full nucleotide flipping, and that the most strongly quenched intermediate 
previously observed is indeed the extrahelical specific recognition complex (14). 
Materials and Methods 
Purification of Wild-type and Mutant AAG Proteins. The catalytic domain of human AAG that 
lacks the first 79 amino acids was expressed in E. coli and purified as previously described (22). 
The Y127W and Y159W mutants were constructed by site-directed mutagenesis and purified 
using the same protocol (22). The concentration of AAG was determined by fluorescent 
titration of εA-DNA, as described below, and the concentration was found to be within 2-fold of 
the concentration determined from the calculated extinction coefficient of the wild-type or 
mutant proteins.  
Synthesis and Purification of Oligodeoxynucleotides. The 25mer oligonucleotides were 
synthesized by Integrated DNA Technologies or by the W.M. Keck Facility at Yale University (see 
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Scheme 2.2 for DNA sequences). The oligonucleotides were desalted using Sephadex G-25 and 
purified using denaturing polyacrylamide gel electrophoresis as previously described (23). 
Oligonucleotides for gel-based assays were labeled on the lesion containing strand with a 5’-
fluorescein (6-fam) label. The concentrations of the single-stranded oligonucleotides were 
determined from the absorbance at 260 nm, using the calculated extinction coefficients for all 
oligonucleotides except those containing εA. For oligonucleotides containing εA, the extinction 
coefficient was calculated for the same sequence with an A in place of the εA and corrected by 
subtracting 9400 M-1cm-1 to account for the weaker absorbance of εA as compared to A (24). 
The lesion-containing oligonucleotides were annealed with a 1.2-fold excess of the complement 
by heating to 90 °C and cooling slowly to 4 °C. Two different sequence contexts were used and 
these are referred to by the central three nucleotides (i.e., TEC has a central εA lesion flanked 
by a 5’T and a 3’C; Scheme 2.2). 
 
Steady-State Fluorescence Measurements. Fluorescence emission spectra were collected with 
a PTI QuantaMaster fluorometer controlled by FeliX software. For εA fluorescence, an 
excitation wavelength of 320 nm (6 nm band-pass) was used and the total fluorescence was 
measured at emission wavelengths from 350-500 nm (6 nm band-pass). Samples (300 µL) of 
400 nM εA-containing DNA were prepared in the standard buffer (50 mM NaMES (pH 6.5), 100 
TXC 5’ –CGATAGCATCCTXCCTTCTCTCCAT 
3’ –GCTATCGTAGGATGGAAGAGAGGTA 
 
AXA 5’ –CGATAGCATCAAXAATTCTCTCCAT 
3’ –GCTATCGTAGTTTTTAAGAGAGGTA 
 
X= εA, inosine, or pyrrolidine  
 
Scheme 2.2 
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mM NaCl, 1 mM EDTA, 1 mM DTT) and spectra were recorded at 25 °C. To determine the 
steady-state fluorescence of εA-containing DNA bound to AAG, the spectra were recorded 
within one minute. No significant excision of εA occurs during this time. Three independent 
titrations were averaged, and the data were fit to a quadratic equation assuming tight binding 
by AAG (Equation 2.1), in which Frel is the relative fluorescence, A is the fractional quenching, 
and Kd is the dissociation constant for the εA-DNA. 
2E
DNA)(4EDNA)E(KDNA)EA(K
1F
2
dd
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
  (2.1) 
Single-turnover Excision of εA Monitored by Fluorescence. Experiments with mutant and wild-
type AAG were performed as previously described (14). Since εA is strongly quenched in duplex 
DNA and when bound to AAG, we were able to follow the release of εA into solution by the 
increase in fluorescence. Single-turnover glycosylase assays were performed in the standard 
buffer at 25 °C with 400 nM DNA duplex and 1.2–2.4 μM AAG. A full emission spectrum was 
recorded at various times between 2 and 120 minutes. The greatest change in fluorescence 
occurred at 405 nm, therefore this wavelength was chosen to follow the release of εA into 
solution. The fluorescence at 405 nm was used to determine the fraction of εA product 
(Fraction Product = (Ft - F0)/Fmax; Ft is the fluorescence at time = t, F0 is the initial fluorescence at 
time = 0 and Fmax is the maximal fluorescence change). This normalization gives fraction product 
values between 0 and 1. These data were fit by a single exponential equation using nonlinear 
least squares regression with Kaleidagraph (Synergy Software), in which kobs is the rate 
constant, t is the time, and A is the amplitude (Equation 2.2). In all cases, the same rate 
constant was measured at two different concentrations of AAG.  This demonstrates that AAG 
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was saturating and that the maximal single-turnover rate constant was determined (see 
Appendix A). Under these conditions, the observed rate constant is equal to the maximal single-
turnover rate constant (kobs = kmax).  
Fraction product   A(1 - e-kobst)    (2.2)  
Gel-based Glycosylase Assay. We also measured single-turnover glycosylase activity with the 
standard glycosylase activity assay that utilizes abasic site cleavage by NaOH followed by DNA 
separation on a denaturing polyacrylamide gel (22, 23). Fluorescein-labeled DNA substrates (50 
nM) containing either εA or inosine (I) were prepared in the standard buffer. The reactions 
were initiated with the addition of 75 nM – 5 µM AAG and incubated at 25 °C. At various time 
points, a sample from the reaction was removed and quenched in 2 volumes of 0.3 M NaOH, 
giving a final hydroxide concentration of 0.2 M. The abasic sites were cleaved by heating at 70 
°C for 10 minutes. Samples were mixed with an equal volume of formamide/EDTA loading 
buffer before loading onto a 15% polyacrylamide gel. Gels were scanned with a Typhoon 
Imager (GE Trio+ Healthcare) to detect the fluorescein label by exciting at 488 nm and 
measuring emission with a 520BP40 filter. The gel bands were quantified using ImageQuant TL 
(GE Healthcare). The data was converted to fraction product [Fraction Product = product / 
(product + substrate)] and then fit by a single exponential (Equation 2.2). The observed rate 
constant for the single-turnover reaction was independent of the concentration of AAG, 
indicating that the maximal rate constant was measured (kobs = kmax; see Appendix A).  
Assignment of Single-turnover Rate Constants. Glycosylases require a nucleotide flipping step 
to gain access to the labile bond and therefore a saturating single-turnover rate constant could 
be limited by either nucleotide flipping or by hydrolysis of the N-glycosidic bond. This reaction 
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scheme is shown below (Scheme 2.3) and the contribution of individual rate constants is given 
in Equation 2.3. For wild-type AAG-catalyzed excision of εA we have previously established that 
the flipping rate constant (kflip) is much faster than the rate of N-glycosidic bond hydrolysis 
 
(kchem). Furthermore, we found that the equilibrium constant for nucleotide flipping (Kflip; 
Equation 2.4) is highly favorable (14). Therefore, for AAG-catalyzed excision of εA the observed 
single-turnover rate constant is simply kchem. The analysis herein suggests that this is true for 
the Y127W and Y159W mutants as well. However, for AAG-catalyzed excision of hypoxanthine 
(Hx), the rates of flipping are unknown and the inverse correlation between base pair stability 
and excision rate strongly suggests that the equilibrium for nucleotide is unfavorable for this 
lesion (3, 25). Therefore, the value of kmax for wild-type and mutant AAG should be considered 
an upper limit for the value of kchem (Equation 2.5).  
kmax = kchem × kflip/(kflip+kunflip)      (2.3) 
Kflip = kflip/kunflip      (2.4) 
kmax = kchem (Kflip/(1+Kflip))     (2.5) 
Stopped-Flow Kinetics. Pre-steady state kinetic experiments were performed on a Hi-Tech SF-
61DSX2, controlled by Kinetic Studio (TgK Scientific). The fluorescence of εA was measured 
using an excitation wavelength of 320 nm and a WG360 long-pass emission filter as previously 
described (14). The fluorescence of tryptophan was measured using an excitation wavelength 
 
           Scheme 2.3 
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of 295 nm and a 330BP20 band-pass emission filter. Due to the weak fluorescence of εA and 
tryptophan, and the fast association rate constant, we monitored binding with equimolar 
concentrations of εA-DNA and protein. Under these conditions the time-dependent changes in 
fluorescence was fit by Equation 2.6, in which F is εA fluorescence as a function of time, C is the 
fluorescence of the free DNA, Y and Z are the changes in fluorescence of the first and second 
intermediates relative to the free DNA, E0 is the starting concentration of AAG and DNA ([AAG] 
= [DNA]), k1 is the bimolecular rate constant for binding (kon; Scheme 2.3), k2,obs is the observed 
unimolecular rate constant for the subsequent flipping step, and t is the time (14). For an 
approach to equilibrium, the observed rate constant is equal to the sum of the rate constants 
for the forward and reverse flipping steps (Equation 2.7). However, in the case of a favorable 
equilibrium constant for flipping (kflip >> kunflip), the observed rate constant for the forward 
reaction is approximately equal to the flipping rate constant (Equation 2.8). Dissociation 
experiments were performed for the mutant proteins to validate this assignment (see below). 
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k2,obs = kflip + kunflip      (2.7) 
  k2,obs ≈ kflip       (2.8) 
Several different concentrations between 0.125 μM and 1.0 μM (all concentrations are 
given after mixing) gave the same rate constants, confirming that the concentration chosen was 
saturating for the mutant and wild-type proteins (see Appendix A and data not shown). At least 
three traces were averaged together for each concentration in two independent experiments, 
and the averaged data was fit by Equation 2.6 using Kaleidagraph. 
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Pulse-Chase Assay to Measure Substrate Dissociation. The macroscopic rate constant for 
dissociation of wild-type and mutant AAG from εA-containing DNA was measured by pulse-
chase in the standard reaction buffer at 25 °C as previously described for wild-type AAG (14). 
Briefly, in 20 μL reactions, 50 nM fluorescein-labeled TEC DNA was mixed with 75 nM or 150 
nM AAG for 20 seconds, and then a chase of 10 μM unlabeled TEC DNA was added.  At various 
time points, a sample from the reaction was removed and analyzed as described for “Gel-based 
glycosylase assay”. Base excision catalyzed by AAG results in fluorescein-labeled product, 
whereas dissociation releases unreacted fluorescein-labeled substrate. The partitioning 
between hydrolysis and dissociation can be determined from either the exponential rate 
constant or by the change in burst amplitude. If AAG dissociates from the labeled DNA before 
the chemical cleavage step and then binds to the unlabeled DNA, less of the reaction will occur 
during the single-turnover part of the curve as compared to the same experiment without 
chase. The data was converted to fraction product and fit by a single exponential (Equation 
2.2).  The observed rate constant was independent of the concentration of AAG.   
According to the two step binding mechanism described in Scheme 2.3, two different 
partitioning equations can be written (26). All labeled substrate is initially bound, and therefore 
the fraction of product formed is given by the fraction that goes on to react. This is indicated by 
Equation 2.9, in which A is the burst amplitude (the fraction of product formed in the burst 
phase of the experiment), kmax is the maximal single-turnover rate constant for formation of 
product, and koff,obs is the macroscopic rate constant for dissociation from the flipped-out 
complex. This expression can be rearranged to solve for the desired dissociation rate constant 
(Equation 2.10). Similarly, for branched pathways, the observed rate constant for the burst 
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phase of the pulse-chase experiment is given by the sum of the rate constants for the 
competing pathways, formation of product is given by kmax and the macroscopic dissociation of 
substrate is designated koff,obs (Equation 2.11). Solving for koff,obs gives Equation 2.12. 
maxobsoff,
max
kk
k
=A

      (2.9) 
max
max
obsoff, k
A
k
k       (2.10) 
maxobsoff,obs kkk        (2.11) 
maxobsobsoff, kkk        (2.12) 
Control reactions in which no chase was added provided the single-turnover rate 
constant, kmax, and confirmed that these concentrations of AAG were saturating. From these 
values, the dissociation rate constant, koff, for AAG dissociating from εA-DNA was calculated by 
two different methods (Equations 2.10 and 2.12). Both methods gave very similar values for 
koff,obs and we report the average of the results obtained with both methods. 
Since the εA-DNA binds in two steps, the observed rate constant for dissociation of 
substrate (koff, obs) could be limited by the unflipping rate (kunflip) or dissociation from nonspecific 
DNA (koff). According to Scheme 2.3, and assuming that the flipped-out complex is stable (i.e., 
kflip >> kunflip), this observed dissociation rate constant can be expressed in terms of the 
microscopic rate constants (Equation 2.13; (26)). Stopped flow fluorescence suggests that 
dissociation from the initial AAG•DNA complex is rapid (koff ~30 s
-1) relative to the forward 
flipping rate constant kflip = 2.6 s
-1, and therefore the observed rate constant for substrate 
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dissociation from the εA-DNA•AAG complex is approximately equal to the reverse rate constant 
for flipping (Equation 2.14).  

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


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 flipoff
off
unflipobsoff,
kk
k
k=k     (2.13) 
unflipobsoff, kk 
      (2.14)
 
Direct Measurement of the Macroscopic Rate for Substrate Dissociation. Stopped-flow 
double-mixing experiments were performed to measure unflipping and dissociation of εA-DNA 
directly. To rapidly form the flipped-out AAG-DNA complex, 2 µM AEA DNA was mixed with 2.8 
µM AAG. After an aging time of one second, 18 µM pyrrolidine-DNA was added as a competitor. 
The final concentrations after mixing were 500 nM AEA DNA, 700 nM AAG, and 9 µM 
pyrrolidine-DNA. The fluorescence of εA was measured using an excitation wavelength of 320 
nm and a WG360 long-pass emission filter. The reaction was followed for 100 seconds; no 
significant excision of εA occurs during this time. Three traces were averaged together for each 
mutant, and the normalized fluorescence was fit by a single exponential (Equation 2.2). As 
described above for the pulse-chase assay, the observed rate constant for dissociation is 
described by Equation 2.13 and simplifies to Equation 2.14 under the conditions of koff >> kflip. 
Free Energy Reaction Profile. The energetic effects of the Y127W and Y159W mutations can 
be illustrated by constructing a free energy reaction profile for the binding, flipping, and 
excision of an εA lesion by wild-type and mutant AAG. A standard state of 25 oC, pH 6.5, 1 nM 
enzyme, and 1 µM εA-DNA was chosen. The E•S state was arbitrarily set to ∆G 0 for all 
enzymes and the individual heights of barriers were determined by Equation 2.15, in which R is 
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the gas constant (1.987 × 10-3 kcal/molK), T is the temperature (298 K), k is the rate constant, h 
is Planck’s constant (1.58 × 10-37 kcal s), and kB is the Boltzmann constant (33 × 10
-27 kcal/K). 
∆G‡ = -RTln(hk/kBT)      (2.15) 
Results 
Tryptophan Fluorescence of Wild-type AAG 
The catalytic domain of AAG (residues 80-298) has almost identical glycosylase activity as the 
full-length protein (22, 27, 28), but is considerably more stable. Therefore, we used this 
construct for all of the experiments described below. To gain insight into the steps involved in 
nucleotide flipping we sought to establish fluorescent probes that could report on ligand 
binding and conformational changes in AAG. Although it is possible to use the natural 
 
Figure 2.2. Location of tryptophan residues in the catalytic domain of AAG. Cartoon representation 
of the AAG (yellow) complex with εA-DNA (green) from the PDB (1EWN) was rendered with Pymol 
(http://www.pymol.org). The three native tryptophan residues are shown in space-filling 
representation (blue). They are all located near the surface of the protein far away from the DNA-
binding surface of AAG. 
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fluorescence of εA to characterize the interaction of AAG with this alkylative lesion, the 
majority of substrates recognized by AAG are not fluorescent (14). The catalytic domain of AAG 
contains three tryptophan residues, raising the possibility that the native protein might 
undergo changes in its intrinsic fluorescence upon binding to DNA. The crystal structure of AAG 
bound to εA-DNA shows that all three of these residues are located near the surface on the 
opposite side of the enzyme from the DNA binding surface (Figure 2.2; (12)). We initially tried 
to remove these tryptophan residues to simplify the fluorescence spectra when additional 
tryptophan residues were added to the protein. Each individual tryptophan could be mutated 
singly to phenylalanine and full glycosylase activity was maintained, however attempts to 
combine these into a triple mutant resulted in insoluble protein in E. coli (data not shown). 
Before embarking on more extensive mutagenesis studies, we tested whether the native 
protein undergoes any changes in tryptophan fluorescence upon binding to εA-containing DNA. 
Whereas binding could be readily detected by changes in the εA fluorescence (excitation at 320 
nm and emission at 400 nm), parallel experiments in which tryptophan fluorescence was 
measured gave no detectable changes in fluorescence (excitation at 295 nm and emission at 
330 nm; see Appendix A). This suggests that the native tryptophan residues do not change their 
environment upon DNA binding and nucleotide flipping. Therefore, the changes in tryptophan 
fluorescence for the Y127W and Y159W mutants simply reflect changes in the local 
environment of the active site tryptophan residue. 
Interaction of Y127W and Y159W AAG with εA-DNA 
We prepared two different mutants of AAG in which one of the active site tyrosines was 
mutated to tryptophan. These tyrosine residues, Y127 and Y159, interact with the flipped-out 
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base in the crystal structure of AAG bound to εA-DNA (13). As tyrosine to tryptophan 
substitutions are often tolerated (20), we investigated the possibility that these mutants might 
exhibit tryptophan fluorescence that reports on the nucleotide flipping step. This would enable 
us to correlate changes in the fluorescence of εA-DNA with protein fluorescence. It was 
previously shown that εA-DNA of the sequence AEA shows a large decrease in fluorescence 
upon binding to wild-type AAG (see Materials and Methods; (14)). Fluorescence titrations were 
performed with a fixed concentration of εA-DNA and increasing concentration of mutant AAG 
proteins to determine the concentration of active AAG (Figure 2.3; see Materials and Methods). 
The active concentration determined by this method was within 60% of the value calculated 
from the UV-absorbance of the mutant proteins and this corrected concentration was used for 
all of the experiments described below. 
 
Figure 2.3. Titration of εA-DNA with AAG mutant proteins. Samples of 400 nM εA-DNA were 
incubated with increasing concentration of either Y127W () or Y159W () AAG and the εA 
fluorescence was recorded. Three independent titrations were performed and the average and 
standard deviation are shown. The normalized fluorescence was fit by the quadratic equation under 
conditions of tight binding (Equation 2.1). These fits indicate that the number of εA-binding sites is 
70% of the expected value for Y127W and 60% of the expected value for Y159W. 
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Glycosylase Activity of AAG Mutants Toward εA-DNA 
 We next measured the single-turnover glycosylase activity of the wild-type and mutant 
proteins. Since εA is strongly quenched in duplex DNA, and becomes fluorescent upon its 
release into solution, we monitored the fluorescence of εA-DNA incubated with either wild-
type or mutant forms of AAG under single-turnover conditions, with enzyme in excess over 
substrate and far above the Kd for substrate binding (Figure 2.4). Two different sequence 
contexts were tested, a heterogenous sequence (TEC) and a polyA sequence (AEA; see Scheme 
2.2; (14)). The analysis of εA excision from the TEC duplex by wild-type AAG gave a single-
turnover rate constant of 0.048 min-1, similar to the previously reported value of 0.034 min-1 
(14). The Y159W mutant is 3-fold slower than wild-type and the Y127W mutant is 4-fold slower 
(Table 2.1). These effects are similar to the respective 3-fold and 8-fold effects of these 
 
Figure 2.4. Single-turnover excision of εA by wild-type and mutant AAG. The reaction time course 
for wild-type (), Y159W (), and Y127W () AAG are shown for two different sequences, TEC (A) 
and AEA (B). The fraction of εA released was determined by measuring the increased fluorescence of 
εA when it is released into solution (see Materials and Methods; (14)). 
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Table 2.1. Kinetic parameters for flipping and excision of damaged bases by wild-type and 
mutant AAGa 
 
 Wild-typeb Y159W Y127W 
kon (M
-1s-1) 2.0 x 108  3.1 x 108 6.8 x 107 
kflip (s
-1) 2.6  13.6 1.1 
kunflip (s
-1) 0.002  0.37 0.12 
Kflip
c 1300  40 9 
kchem εA (s
-1)d 8.0 x 10-4 3.0 x 10-4 2.0 x 10-4 
kchem Hx (s
-1)e 4.9 x 10-2 2.8 x 10-4 8.7 x 10-5 
 
aThe binding and flipping rate constants were determined from stopped-flow fluorescence 
using the TEC oligonucleotide. The values shown are from the changes in εA fluorescence, 
but the tryptophan fluorescence of Y159W and Y127W gave almost identical values (see 
Appendix A). The standard conditions were 25 °C, 50 mM NaMES (pH 6.5), 100 mM NaCl, 1 
mM EDTA, and 1 mM DTT. 
 
bThe values for wild-type AAG were previously reported (14).  
 
cThe equilibrium constant for flipping is given by the ratio of the flipping and unflipping rate 
constants (Kflip = kflip/kunflip).  
 
dThe rate constants for single-turnover excision of εA from TEC DNA are from Figure 2.4A, 
and reflect the rate of N-glycosidic bond cleavage.  
 
eThe rate constants for single-turnover excision of Hx from the same TEC sequence context 
are from Figure 2.8, and are an underestimate of the rate of AAG-catalyzed N-glycosidic 
bond hydrolysis, because this step is preceded by an unfavorable flipping equilibrium 
(Equation 2.5). 
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mutations on the single-turnover excision of εA measured by abasic site formation under 
different reaction conditions (22). Similar results were obtained for the AEA sequence context 
with 3-fold and 5-fold decreases in the single-turnover rate constant for Y159W and Y127W, 
relative to wild-type AAG. The relatively modest decreases in the single-turnover glycosylase 
activity raised the possibility that these introduced tryptophan residues could serve as useful 
reporters on the rates of conformational changes within the protein. For wild-type AAG, the 
maximal single-turnover rate constant is likely to be N-glycosidic bond hydrolysis since the 
equilibrium constant for flipping is highly favorable. However, the maximal single-turnover rate 
constant could be limited by either the nucleotide flipping step or the N-glycosidic bond 
cleavage step for these mutants (Scheme 2.3).  
Stopped-Flow Fluorescence of εA 
To evaluate whether the Y127W or Y159W mutants alter the rate constants for DNA binding or 
nucleotide flipping, we performed rapid mixing experiments with εA-DNA. We used equimolar 
concentrations of DNA and protein far above the dissociation constant for DNA binding to 
monitor fluorescence changes in εA, as previously described for wild-type AAG (14). This 
experiment provides optimal signal for both binding and flipping steps and is necessary given 
the fast binding of AAG and the weak fluorescence of εA. Representative data are shown in 
Figure 2.5 (A & C). Both mutants exhibit transient increases and subsequent decreases in εA 
fluorescence similar to the two-step binding that was observed for wild-type AAG. We 
previously found that the first phase of the binding reaction is concentration-dependent, and 
reflects the initial binding of AAG to the site of damage. The second phase of the binding 
reaction is independent of DNA concentration and corresponds to the flipping of the εA lesion 
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Figure 2.5. Stopped-flow fluorescence to measure binding and nucleotide flipping by Y127W and 
Y159W mutants of AAG. Equimolar mixtures of AAG and εA-DNA were mixed in the stopped-flow (1 
µM after mixing) and either εA fluorescence or tryptophan fluorescence was measured as described in 
the Materials and Methods. (A) εA fluorescence for Y127W. (B) Tryptophan fluorescence for Y127W. 
(C) εA fluorescence for Y159W. (D) Tryptophan fluorescence for Y159W. The data is the average of 
three independent reactions and the lines indicate the best fits of Equation 2.6. The rate constants are 
given in Table 2.1.  
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into the active site pocket (14). 
For the Y127W mutant, the initial binding step yielded an observed rate constant that is 
similar to the rate constant for wild-type AAG under these conditions (Table 2.1). In contrast, 
the second step is approximately 3-fold slower for the mutant than for wild-type AAG. This 
observed rate constant is equal to the sum of the rate constants for the flipping and unflipping 
steps, because it is an approach to equilibrium (Equation 2.7). However, the results from 
dissociation experiments suggest that the rate constant for flipping is significantly faster than 
the rate constant for unflipping (see below). This indicates that the observed rate constant for 
the second phase of the reaction is approximately equal to the microscopic rate constant for 
flipping (kflip). Therefore, the Y127W mutation decreases the rate constant for flipping by a 
factor of 3-fold.  
The Y159W mutant showed a lower level of εA fluorescence in the transient formation 
of the initial intermediate. Given this decrease in signal it was more difficult to accurately 
measure the rate constant for the initial phase of the binding reaction, but the best fits yielded 
a binding rate constant that is also similar to that of wild-type and the Y127W mutant (Table 
2.1). Remarkably, the observed rate constant for the second phase of the reaction (flipping) is 
more than 5-fold faster for the Y159W mutant than for the wild-type protein.  This places an 
upper limit on the rate constant for flipping, but does not provide sufficient information to 
establish whether or not this mutation increases the rate constant for nucleotide flipping. This 
faster observed rate constant could also be explained by a 6000-fold increase in the reverse 
rate constant for flipping with no change in the forward rate constant for flipping. Therefore, 
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additional experiments were performed to resolve this ambiguity and to establish that the 
Y159W mutation does increase the rate constant for nucleotide flipping (see below). 
Stopped-Flow Fluorescence of Tryptophan 
We also followed the fluorescence of the tryptophan during the rapid mixing experiments, and 
the results are shown in Figure 2.5 (B & D). Control reactions in which the tryptophan 
fluorescence was recorded for wild-type AAG mixed with εA-DNA (295 nm excitation, 330/20 
nm emission) established that none of the three tryptophan residues present in AAG are 
sensitive to DNA binding (see Appendix A). When the Y127W and Y159W mutants were mixed 
with εA-DNA, two phases of decreasing fluorescence were observed (Figure 2.5 B & D). These 
data were fit by the same equation used to monitor εA fluorescence (Equation 2.6), and yielded 
almost identical rate constants as were observed for εA fluorescence changes. These 
experiments reveal that tryptophan at position 127 and 159 in the active site pocket are 
perturbed in the initial AAG•DNA complex, relative to when AAG is free in solution. The 
tryptophan quenching in the first phase, corresponding to formation of an initial recognition 
complex, is coincident with the increased fluorescence of εA, suggesting that the protein 
changes its local conformation as fast or faster than the DNA conformational change that is 
monitored by the εA fluorescence. In the second step, tryptophan residues at either position 
127 or 159 are quenched in the flipped-out complex with the same rate constant as the εA is 
quenched. This correlation is consistent with the simple model that the εA lesion interacts with 
the tyrosine or tryptophan residues at positions 127 and 159 (Figure 2.1). 
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Pulse-Chase Experiments to Determine the Rate of Substrate Dissociation 
As the nucleotide flipping step is an approach to equilibrium, it is important to measure the 
kinetics of the reaction in the reverse direction. Therefore, we performed pulse-chase 
experiments in which wild-type or mutant AAG proteins were initially mixed with fluorescently 
labeled εA-DNA and then chased with excess unlabeled εA-DNA (Figure 2.6). This experiment 
allows the partitioning between dissociation and base excision to be directly determined (see 
Materials and Methods). The wild-type protein gave the same results as previously reported, 
with 30% of the substrate partitioning forward to product and 70% dissociating. The 
dissociation of AAG from nonspecific DNA is relatively fast, and therefore the observed rate 
 
Figure 2.6. Pulse-chase experiments to measure dissociation of εA-DNA. The partitioning between 
the forward reaction (base excision) and substrate dissociation were measured for wild-type, Y127W, 
and Y159W AAG. Either wild-type (A) or mutant (B) AAG was mixed with fluorescein-labeled εA-DNA 
in the presence (open symbols) or absence (closed symbols) of excess unlabeled εA-DNA as described 
in the Materials and Methods. The fraction of fluorescent abasic DNA product was quantified using 
the standard gel-based glycosylase assay. For the wild-type enzyme approximately 30% of the εA-
DNA is committed to excision. In contrast, essentially all of the εA-DNA dissociated from both Y127W 
() and Y159W () mutant proteins under these conditions, indicating the kunflip is much greater 
than kchem (Scheme 2.3). 
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constant is simply the rate constant for unflipping [kobs = kunflip = 1.6 × 10
-3 s-1; (14)]. In contrast, 
the addition of chase completely blocked the reaction by the Y127W and Y159W mutants 
(Figure 2.6B). This indicates that the rate of substrate dissociation is much faster than the rate 
of N-glycosidic bond cleavage and places a lower limit on the rate of εA dissociation of 20-fold 
faster than the rate of N-glycosidic bond cleavage, assuming that 5% abasic product could have 
been detected. However, a much bigger effect on the unflipping rate could have been masked. 
Therefore, we adopted an alternative approach to measure the rate of substrate dissociation, 
and to determine the rate constant for the unflipping step with these mutant enzymes.  
Double-mixing Experiments to Measure Unflipping and Dissociation of εA-DNA 
We used double-mixing experiments to rapidly form the flipped-out AAG-DNA complex with the 
AEA substrate, and then challenge it with a tight-binding pyrrolidine-DNA competitor. 
Pyrrolidine is positively charged at the pH of these reactions and binds tightly to AAG as a 
transition state analog (12, 29). The change in fluorescence is adequately fit by a single 
exponential increase for both the Y127W and Y159W mutant proteins (Figure 2.7). We interpret 
these data as a rate-limiting unflipping step, followed by rapid dissociation of the nonspecific 
DNA. The small deviations from a simple exponential could be explained by a small amount of 
rebinding of εA-DNA. Consistent with this interpretation, experiments performed with a lower 
concentration of pyrrolidine-DNA chase resulted in a larger deviation from single exponential 
behavior (data not shown). The values of 0.12 s-1 for Y127W and 0.37 s-1 for Y159W are 75-fold 
and 250-fold faster than the rate of εA-unflipping for the wild-type protein (Table 2.1). 
Nevertheless, these unflipping rate constants are significantly slower than the observed rate 
constants for flipping, indicating that the observed rate constant for εA and tryptophan 
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quenching that we have assigned to the nucleotide flipping step is approximately equal to the 
microscopic rate constant for flipping (Equation 2.8). The ratio of the rate constants for flipping 
and unflipping yields the equilibrium constant for nucleotide flipping (Equation 2.4; Table 2.1).  
Single-turnover Excision of Hx 
The decreased stability of the flipped-out εA-DNA complex for the Y127W and Y159W mutants 
suggests that these mutations are likely to have a much larger deleterious effect on the flipping 
of more stably paired lesions. Therefore, we examined the single-turnover excision of Hx from 
the most favorable Hx•T context. Wild-type AAG catalyzes the excision of Hx with a rate 
constant that is 60-fold faster than the single-turnover excision of εA when T is the opposing 
base (Figure 2.8A; Table 2.1). This is very similar to the 54-fold difference that was reported 
 
Figure 2.7. Direct measurement of εA-DNA dissociation from Y127W and Y159W AAG. Double-
mixing experiments were performed using stopped-flow fluorescence. The AAG•DNA complex was 
formed, aged for one second, and then chased with an excess of pyrrolidine-DNA as a competitor. The 
normalized fluorescence was obtained by dividing the observed fluorescence signal by the 
fluorescence of the sample after the dissociation reaction was complete. The traces reflect the 
average of three separate mixing experiments and the solid lines depict the best fit to a single 
exponential. Only one out of every twenty data points is shown for clarity. The observed rate 
constants for dissociation are 0.12 s-1 for Y127W () and 0.37 s-1 for Y159W () mutant proteins. 
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previously at a higher temperature (3). In contrast, the single-turnover rate constants for the 
AAG mutant proteins are essentially identical for excision of both εA and Hx (Figure 2.8B; Table 
2.1). We believe this is a coincidence, because the single-turnover rate constants report on 
different steps for the excision of εA and Hx. For εA excision, the N-glycosidic bond cleavage 
step is likely to be rate-limiting. In the case of Hx excision, the observed rate constant is 
significantly smaller than the rate constant for the chemical step because there is an 
unfavorable equilibrium for nucleotide flipping (Equation 2.5). In the absence of direct 
measurements of nucleotide flipping for this lesion, it is also possible that the nucleotide 
flipping step becomes rate-limiting for these mutants. Importantly, the Y127W and Y159W 
mutations have severe (>100-fold) reductions in the observed rate constant for excision of Hx 
(Table 2.1). 
 
Figure 2.8. Single-turnover excision of Hx. The reaction progress curves are shown for wild-type (A), 
Y159W (), and Y127W () AAG (B). Note that the time scales are different for experiments with 
the wild-type and mutant proteins. Saturating amount of enzyme (1-5 µM) was always in excess over 
fluorescein-labeled DNA (50 nM). Reactions were followed in triplicate and the average values are 
shown; errors bars indicate one standard deviation. The lines indicate the best fit to a single 
exponential and the rate constants are reported in Table 2.1 (see Materials and Methods for details).  
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Discussion 
We mutated the two tyrosine residues in the AAG active site pocket to tryptophan in 
order to gain insight into the mechanism by which AAG recognizes DNA damage. Tryptophan 
was chosen as a conservative replacement with the intent of being able to directly monitor 
conformational changes and binding of base lesions in the active site. For both the Y127W and 
the Y159W mutant proteins, the changes in tryptophan fluorescence were coincident with the 
changes in εA fluorescence, supporting the previous assignments of the εA fluorescence 
changes to an initial recognition complex and to an excision-competent extrahelical complex 
(14). Although these mutants are efficient catalysts for the excision of εA lesions, the full kinetic 
analysis demonstrates that these mutations severely impair the equilibrium for flipping by AAG. 
The large perturbation of the equilibrium constant for nucleotide flipping explains why these 
mutations have a much larger deleterious effect on the excision of other lesions, such as Hx. 
Functional Consequences of the Y127W and Y159W Mutations 
We performed a pre-steady state kinetic analysis of the interaction of these mutant proteins 
with εA-DNA under the same conditions that were previously used to characterize wild-type 
AAG. These experiments provide an unambiguous kinetic characterization of the binding, 
flipping, and base excision steps (Scheme 2.3). The resulting microscopic rate constants are 
reported in Table 2.1, and can be used to calculate the free energy profile for the reactions 
catalyzed by wild-type and mutant forms of AAG (Figure 2.9). From this analysis it is apparent 
that the substitution of either tyrosine with tryptophan significantly destabilizes the active 
complex with the flipped-out εA lesion.  
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Perhaps the most remarkable finding is that the Y159W mutation conferred a 5-fold 
increase in the rate constant for flipping (Table 2.1). This could be due to a favorable interaction 
with the side chain of W159 that stabilizes the transition state for flipping of εA. The crystal 
structure of the wild-type protein shows a T-shaped interaction between Y159 and the εA 
lesion, and it may be possible for the slightly larger tryptophan to contact the lesion before it 
fully enters the nucleobase binding pocket (Figure 2.1). This faster flipping is countered by a 
much greater increase in the unflipping rate constant (200-fold; Table 2.1) and the overall 
equilibrium for nucleotide flipping is perturbed by 30-fold. This destabilization may be due to 
the loss of the hydroxyl moiety or to the slightly increased side chain volume of tryptophan 
 
 
 
Figure 2.9. Free energy profile to illustrate the effects of the Y127W and Y159W mutations on the 
AAG-catalyzed excision of εA. The relative barrier heights for wild-type (dark blue), Y127W (light 
blue), and Y159W (purple) were calculated as described in the Materials and Methods. Whereas 
there are relatively large effects on the nucleotide flipping step and the stability of the flipped-out 
nucleotide, similar destabilization of the transition state results in much more modest effects on the 
rate of N-glycosidic bond hydrolysis (kchem).  
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relative to tyrosine. In contrast, there is only a subtle effect on the rate constant for εA excision 
(3-fold; Table 2.1). As the equilibrium constant for flipping remains favorable, this suggests that 
the Y159W mutation has a very similar destabilizing effect in the ground state of the flipped-out 
complex as in the transition state for N-glycosidic bond cleavage (Figure 2.9). 
The Y127W mutation destabilizes the flipped-out complex to a greater extent than the 
Y159W mutation. Whereas there is a modest 2.4-fold decrease in the rate constant for flipping, 
the unflipping rate constant is increased by 60-fold, resulting in 140-fold decrease in the 
stability of the flipped-out complex. The Y127W mutant has only a 4-fold decreased rate 
constant for εA excision, relative to wild-type, which is very similar to the 3-fold deleterious 
effect of the Y159W mutation (Table 2.1). We conclude that the increase in the size of Y127 
from tyrosine to tryptophan does not greatly alter the transition state for flipping, but 
destabilizes the flipped-out εA-DNA complex by a similar extent in both the ground state and 
the transition state for N-glycosidic bond cleavage.  
Wild-type AAG has a highly favorable equilibrium for flipping of εA, and therefore the 
Y127W and Y159W mutant proteins retain favorable equilibrium constants for flipping despite 
the deleterious effects of these substitutions. This results in relatively small effects on the 
overall rates of εA excision by the Y127W and Y159W mutants. It is likely that the inability of εA 
to form hydrogen bonds with an opposing base facilitates this highly favorable flipping 
equilibrium. In contrast to εA, most of the lesions recognized by AAG, including 7-
methylguanine and Hx, do not appear to be bound stably in the flipped-out conformation by 
AAG (3, 25, 30). Consistent with this model, the Y127W and Y159W mutations have much larger 
deleterious effects of 520- and 140-fold for the excision of Hx from a Hx•T wobble pair (Table 
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2.1). These defects are larger by a factor of four than the defects in the flipping equilibrium for 
εA (Table 2.1), suggesting that the tryptophan mutations specifically compromise the 
positioning of Hx in the transition state for N-glycosidic bond cleavage. 
Insight Into the Mechanism of AAG-catalyzed Nucleotide Flipping 
Although the Y127W and Y159W mutations were more disruptive than expected, the 
characterization of these mutant proteins provided valuable insight into the mechanism of 
AAG-catalyzed nucleotide flipping. In spite of the large decreases in the stability of the flipped-
out, pre-hydrolysis complex, the stopped-flow fluorescence experiments showed that these 
mutant proteins exhibit the same two-state binding model as was observed for wild-type AAG. 
The same rate constants were observed for tryptophan and εA fluorescence with both mutants 
(Figure 2.5). These observations indicate the εA lesion and tryptophan side chains located in the 
AAG active site both report on the initial recognition complex and on the fully flipped, active 
complex. Structural and biochemical studies of two distinct DNA glycosylases, uracil DNA 
glycosylase (UNG) and 8-oxoguanine DNA glycosylase (OGG1) have suggested that these 
glycosylases have a pre-binding site for prospective damaged bases that has been referred to as 
the exosite (31-34). The finding that two different fluorescent reporters in the AAG active site 
report on an intermediate that forms prior to nucleotide flipping is consistent with a similar 
initial recognition complex in which a partially flipped εA lesion interacts directly with the 
tryptophan side chains at the active site. However, we cannot exclude the possibility that other 
conformational changes in the protein or in the DNA (perhaps accompanying DNA bending) are 
responsible for the concerted changes in εA and tryptophan fluorescence.  
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Substitution of tyrosine with tryptophan is expected to be a relatively conservative 
mutation, since both side chains occupy similar volumes and can make similar stacking 
interactions. However, positions 127 and 159 in homologs of human AAG are invariably 
tyrosine. Extensive mutagenesis of AAG and selection for active site variants that conferred 
resistance to DNA alkylating agents has identified hundreds of allowed mutations, but no active 
variants at position 127 and only two active variants at position 159 were identified (5, 21). The 
finding that Y159N and Y159C had detectable activity is consistent with the finding that Y159W 
has less severe defects on nucleotide flipping than Y127W. Another study sought to identify 
AAG mutants that increased the frequency of mutations and identified Y127I as conferring a 
strong mutator phenotype (11).  
We were surprised to find that the Y127W mutation has such severe defects in flipping, 
as a tryptophan side chain would be well-accommodated in the crystal structure of the εA-DNA 
complex (see Appendix A). Nevertheless, our results and the failure to observe active variants 
at this position point toward a very precise role in positioning the substrate in the flipped-out, 
active conformation. It is interesting that the Y127I mutation has been reported to exhibit only 
a 3-fold decrease in the single-turnover excision of εA, but a much greater decrease in the 
single-turnover excision of Hx (11). This is similar to the 4-fold defect in excision of εA that we 
measured for the Y127W mutant. It has been suggested that the mutator phenotype of Y127I is 
due to tighter binding to undamaged, bulged nucleotides that can occur from polymerase 
errors in repetitive sequences (11). It will be interesting to test whether the Y127I mutation 
changes the rate constants for flipping of normal bases, but this will require the development of 
new fluorescence-based assays. 
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Appendix A 
Additional data figures to support Chapter 2 
 
 
Figure A-1. Substitution of tyrosine with tryptophan can be accommodated in the AAG active 
site. Tyrosine 127 (A) and tyrosine 159 (B) were substituted with tryptophan and a rotamer was 
selected that avoided steric clashes with both DNA and protein side chains (Pymol). No energy 
minimization or additional modeling was performed, but these exercises suggest that the 
sligh3tly larger tryptophan side chains could be accommodated in the AAG active site without 
large-scale changes in other active site residues. 
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Figure A-2. Tryptophan fluorescence of wild-type AAG does not change upon binding to εA-
DNA. Stopped-flow fluorescence was monitored with 1 µM wild-type AAG and 1 µM εA-DNA, 
exactly as described for the Y159W and Y127W mutants with excision at 295 and a 330 nm (20 
nm band-pass) emission filter. The absence of time-dependent decrease in fluorescence 
indicates that the fluorescence of the native tryptophan residues do not change upon binding 
to DNA damage and that the changes in the fluorescence of Y127W and Y159W proteins can be 
ascribed to the new tryptophan residues present in the AAG active site. 
  
 
53 
 
 
 
 
Figure A-3. Stopped-flow fluorescence to measure binding and nucleotide flipping by Y127W 
and Y159W mutants of AAG. Equimolar mixtures of AAG and εA-DNA were mixed in the 
stopped-flow exactly as described for Figure 2.5 in the main text, except the concentrations 
were one half (0.5 µM after mixing). (A) εA fluorescence for Y127W. (B) Tryptophan 
fluorescence for Y127W. (C) εA fluorescence for Y159W. (D) Tryptophan fluorescence for 
Y159W.  The data is the average of three independent reactions and the lines indicate the best 
fits of Equation 2.6.  Several different concentrations between 0.125 µM and 1.0 µM (all 
concentrations given after mixing) gave the same rate constants, confirming that the 
concentration chosen was saturating for the mutant and wild-type proteins (data not shown). 
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Figure A-4. Kinetic parameters for DNA binding and nucleotide flipping by Y159W AAG. (A) 
Representative fit for εA association kinetics. (B) Representative fit for tryptophan (W) 
association kinetics. (C) Representative fit for εA dissociation kinetics.  (D) Table summarizing 
individual fits (Table 2.1 in the main text) and global analysis of curves shown in A-C (using 
Scheme 2.3 in the main text and the program Berkeley Madonna (BM)).  
 
  
Y159W Individual Fits BM εA Association BM W Association BM εA Dissociation 
kon (M
-1s-1) 3.1 x 108 2.2 x 108 2.8 x 108 1.6 x 108 
koff (s
-1) ND 25.2 35.8 10.0 
kflip (s
-1) 13.6 18.7 17.0 16.4 
kunflip (s
-1) 0.37 0.31 0.60 0.56 
Kflip 40 60 28 29 
D 
C B A 
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Figure A-5. Kinetic parameters for DNA binding and nucleotide flipping by Y127W AAG. (A) 
Representative fit for εA association kinetics. (B) Representative fit for tryptophan association 
kinetics. (C) Representative fit for εA dissociation kinetics. (D) Summary table summarizing 
individual fits (Table 2.1) and global fits shown in part A-C (using Scheme 2.3 in the main text 
and the program Berkeley Madonna). The rate constants for binding and dissociation are 
relatively poorly defined, but very similar flipping rate constants are observed in all fits. 
 
  
Y127W Individual Fits BM εA Association BM W Association BM εA Dissociation 
kon (M
-1s-1) 6.8 x 107 4.1 x 107 3.4 x 107 2.6 x 107 
koff (s
-1) ND 3.3 2.1 38.4 
kflip (s
-1) 1.1 0.9 1.0 1.6 
kunflip (s
-1) 0.12 0.10 0.21 0.10 
Kflip 9 9 5 16 
D 
C B A 
56 
 
 
Figure A-6. Single-turnover excision of εA for wild-type (WT) and mutant AAG. Essentially 
identical rate constants were obtained for excision of εA from TEC DNA (400 nM) and either 2 
µM () or 4 µM () of (A) wild-type AAG, (B) Y159W, and (C) Y127W. The lines indicate the 
best fit of a single exponential, as described in the main text, and yielded average values of 
0.048 min-1 for wild-type, 0.019 min-1 for Y159W, and 0.012 min-1 for Y127W AAG. 
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Figure A-7. Single-turnover excision of Hx for wild-type and mutant AAG. Essentially identical 
rate constants were obtained for excision of Hx from TIC DNA (400 nM) and either 3 µM () or 
5 µM () of wild-type AAG (A), Y159W (B), and Y127W (C). The lines indicate the best fit of a 
single exponential equation, and yield single- turnover rate constants (kmax) of 2.94 min
-1 for 
wild-type, 0.017 min-1 for Y159W, and 0.0052 min-1 for Y127W AAG. 
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CHAPTER 3 
Critical Role of DNA Intercalation in Enzyme-catalyzed Nucleotide Flipping 
 
Although DNA is a remarkably stable molecule, it is nevertheless subject to damage by a 
variety of reactive intracellular and environmental agents. DNA damage can alter gene 
expression, affect epigenetic profiles, and even cause cell death (3, 4). To recognize and repair 
DNA, enzymes must gain access to damaged bases that are normally embedded in the duplex.  
This is aided by a process called nucleotide flipping that involves the complete 180° rotation of 
a nucleotide into the enzyme active site (5). It is proposed that both DNA bending and DNA 
intercalation are important for nucleotide flipping (5, 6). Even though nucleotide flipping is 
prevalent among DNA repair enzymes, the mechanism is not well understood. In particular, the 
timing and the energetic contributions provided by DNA intercalation are not known.  
Human alkyladenine DNA glycosylase (AAG), also known as methylpurine DNA 
glycosylase (MPG), is one of many enzymes that use nucleotide flipping to engage substrates. 
AAG initiates the base excision repair (BER) pathway by locating sites of damage and catalyzing 
the hydrolysis of the N-glycosidic bond to release the damaged base (8). This monomeric repair 
protein is responsible for removing a diverse set of alkylated and deaminated purine lesions (9-
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12). One of the lesions that is most efficiently excised by AAG is 1,N6-ethenoadenine (εA) that is 
formed by lipid oxidation or exposure to exogenous alkylating agents (12, 13). The minimal 
kinetic mechanism for multi-step recognition of εA damage has been reported, including the 
rate of nucleotide flipping which was directly monitored by fluorescence to follow changes in 
the intrinsic fluorescence of εA (14, 15). Given the excess of undamaged DNA, initial binding of 
AAG is not at the site of damage (Figure 3.1C). AAG uses nonspecific binding and facilitated 
 
Figure 3.1. Nucleotide flipping by AAG. (A) Crystal structure of human alkyladenine DNA glycosylase 
(E125Q) bound to εA-containing DNA (1, 2). Image was rendered with Pymol (http://www.pymol.org) 
using coordinates from the PDB (1EWN). The εA base is flipped into the active site, and the 
intercalating residue (Y162) is shown in red. (B) Sequences of the 25mer oligonucleotide substrates. 
(C) Minimal mechanism for the initiation of base excision repair. AAG (crescent) binds to nonspecific 
DNA and rapidly searches for DNA damage. This searching process is described by the macroscopic 
rate constant kfind. Once a lesion (solid rectangle) is encountered in an initial recognition complex, it 
can be flipped into the enzyme active site to form the specific recognition complex. In this specific 
complex, Y162 (red circle) intercalates into the DNA where it takes the place of the extrahelical 
lesion. AAG catalyzes hydrolysis of the N-glycosidic bond (kchem) from this complex. 
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diffusion (16) to search for sites of damage. Once an εA is found, AAG forms an initial 
recognition complex that is accompanied by changes in the stacking of the lesion base (14). 
From this intermediate, AAG catalyzes nucleotide flipping to form a more stable specific 
recognition complex that positions the substrate for N-glycosidic bond cleavage, which releases 
the damaged base (2). Multi-step recognition provides multiple opportunities for discrimination 
between damaged and undamaged nucleotides and similar mechanisms have been proposed 
for independently evolved DNA repair glycosylases, including 8-oxoguanine DNA glycosylases 
and uracil DNA glycosylases (17-20). 
Crystal structures of AAG bound to εA-DNA revealed that the DNA is bent in the specific 
recognition complex and a tyrosine (Y162) intercalates into the space left by the flipped-out 
damaged nucleotide (Figure 3.1A; (1, 2)). Similar intercalating interactions are observed in all 
nucleotide flipping enzymes, but the identity of the intercalating amino acid varies and the 
function(s) of the intercalating residue remains unknown (21, 22). The two models for how DNA 
intercalation could contribute to nucleotide flipping have been described as “pushing” and 
“plugging”(23-25). In the pushing model, DNA intercalation destabilizes the DNA duplex to 
accelerate nucleotide flipping. In the plugging model, DNA intercalation occurs subsequent to 
nucleotide flipping and provides a barrier to the return of the nucleotide to the duplex, 
effectively slowing the rate of unflipping. These two mechanisms are not mutually exclusive, 
and both models can be addressed by kinetic studies of proteins in which the identity of the 
intercalating residue has been varied. 
We investigated the functional contributions of the intercalating residue to each of the 
steps in the AAG catalytic mechanism by mutating the intercalating tyrosine residue to 
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phenylalanine (Y162F) and alanine (Y162A). Remarkably, the Y162A mutation increases the rate 
of nucleotide flipping by 50-fold relative to wild-type (WT) AAG. This mutant also exhibits faster 
unflipping, resulting in a 140-fold reduction in the equilibrium constant for formation of the 
flipped-out complex. In contrast, the kinetic parameters for the Y162F and wild-type enzymes 
are very similar, suggesting that the hydroxyl of tyrosine is not necessary for function. These 
results establish that DNA intercalation contributes to the specific recognition of DNA damage 
by acting as a plug to stabilize the specific recognition complex. DNA intercalation stabilizes the 
initial recognition complex without providing a push, slowing the rate of nucleotide flipping. 
Nevertheless, tyrosine 162 plays a critical role in the discrimination between damaged and 
undamaged nucleotides, by increasing the amount of the extrahelical lesion recognition 
complex and enabling efficient repair of rare sites of damage. 
Materials and Methods 
Purification of Wild-type and Mutant AAG Proteins. The catalytic domain of human AAG that 
lacks the first 79 amino acids was expressed in E. coli and purified as previously described (26). 
The Y162F and Y162A mutants were constructed by site-directed mutagenesis and purified 
using the same protocol. The concentration of Y162A AAG was determined from the UV 
absorbance and predicted extinction coefficient and the concentration of wild-type and Y162F 
AAG were determined by active site burst (16). 
Synthesis and Purification of Oligodeoxynucleotides. Oligonucleotides were synthesized by 
Integrated DNA Technologies or the W.M. Keck Facility at Yale University, were purified and the 
concentrations determined from the calculated extinction coefficients as previously described 
(16). Duplexes were annealed with a 1.2-fold excess of the unmodified complement by heating 
62 
 
to 90 °C and cooling slowly to 4 °C. Two different sequence contexts were used and these are 
referred to by the central three nucleotides (i.e., TEC has a central εA lesion flanked by a 5’T 
and a 3’C; Figure 3.1B). 
Steady-State Fluorescence Measurements. Fluorescence emission spectra were collected with 
a PTI QuantaMaster fluorometer controlled by FeliX software. For εA fluorescence, an 
excitation wavelength of 314 nm (6 nm band-pass) was used and the total fluorescence was 
measured at emission wavelengths from 340-480 nm (6 nm band-pass). Samples (300 µL) of 
400 nM εA-containing DNA were prepared in the standard buffer [50 mM NaMES (pH 6.5), 100 
mM NaCl, 1 mM EDTA, 1 mM DTT] and spectra were recorded at 25 °C. To determine the 
steady-state fluorescence of εA-containing DNA bound to AAG, the spectra were recorded 
within one minute to ensure that no significant excision of εA occurred. Four independent 
titrations were averaged, and the data were fit by a quadratic equation assuming tight binding 
by AAG (Equation 3.1), in which Frel is the relative fluorescence, A is the fractional quenching, 
and Kd is the dissociation constant for the εA-DNA.  
2E
DNA)(4EDNA)E(KDNA)EA(K
1F
2
dd
rel

  (3.1) 
Gel-based Glycosylase Assay. Single-turnover glycosylase activity was measured with a 
discontinuous assay that utilizes abasic site cleavage by NaOH followed by DNA separation on a 
denaturing polyacrylamide gel (14). Fluorescein-labeled (5’-6-fam) DNA substrates (50 nM) 
containing εA were prepared in the standard buffer. Reactions were initiated with the addition 
of 75 nM – 600 nM AAG and incubated at 25 °C. At various time points, a sample from the 
reaction was removed and quenched in 2 volumes of 0.3 M NaOH, giving a final hydroxide 
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concentration of 0.2 M. The abasic sites were cleaved by heating at 70 °C for 15 minutes. 
Samples were mixed with an equal volume of formamide/EDTA loading buffer before loading 
onto a 15% polyacrylamide gel. Gels were scanned with a Typhoon Imager (GE Trio+ 
Healthcare) to detect the fluorescein label by exciting at 488 nm and measuring emission with a 
520BP40 filter. The gel bands were quantified using ImageQuant TL (GE Healthcare). The data 
were converted to fraction product [Fraction Product = product / (product + substrate)] and 
then fit by a single exponential (Equation 3.2) using Kaleidagraph (Synergy Software). Single-
turnover rates were independent of the concentration of AAG, indicating that the maximal rate 
constant was measured (kobs = kmax; see Appendix B). 
Fraction product   A(1 - e-kobst)    (3.2)  
 To measure competition between εA-DNA and undamaged DNA, single-turnover 
reactions containing 200 nM fluorescein-labeled εA DNA and 0–50 µM undamaged DNA, in 
which the εA was replaced by a normal A, were initiated with the addition of 300 nM AAG. Data 
for Y162A AAG was fit by an IC50 equation (Equation 3.3); wild-type and Y162F AAG were fit by a 
line with a slope of zero.    
Activity   
1
1 [I] IC50
                   (3.3) 
Stopped-Flow Kinetics. Pre-steady state kinetic experiments were performed on a Hi-Tech SF-
61DSX2, controlled by Kinetic Studio (TgK Scientific). The fluorescence of εA was measured 
using an excitation wavelength of 313 nm and a WG360 long-pass emission filter (14, 15). At 
least three traces were averaged together at each concentration. The traces for wild-type and 
Y162F AAG were fit by a triple exponential (Equation 3.4) where F is the fluorescence as a 
function of time, C is the fluorescence of free DNA, X, Y, and Z are the changes in fluorescence 
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of the intermediates, and t is the time. The traces for Y162A AAG were fit by a single 
exponential (Equation 3.2) and kobs is equal to kflip + kunflip.  
)e-Z(1- )e-Y(1-)e-X(1-C=F
t-kt-kt-k obs2,obs2,obs1,     (3.4) 
Observed rate constants were plotted versus concentration and fit by a straight line. k1,obs 
showed a linear concentration dependence, and the slope is equal to kon (M
-1s-1). Negative y-
intercepts were observed under these conditions. Similar negative intercepts were reported for 
another DNA binding protein with high affinity for DNA (7). The value of k2,obs was independent 
of concentration and is equal to kflip + kunflip.  
Pulse-Chase Assay to Measure Substrate Dissociation. The macroscopic rate constant for 
dissociation of wild-type and mutant AAG from εA-containing DNA was measured by pulse-
chase in the standard reaction buffer at 25 °C as previously described for wild-type AAG (14, 
15). In 20 μL reactions, 50 nM fluorescein-labeled TEC DNA was mixed with 300 nM or 600 nM 
AAG for 20 seconds, and then a chase of 10 μM pyrrolidine-containing DNA was added. 
Pyrrolidine binds tightly to AAG as a transition state analogue (1, 27). At various time points, a 
sample from the reaction was removed to evaluate the partitioning of a bound E•S complex 
between N-glycosidic bond hydrolysis and dissociation with the standard glycosylase assay. The 
fraction of product was fit by a single exponential (Equation 3.2). Control reactions in which no 
chase was added provided the single-turnover rate constant, kmax, and confirmed that these 
concentrations of AAG were saturating. From these values, the dissociation rate constant, koff, 
for AAG dissociating from εA-DNA was calculated as previously described (14, 15). The 
rearranged equation is indicated by Equation 3.5, in which A is the burst amplitude (the fraction 
of product formed in the burst phase of the experiment), kmax is the single-turnover rate 
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constant for formation of product, and koff,obs is the macroscopic rate constant for dissociation 
from the flipped-out complex.    
max
max
obsoff, k
A
k
k       (3.5) 
Since the εA-DNA binds in two steps, the observed rate constant for dissociation of 
substrate (koff, obs) could be limited by the unflipping rate (kunflip) or dissociation from nonspecific 
DNA (koff). According to Figure 3.1C, and assuming that the flipped-out complex is stable (i.e., 
kflip >> kunflip), this observed dissociation rate constant can be expressed in terms of the 
microscopic rate constants (Equation 3.6; (28)). Given rapid dissociation from nonspecific DNA, 
the observed rate of dissociation from the εA-DNA•AAG complex is approximately equal to the 
reverse rate constant for flipping (koff,obs ≈ kunflip).  








 flipoff
off
unflipobsoff,
kk
k
k=k     (3.6)  
Direct Measurement of Substrate Dissociation. Stopped-flow double-mixing experiments 
were performed to measure unflipping and dissociation of εA-DNA by Y162A. To rapidly form 
the flipped-out AAG-DNA complex, 2.8 µM AEA DNA was mixed with 2 µM Y162A. After an 
aging time of one second, 18 µM or 36 μM pyrrolidine-DNA was added as a competitor. The 
final concentrations after mixing were 700 nM AEA DNA, 500 nM Y162A, and 9 µM or 18 μM 
pyrrolidine-DNA. The reaction was followed for 10 seconds; no significant excision of εA occurs 
during this time. Three traces were averaged together and the change in fluorescence was fit by 
a single exponential (Equation 3.2). As described for the pulse-chase assay, the observed rate 
constant for dissociation is equal to the rate constant for unflipping. 
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Results 
Binding and Excision of εA by AAG Mutants 
We used site-directed mutagenesis to create Y162F and Y162A variants, and characterized their 
ability to bind and excise εA from synthetic 25mer oligonucleotides containing a central εA•T 
mismatch. Unless otherwise indicated, the previously characterized TEC sequence context was 
used (Figure 3.1B). As AAG has a relatively slow rate of base excision, steady-state fluorescence 
titrations could be used to measure binding of active enzyme to εA-DNA (14). For this 
experiment it is advantageous to use a DNA sequence with high εA fluorescence (AEA), and the 
stable binding of the extrahelical εA lesion results in a 5-fold quenching of fluorescence for 
wild-type AAG (Figure 3.2A). Titrations of Y162A and Y162F AAG showed somewhat less 
quenching of εA-fluorescence (2–3-fold), but nonetheless indicate tight binding of εA-DNA. The 
similar 1:1 stoichiometry at the equivalence point validates the protein concentrations that 
were determined either by UV absorbance or burst analysis.  
 To evaluate if the mutant proteins retain catalytic activity, single-turnover experiments 
were performed with enzyme in excess over εA-DNA substrate (Figure 3.2B). For wild-type AAG 
the single-turnover rate constant reflects the N-glycosidic bond hydrolysis step (14). The rate 
constant for wild-type AAG (0.05 min-1) matches the previously reported value (14, 15). The 
rate constant for excision of εA by Y162F (0.03 min-1) is similar to wild-type, consistent with 
reports that the Y162F mutation is well tolerated (29, 30). We were surprised to find that the 
rate constant for excision of εA is only slightly smaller for Y162A AAG (0.02 min-1), because 
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previous work suggested that this mutant may lack catalytic activity (2). The similar rate 
constants for base excision strongly suggest that the active site is not disrupted by these 
mutations, but larger effects on recognition and flipping of the damaged base could be masked 
by the high affinity binding of AAG to εA-DNA. Therefore, it is important to measure individual 
reaction steps to address the question of how DNA intercalation by Y162 contributes to 
recognition and flipping of damaged nucleotides.  
Stopped-flow Fluorescence to Monitor Binding and Flipping of εA-DNA 
We performed rapid mixing experiments of wild-type and mutant enzymes with εA-DNA to 
determine the rate constants for association and flipping. By improving the sensitivity of the 
stopped-flow, we were able to make measurements over a wider concentration range than was 
 
 
Figure 3.2. Binding and excision of εA by AAG. (A) Titration of 0.4 µM εA-DNA with wild-type and 
mutant AAG proteins. Steady-state fluorescence was monitored within one minute, before excision 
can occur, and normalized by dividing by the fluorescence of free DNA. Wild-type and mutants show 
tight binding to εA-DNA (Equation 3.1). (B) Single-turnover excision of εA by wild-type and mutant 
AAG with 50 nM DNA and saturating (300 nM) enzyme was fit by a single exponential (Equation 3.2) 
to obtain the rate constants for N-glycosidic bond cleavage (Table 3.1). Data points are the average ± 
SD from three independent experiments. 
 
68 
 
previously possible (14, 15). When εA-DNA was mixed with excess wild-type AAG, we observed 
an initial increase in fluorescence that was followed by a decrease in fluorescence (Figure 3.3A). 
The first phase is linearly dependent on the enzyme concentration (Figure 3.3C) and this was 
previously assigned to binding and formation of the initial recognition complex (14). The second 
phase is independent of concentration and corresponds to nucleotide flipping to form the 
specific recognition complex (Figure 3.4D). We often observed a much slower third phase, with 
a small change in amplitude, that may reflect an artifact such as photobleaching. This phase 
was not observed in all experiments and was not reproducible. When three phases were 
observed, we fit the traces by a triple exponential (Equation 3.4), because this gives the most 
consistent fits to the first two phases (see Appendix B for representative rate constants). 
Experiments with Y162F AAG yielded very similar results as the wild-type enzyme, with a 
transient increase in εA-fluorescence followed by a decrease in fluorescence (Figure 3.3B). Both 
the second order rate constant for the binding step (Figure 3.3C), and the observed first order 
rate constant for formation of the flipped-out specific recognition complex (Figure 3.3D) are 2-
fold larger for the Y162F mutant as compared to wild-type (Table 3.1). 
We previously noted that the initial recognition complex, in which the εA lesion is 
partially unstacked, appears to form with the bimolecular rate constant for association (14). As 
AAG uses facilitated diffusion to search for sites of damage (16), the searching steps must be 
faster than the association with nonspecific DNA (Figure 3.1C). We hypothesized that this fast 
searching could be due to multiple proteins simultaneously searching for the εA site under 
conditions of excess protein. This suggests that the searching time by a single protein would be 
significantly slower. Therefore, we also performed stopped-flow association experiments in 
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Table 3.1. Kinetic parameters for recognition and excision of εAa  
 Wild-type Y162F Y162A 
kon (M
-1s-1) (1.1 ± 0.03) x 109 (2.1 ± 0.2) x 109 Fastd 
kfind (s
-1) 116 ± 11 114 ± 4 Fastd 
kflip (s
-1) 3.6 ± 0.7 (3.6 ± 0.3)c 7.9 ± 1.0 (7.4 ± 0.5)c 170 ± 16e 
kunflip (s
-1) (1.6 ± 0.3) x 10-3 (4.6 ± 0.2) x 10-3 10 ± 1f 
Kflip
b 2300 1700 17 
kchem (s
-1) (8.0 ± 0.6) x 10-4 (4.3 ± 0.2) x 10-4 (3.8 ± 0.1) x 10-4 
 
aRate constants were determined from changes in εA fluorescence or glycosylase activity 
using the TEC oligonucleotide, unless otherwise indicated. The standard conditions were 25 
oC, 50 mM NaMES (pH 6.5), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT.  
 
bThe equilibrium constant for flipping is given by the ratio of the flipping and unflipping rate 
constants (Kflip = kflip/kunflip).  
 
cValues from stopped-flow experiments with excess protein (values with excess DNA are in 
parenthesis).  
 
dkon and kfind are too fast to measure for Y162A.  
 
eA value of 66 ± 2 s-1 was determined for the AEA oligonucleotide with excess protein 
(Figure 3.5D).  
 
fThe AEA oligonucleotide was used, because it gives a larger change in fluorescence (Figure 
3.6B).     
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Figure 3.3. Stopped-flow fluorescence with excess protein to measure binding and nucleotide 
flipping by wild-type and Y162F AAG. Representative data from experiments in which 50 nM TEC 
DNA was mixed with wild-type (A) or Y162F (B). Traces are the average of three binding reactions 
and are fit by the sum of exponentials (Equation 3.4). (C) The rate constant for the first phase of the 
binding reaction (k1,obs) is dependent on the concentration of AAG and a linear fit yields the 
bimolecular rate constant for binding (kon) with the values summarized in Table 3.1. It is notable that 
the intercepts are negative, similar to what has been observed in another case of extremely fast and 
tight binding (7). (D) The rate constants for the second phase of the binding reaction (k2,obs) are 
independent of the concentration of AAG and reflect the sum of the forward and reverse rate 
constants for nucleotide flipping. Rate constants in C and D are from three independent experiments 
(average ± SD).  
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which εA-DNA was in excess over wild-type (Figure 3.4A) or Y162F AAG (Figure 3.4B). Although 
the fraction of DNA that is bound is much smaller under these conditions, there is sufficient 
signal to accurately measure protein binding. As was observed for conditions of excess protein, 
the individual fluorescence traces showed biphasic increase and decrease in fluorescence, but 
now the first observed rate constant was independent of concentration (Figure 3.4C). We 
designate this observed rate constant as kfind, the macroscopic rate constant for the rapidly 
reversible searching steps that culminate in the formation of the initial recognition complex 
(Figure 3.1C). The Y162F mutation did not alter the searching process significantly (Figure 3.4C; 
kfind = 114 s
-1). The observed rate constant for the formation of the flipped-out specific 
recognition complex when there was excess DNA was the same within error as when there was 
excess protein (Figure 3.4D; Table 3.1). This indicates that excess protein does not interfere 
with nucleotide flipping. 
Association experiments with Y162A AAG yielded surprisingly different fluorescence 
traces. When excess Y162A AAG was mixed with εA-DNA (TEC), only a single time dependent 
decrease in fluorescence was observed (Figure 3.5A). Even at low concentrations of protein, the 
first phase of the reaction was complete in the dead time of the stopped-flow (kon ≥ 10
9 M-1s-1). 
The exponential decrease in fluorescence, which indicates formation of the flipped-out specific 
recognition complex, was independent of concentration and much faster than either the wild-
type or Y162F AAG (Figure 3.5D, orange symbols). The changes in fluorescence were quite small 
for the TEC DNA. Therefore we also measured association kinetics for the AEA DNA with excess 
protein (Figure 3.5B) and with excess DNA (Figure 3.5C). For the Y162A mutant protein, almost 
identical rate constants were observed whether protein or DNA was in excess (Figure 3.5D, blue 
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Figure 3.4. Stopped-flow fluorescence with excess DNA to measure kfind for wild-type and Y162F 
AAG. Conditions of excess DNA ensure that binding events involve only a single protein. 
Representative data from experiments in which 100 nM of wild-type (A) or Y162F (B) protein was 
mixed with increasing concentrations of TEC DNA. The εA-fluorescence was collected and fit by 
Equation 3.4 as described for Figure 3.3. (C) With excess DNA, the rate constant for the first phase 
(k1,obs) is independent of concentration and is designated kfind. (D) The rate constant for the second 
phase (k2,obs) is also concentration independent and corresponds to nucleotide flipping. This value is 
identical to that measured in stopped-flow experiments with excess protein (Table 3.1). Rate 
constants in C and D are from three independent experiments (average ± SD).  
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Figure 3.5. Stopped-flow fluorescence to measure nucleotide flipping by Y162A AAG. 
Representative reactions in which 100 nM of TEC (A) or AEA (B) εA-DNA was mixed with increasing 
concentrations of excess Y162A protein. (C) Representative data for binding of 100 nM Y162A AAG 
with increasing concentrations of AEA DNA. In each case, the changes in fluorescence were fit by a 
single exponential. (D) Observed rate constants from three independent experiments are plotted as 
a function of concentration (average ± SD). Remarkably, this rate constant (kobs = kflip + kunflip) is much 
larger for Y162A than for the wild-type enzyme. The initial binding and the formation of the initial 
recognition complex are not observed, indicating that they are both faster than the nucleotide 
flipping step.   
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symbols). These data indicate that Y162A AAG associates with nonspecific DNA and searches 
significantly faster than the wild-type enzyme, such that the searching step is not rate-limiting 
under any of the conditions tested. Remarkably, the observed flipping step is also significantly 
faster for the Y162A mutant than for wild-type AAG (50-fold faster for the TEC DNA; Table 3.1). 
Measurement of Unflipping and Dissociation of εA-DNA 
As the binding and nucleotide flipping steps are reversible, the observed association is affected 
by both forward and reverse rates. Therefore, it is necessary to measure the dissociation 
kinetics to define individual microscopic rate and equilibrium constants. The dissociation of 
AAG from εA-containing DNA was investigated using the pulse-chase method, whereby the 
AAG•εA-DNA complex is allowed to form and is subsequently chased with an excess of tight 
binding pyrrolidine-DNA inhibitor (27). Any AAG that dissociates is bound to the inhibitor, 
allowing measurement of the partitioning forward (abasic DNA product) and backward (εA-DNA 
substrate) as previously described (14, 15). For wild-type AAG, 30% of the complex partitions 
forward to produce product and 70% dissociates (Figure 3.6A). Assuming that dissociation of 
AAG from nonspecific DNA is fast, these data yield the microscopic rate constant for unflipping  
(Equation 3.6). More complete analysis is consistent with fast dissociation from nonspecific 
DNA (see Appendix B). The Y162F mutant showed greater dissociation of the substrate (90% 
dissociated; Figure 3.6A), indicating a 3-fold faster value of kunflip compared to wild-type (Table 
3.1). In contrast, 100% of the Y162A mutant dissociated and no product could be detected in 
the presence of chase (Figure 3.6A), indicating that unflipping is much faster than N-glycosidic 
bond cleavage. In order to precisely measure the rate of unflipping for the Y162A mutant we 
next performed a double-mixing experiment in the stopped-flow.  
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In the double-mixing experiment, the flipped-out complex of Y162A AAG with εA-DNA 
was formed and then challenged with pyrrolidine-DNA competitor (Figure 3.6B; inset scheme). 
The time-dependent increase in εA fluorescence is fit by a single exponential, which 
corresponds to the rate-limiting unflipping step. This experiment reveals that the rate of εA 
unflipping for Y162A AAG (kunflip = 10.3 s
-1) is 6,000-fold faster than that of wild-type AAG (Table 
3.1). Although the Y162A mutation causes only a modest defect in glycosylase activity towards 
εA, it imparts a dramatic effect on nucleotide unflipping. This observation supports the model 
that tyrosine intercalation acts as a plug to block the unflipping of εA. 
 
 
Figure 3.6. Pulse-chase experiments to measure dissociation of εA-DNA. (A) The partitioning 
between the forward reaction (base excision) and substrate dissociation was measured using a gel-
based assay. The commitment for wild-type (30%), Y126F (8%), and Y162A (0%) were used to 
calculate the rates of unflipping (see Materials and Methods). The low commitment for Y162F AAG 
was reproducible and readily distinguished from the control in which chase and substrate are added 
at the same time (see Appendix B). (B) Double-mixing experiments were performed using stopped-
flow fluorescence to monitor the increase in fluorescence upon release of εA-DNA. The AAG•DNA 
complex was formed, aged for one second, and then chased with an excess of pyrrolidine-DNA as a 
competitor. The data were fit by a single exponential and the average ± SD from three independent 
experiments is included in Table 3.1.  
 
76 
 
With the rate constants for unflipping in hand, the rate and equilibrium constants for 
nucleotide flipping could be determined for wild-type and mutant enzymes (Table 3.1). The 
microscopic rate constant for flipping was calculated from the observed rate constant for 
formation of the extrahelical complex (kflip = k2,obs - kunflip), and the equilibrium constant for 
nucleotide flipping is the ratio of the two values (Kflip = kflip/kunflip). The Y162F mutant exhibits a 
Kflip value that is almost identical to wild-type AAG, with 2-fold faster rates for both flipping and 
unflipping. In contrast, the Y162A mutant has a greatly reduced equilibrium constant for 
flipping that is 140-fold less favorable than that of the wild-type enzyme. The destabilization of 
the specific recognition complex is caused by a 6,000-fold increased rate of unflipping that is 
only partially balanced by a 50-fold increased rate of flipping (Table 3.1). Thus, kinetic 
characterization supports the model that tyrosine serves as a plug and argues against the 
pushing mechanism. Instead of pushing, the intercalation of tyrosine stabilizes the initial 
recognition complex and effectively slows the nucleotide flipping transition to the stable 
specific recognition complex.  
Competition Between εA-DNA and Undamaged DNA 
Although Y162A exhibits only a modest decrease in single-turnover glycosylase activity, the 
decreased stability of the flipped-out complex suggests that this mutant would be unable to 
efficiently find sites of εA damage when sites of damage are rare. We tested this hypothesis by 
using undamaged DNA as a competitor. Under single-turnover conditions, with enzyme in 
excess over the εA-labeled DNA substrate, the single-turnover rate constant for εA excision by 
wild-type and Y162F AAG was unchanged in the presence of excess undamaged DNA (Figure 
3.7). In contrast, Y162A AAG is inhibited by undamaged DNA with an IC50 value of 20 µM. This 
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concentration of undamaged DNA corresponds to 5,000-fold excess of undamaged over 
damaged nucleotides, which is far below the expected ratio of undamaged to damaged sites in 
the human genome. Thus, Y162A is less efficient than the wild-type protein at repairing sites of 
damage when sites of damage are rare. 
Discussion 
Structures of DNA repair glycosylases in complex with DNA suggest that nucleotide 
flipping is aided by intercalating residues (1, 5, 21, 25). The prevalence of nucleotide flipping 
and the dramatic nature of the conformational change that accompanies DNA bending and 
nucleotide flipping have captured the interest of biologists and chemists alike. However, little is 
known about the fundamental mechanisms by which nucleotide flipping is accomplished 
 
 
Figure 3.7. Competition between εA-DNA and undamaged DNA. Single-turnover excision of εA by 
wild-type and mutant AAG was measured as described in Figure 3.2B with 200 nM εA-DNA, 300 nM 
enzyme, and the indicated concentration of undamaged DNA. The observed rate constants were 
normalized by dividing by the rate constant in the absence of competitor (average ± SD; three 
independent experiments). Wild-type and Y162F AAG are unaffected by the presence of excess 
undamaged DNA. In contrast, Y162A AAG is inhibited by the addition of competitor DNA (IC50 = 20 
µM).  
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because it is difficult to observe rapid conformational changes that occur on the millisecond 
time scale. To understand the contribution of DNA intercalation to the energetic landscape for 
specific recognition and nucleotide flipping, we performed comprehensive kinetic analysis of 
mutant forms of AAG in which the conserved intercalating tyrosine (Y162) was mutated. These 
results provide support for the model that intercalation by an aromatic side chain greatly 
stabilizes the extrahelical conformation of the specific recognition complex. Unexpectedly, we 
further identify a role for Y162 in slowing the rate of nucleotide flipping, apparently by 
stabilizing the initial recognition complex. The new model that emerges suggests that DNA 
intercalation contributes to the specificity of AAG, but the increased specificity comes at the 
cost of reduced speed. These results provide new insight into the mechanism of AAG, and have 
implications for many other enzymes that use nucleotide flipping for DNA repair or epigenetic 
DNA modification. 
Kinetic Mechanism of AAG 
Since crystal structures cannot capture the dynamic nature of DNA glycosylases, spectroscopic 
assays are needed to elucidate reaction mechanisms. Previous work found that AAG and other 
DNA glycosylases use multi-step recognition to distinguish damaged sites from among an excess 
of undamaged sites (14, 15, 21, 31). We performed a series of transient kinetic experiments to 
dissect the individual steps of binding, searching, flipping, and base excision by AAG (Figure 
3.1C). Our results with the wild-type enzyme are in agreement with previously reported values 
(14), but we have gained new insight into the DNA searching process by directly measuring the 
rate of searching under conditions of excess DNA.  
79 
 
 By employing a DNA sequence context in which the εA lesion is quenched (TEC), we 
observed a transient intermediate in which the εA is less strongly quenched and presumably 
partially unstacked (Figure 3.3A). Although binding of AAG to the εA lesion appears to be a 
bimolecular reaction (Figure 3.3C), we favor the model that nonspecific DNA binding and rapid 
facilitated diffusion allow AAG to locate and bind the damaged nucleotide. Under the 
conditions of excess protein that are most commonly employed to monitor labeled DNA, 
simultaneous searching by multiple AAG molecules makes this searching step too fast to detect 
(14). We have modeled searching by multiple proteins explicitly to show that an additive model, 
in which two proteins search twice as fast as one protein, is consistent with the experimental 
data (see Appendix B). To directly measure the searching by a single molecule of AAG we 
employed conditions of excess DNA (Figure 3.4). Under these conditions the initial recognition 
complex is formed with a unimolecular rate constant of 120 s-1 (Table 3.1). This observed rate 
constant (kfind) is equal to the sum of the rate constants for finding and leaving the site of 
damage. For wild-type AAG this initial recognition complex is significantly populated, indicating 
that the rate of finding the εA site is faster than the rate of leaving the site. 
 Although multiple AAG molecules can bind to a single oligonucleotide, the observed rate 
constant for nucleotide flipping is identical under conditions of excess DNA or excess protein 
(Table 3.1). This indicates that multiple proteins do not affect the flipping step and that rate 
constants obtained in experiments with multiple or single proteins bound can be directly 
compared. To define the microscopic rate constants for flipping and the equilibrium constant 
for flipping, the dissociation of the bound εA-DNA must also be measured. Wild-type AAG has a 
very slow rate of unflipping and an extremely favorable equilibrium constant for stabilizing the 
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flipped-out nucleotide (Table 3.1). AAG compensates for slow N-glycosidic bond cleavage by 
binding very tightly to εA. We tested the specificity of AAG by employing conditions with 
12,500-fold excess of undamaged sites (50 µM undamaged oligonucleotide) and found that the 
observed rate of εA excision was unaffected (Figure 3.7).  
Contributions of DNA Intercalation by Tyr 162 
We focused on the role of the intercalating tyrosine, which is universally conserved among 
eukaryotic AAG homologs (1, 32). We find that both the Y162F and Y162A mutations are well 
tolerated in vitro and do not appear to greatly perturb the structure, because the N-glycosidic 
bond cleavage step is within 2-fold of wild-type AAG. Therefore, the comparison of wild-type 
and mutant proteins provides valuable insights into the functional contributions of tyrosine to 
individual microscopic steps in the recognition of εA lesions. 
Although the Y162F variant has not been found in nature, the kinetic parameters are 
almost identical to wild-type (Table 3.1). Association, flipping, and unflipping are approximately 
2-fold faster for this mutant, whereas the searching rate constant and the overall equilibrium 
constant for flipping are essentially identical to wild-type AAG. Therefore, the hydroxyl group of 
tyrosine is not necessary for any of the microscopic steps associated with finding and flipping 
out εA lesions. This suggests that aromatic stacking interactions are responsible for the 
stabilization of the initial recognition complex and that both tyrosine and phenylalanine act as a 
plug to stabilize the flipped-out complex. Some prokaryotic homologs of AAG have been 
identified that appear to substitute histidine for tyrosine at the intercalating position (1, 33). It 
is easy to imagine that histidine could make similar interactions as tyrosine and phenylalanine. 
Interestingly, Y162 has been identified as the primary site of nitration, which is reported to 
81 
 
decrease glycosylase activity (30). It is possible that nitration of tyrosine serves a biological 
function that could account for the conservation of this residue. Future in vivo experiments 
with the Y162F mutant, that cannot be nitrated, may be able to shed light on this issue (30). 
 The comparison of Y162A to wild-type AAG allows the energetic contribution of DNA 
intercalation to be measured for individual steps in the kinetic mechanism. Both association 
and searching are significantly faster for Y162A, but were too fast to measure with stopped-
flow assays. Parallels can be drawn with recent reports that mutation of intercalating residues 
to alanine in other DNA glycosylases increases the rate of diffusion (34, 35). Thus, a theme 
emerges that DNA intercalation slows the macroscopic rate of diffusive searching. Although the 
Y162A mutant engages εA sites significantly faster than the wild-type enzyme, the 
destabilization of the specific recognition complex greatly reduces the specificity of the enzyme. 
This mutant is not able to effectively find sites of damage when challenged by an excess of 
undamaged bases (Figure 3.7), leading to the prediction that DNA intercalation is essential for 
in vivo DNA repair. Consistent with this conclusion, heterologous expression of Y162A AAG fails 
to fully protect cells against an exogenous DNA alkylating agent (2). 
Conclusions 
Structures of AAG bound to εA-DNA (1) raised the possibility that intercalation by Y162 could 
increase the rate constant for flipping by “pushing” or destabilizing the duplex and decrease the 
rate constant for unflipping by “plugging” the hole vacated by the flipped-out nucleobase, as 
has also been suggested for other glycosylases (21, 25). Our study provides a rigorous test of 
these models. The kinetic parameters for Y162A support the plugging model, with this mutant 
showing a 6,000-fold increase in the rate of unflipping relative to wild-type AAG. Surprisingly, 
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the Y162A mutant does not show a reduced rate of flipping, but instead it flips out εA lesions 
50-fold faster than the wild-type enzyme. This argues against the pushing model for Y162 and 
demonstrates that intercalation of Y162 dramatically slows the nucleotide flipping step. The 
slower rate constant for flipping by wild-type AAG is presumably explained by tight binding of 
εA in an initial recognition complex. Consistent with this view, the initial recognition complex 
does not appear to stably form for Y162A (Figure 3.5). Overall, the Y162A mutation greatly 
destabilizes the specific recognition complex, and we obtain an estimate of 140-fold 
stabilization for the contribution of tyrosine intercalation to the equilibrium constant for 
flipping. AAG is a particularly attractive system to delve into the biophysical and biochemical 
mechanism of multi-step DNA recognition, but it is apparent that many different enzymes must 
employ similar strategies to discriminate between non-specific and specific sites, and the 
lessons learned from AAG may be more widely applicable to other DNA modifying enzymes.  
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Appendix B 
Additional data figures to support Chapter 3 
 
 
 
  
 
 
 
                                         
Figure B-1. Single-turnover excision of εA for wild-type and mutant AAG. Essentially 
identical rate constants were obtained for excision of εA from TEC DNA (50 nM) and either 
300 nM or 600 nM AAG. These data indicate that 300 nM enzyme is saturating for all of the 
AAG variants tested.  
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Figure B-2. Pulse-chase experiment for measuring the partitioning between excision and 
dissociation of εA-DNA for wild-type (A) Y162F (B) and Y162A (C) AAG. As a control to test 
the effectiveness of the unlabeled pyrrolidine-DNA chase, reactions were initiated by adding 
AAG to a mixture of chase and 5’-fam εA-DNA substrate (triangles). The reactions in the 
presence (squares) and absence (circles) of chase are from Figure 3.6 in the text. 
Comparison of the +chase reaction and the chase control for Y162F supports a small, but 
measurable commitment to excision. 
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Figure B-3. Representative Berkeley Madonna (BM) global fits to excess protein stopped-flow 
experiments (A) wild-type (B) Y162F (C and D) Y162A AAG. Lines show the best fits obtained 
with Berkeley Madonna (see Figure B-5), and the plot below shows the residual between the fit 
and the experimental data. (E) Table summarizing individual fits (Table 3.1 in main text) and 
global analysis of curves shown in A–D.   
  
Excess 
Protein 
Experimental 
WT (TEC) 
BM  
WT  
Experimental 
Y162F (TEC) 
BM 
Y162F  
Experimental 
Y162A (TEC) 
BM 
Y162A  
Experimental 
Y162A (AEA) 
BM 
Y162A  
k1 = kon 1.1 x 10
9 1.3 x 109 2.1 x 109 2.4 x 109 n/a 1.8 x 1010 n/a 1.6 x 109 
k2 = koff n/a 41.4 n/a 62.9 n/a 12.9 n/a 63.4 
k3  n/a 84.2 n/a 93.7 n/a 226.9 n/a 148.5 
k4  n/a 31.3 n/a 15.7 n/a 693.5 n/a 67.6 
kfind = k3 + k4 116 115.5 114 109.4 n/a 920.4 n/a 216.1 
k7 = kflip 3.6 3.3 7.7 7.5 171.8 171.0 66.0 66.3 
k8 = kunflip 0.002 0.0012 0.005 0.005 10.3 10.3 10.3 10.4 
k9 = kartifact 0.51 – 1.72 0.012 0.66 – 2.14 1.3 0.03 – 1.8 16.6 1.22 – 12.9 6.5 
E 
C D B A 
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Figure B-4. Representative global fits to stopped-flow experiments with excess DNA and (A) 
wild-type (B) Y162F or (C) Y162A. Lines show the best fits obtained with Berkeley Madonna (see 
Figure B-6), and the plot below shows the residual between the fit and the experimental data. 
(D) Table summarizing the exponential fits described in the main text (Table 3.1) and the global 
analysis of the experimental data at different concentrations of DNA or protein (A–C). 
 
 
  
Excess DNA Experimental 
WT 
BM WT 
(TEC) 
Experimental 
Y162F 
BM Y162F 
(TEC) 
Experimental 
Y162A 
BM Y162A 
(AEA) 
k1 = kon 1.1 x 10
9 3.8 x 109 2.1 x 109 4.3 x 109 n/a 1.2 x 1010 
k2 = koff n/a 52.9 n/a 62.3 n/a 65.2 
k3  n/a 104.9 n/a 102.6 n/a 173.4 
k4  n/a 18.3 n/a 16.8 n/a 56.2 
kfind = k3 + k4 116 123.2 114 119.4 n/a 229.6 
k5 = kflip 3.6 3.6 7.4 7.6 52.6 52.4 
k6 = kunflip 0.002 0.0020 0.005 0.005 10.3 10.1 
k7 = kartifact 0.74 – 2.98 0.44 1.03 – 2.75 0.77 0.01 – 0.20 0.12 
B A 
D 
C 
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Figure B-5. Example of Berkeley Madonna script for global fits to stopped-flow experiments 
with excess protein  
METHOD RK4 
STARTTIME = 0 
STOPTIME = 9.96 
DT = 5e-5 
 
d/dt (E[1..3]) = -k1*E[i]*S[i] + k2*ESns[i] + k12*(E2Sns[i] + E2S[i] + E2S1[i]) + k14*(E3Sns[i] + E3S[i] + 
E3S1[i])    
 
d/dt (S[1..3]) = -k1*E[i]*S[i] + k2*ESns[i]  
d/dt (ESns[1..3]) = k12*E2Sns[i] - (k2 + k3 + k11*E[i])*ESns[i] + k1*E[i]*S[i] + k4*ES[i] 
d/dt (E2Sns[1..3]) = k11*E[i]*ESns[i] + k14*E3Sns[i] + k4*E2S[i] - (k12 + k5 + k13*E[i])*E2Sns[i] 
d/dt (E3Sns[1..3]) = k13*E[i]*E2Sns[i] + k4*E3S[i] - (k14 + k6)*E3Sns[i]  
d/dt (ES[1..3]) = k8*ES1[i] - (k4 + k11*E[i] + k7)*ES[i] + k3*ESns[i] + k12*E2S[i]  
d/dt (E2S[1..3]) = k11*E[i]*ES[i] + k5*E2Sns[i] + k14*E3S[i] + k8*E2S1[i] - (k12 + k4 + k13*E[i] + k7)*E2S[i] 
d/dt (E3S[1..3]) = k6*E3Sns[i] + k13*E[i]*E2S[i] + k8*E3S1[i] - (k14 + k4 + k7)*E3S[i] 
d/dt (ES1[1..3]) = k12*E2S1[i] + k7*ES[i] - (k8 + k11*E[i] + k9)*ES1[i] 
d/dt (E2S1[1..3]) = k11*E[i]*ES1[i] + k7*E2S[i] + k14*E3S1[i] - (k8 + k13*E[i] + k9 + k12)*E2S1[i] 
d/dt (E3S1[1..3]) = k13*E[i]*E2S1[i] + k7*E3S[i] - (k8 + k14 + k9)*E3S1[i] 
d/dt (ESc[1..3]) = k9*ES1[i] + k9*E2S1[i] + k9*E3S1[i] 
 
init S[1..3] = Sub 
Sub = 50e-9 
init ESns[1..3] = 0 
init E2Sns[1..3] = 0 
init E3Sns[1..3] = 0 
init ES[1..3] = 0 
init E2S[1..3] = 0 
init E3S[1..3] = 0 
init ES1[1..3] = 0 
init E2S1[1..3] = 0 
init E3S1[1..3] = 0 
init ESc[1..3] = 0 
 
init E[1] = E1 
init E[2] = E2 
init E[3] = E3 
E1 = 150e-9 
E2 = 250e-9 
E3 = 400e-9 
 
k1 = 1.1e9 
k2 = 48 
k3 = 85 
k4 = 30 
k5 = 2*k3 
Scheme for multiple proteins binding, where E = AAG, S = DNA substrate, 
ESns   nonspecific complex, ES   initial recognition complex, ES’   flipped-
out specific recognition complex, ESc = artifact phase. E2 assumes binding 
of two proteins, while E3 is binding of three proteins. To fit this mechanism 
to fluorescence data, we also define the fluorescence of each species (FA, 
FB, FC, and FD).  
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k6 = 3*k3 
k7 = 3.6 
k8 = 0.002 
k9 = 0.1 
k11 = k1 
k12 = k2 
k13 = k1 
k14 = k2 
 
F[1..3] = OS[i] + FA[i]*(S[i] + ESns[i] + E2Sns[i] + E3Sns[i]) + FB[i]*(ES[i] + E2S[i] + E3S[i]) + FC[i]*(ES1[i] + 
E2S1[i] + E3S1[i]) + FD[i]*ESc[i]  
 
F1 = F[1] 
F2 = F[2] 
F3 = F[3] 
FA[1] = FA1  
FA[2] = FA2 
FA[3] = FA3 
FB[1] = FB1  
FB[2] = FB2  
FB[3] = FB3  
FC[1] = FC1  
FC[2] = FC2 
FC[3] = FC3 
FD[1] = FD1  
FD[2] = FD2 
FD[3] = FD3  
 
FA1 = 2.0e8 
FA2 = 4.0e8 
FA3 =5.0e8 
FB1 = 6.0e8 
FB2 = 6.3e8 
FB3 = 6.4e8 
FC1 = 2.0e7 
FC2 = 5.0e7 
FC3 = 9.0e7 
FD1 = 5.0e6 
FD2 = 1e7 
FD3 = 1.5e7 
 
OS[1] = OS1 
OS[2] = OS2 
OS[3] = OS3 
OS1 = 102.3 
OS2 = 101.8 
OS3 = 102.5 
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Figure B-6. Example of Berkeley Madonna script for global fits to stopped-flow experiments 
with excess DNA  
 
METHOD RK4 
STARTTIME = 0 
STOPTIME = 9.96 
DT = 5e-5 
 
d/dt (E[1..3]) = -k1*E[i]*S[i] + k2*ESns[i] 
d/dt (S[1..3]) = k2*ESns[i] - k1*E[i]*S[i] 
d/dt (ESns[1..3]) = k4*ES[i] - (k2 + k3)*ESns[i] + k1*E[i]*S[i] 
d/dt (ES1[1..3]) = -k6*ES1[i] + k5*ES[i]  - k7*ES1[i] 
d/dt (ES[1..3]) = k6*ES1[i] - (k4 + k5)*ES[i] + k3*ESns[i] 
d/dt (ESc[1..3]) = k7*ES1[i] 
 
init E[1..3] = En 
En = 100e-9 
init ESns[1..3] = 0 
init ES[1..3] = 0 
init ES1[1..3] = 0 
init ESc[1..3] = 0 
 
init S[1] = S1 
init S[2] = S2 
init S[3] = S3 
S1 = 200e-9 
S2 = 600e-9 
S3 = 900e-9 
 
k1 = 5e9 
k2 = 53 
k3 = 105 
k4 = 18 
k5 = 3.6 
k6 = 0.002 
k7 = 1.1 
 
F[1..3] = OS[i] + FA[i]*S[i] + FA[i]*ESns[i] + FB[i]*ES[i] + FC[i]*ES1[i] + FD[i]*ESc[i]  
 
F1 = F[1] 
F2 = F[2] 
F3 = F[3] 
 
FA[1] = FA1  
FB[1] = FB1 
FC[1] = FC1  
FD[1] = FD1 
FA1 = 3e8 
FB1 = 7e8 
FC1 = 3e6 
FD1 = 1e6 
FA[2] = FA2 
Scheme for binding of a single protein, where E = AAG, S = DNA substrate, 
ESns = nonspecific complex, ES = initial recognition complex, ES’   flipped-
out specific recognition complex, ESc = artifact phase. To fit this 
mechanism to fluorescence data, we also define the fluorescence of each 
species (FA, FB, FC, and FD).  
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FB[2] = FB2 
FC[2] = FC2 
FD[2] = FD2 
FA2 = 2e8 
FB2 = 3e8 
FC2 = 2e6 
FD2 = 1e6 
FA[3] = FA3 
FB[3] = FB3 
FC[3] = FC3 
FD[3] = FD3 
FA3 = 1e8 
FB3 = 2e8 
FC3 = 2.5e6 
FD3 = 1e6 
 
OS[1] = OS1 
OS[2] = OS2 
OS[3] = OS3 
OS1 = 73 
OS2 = 30 
OS3 = 20 
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CHAPTER 4 
Evidence for Early Intercalation during the Search for DNA Damage by 
Human Alkyladenine DNA Glycosylase 
 
DNA is subject to a variety of modifications by reactive intracellular and environmental 
agents. Failure to repair DNA damage leads to mutations or cell death (1, 2). The base excision 
repair (BER) pathway is responsible for removing single base lesions from the DNA. This 
pathway is initiated by a DNA glycosylase that is responsible for finding the damaged site and 
catalyzing the hydrolysis of the N-glycosidic bond. Subsequent action of an abasic-site specific 
endonuclease, a 5’-deoxyribose phosphate lyase, a DNA repair polymerase, and a DNA ligase 
are required to restore the correct DNA sequence, using the intact strand as a template.  
Human alkyladenine DNA glycosylase (AAG) is a monomeric DNA glycosylase responsible 
for recognizing a wide variety of structurally diverse deaminated and alkylated purine lesions 
(3-5). This enzyme gains access to damaged bases that are normally embedded in the duplex 
through a process called nucleotide or base flipping, which involves the complete 180° rotation 
of a nucleobase into the enzyme active site (6, 7). Crystal structures of AAG complexed with 
damaged DNA reveal the DNA is bent where a tyrosine (Y162) intercalates into the space left by 
the flipped-out damaged nucleotide (Figure 4.1A; (7)). Nucleotide flipping is common in nature, 
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and it is universally conserved by repair enzymes, however the timing of intercalation remains 
unknown.  
 We previously used the intrinsic fluorescence of 1,N6-ethenoadenine (εA) to 
characterize the minimal kinetic mechanism for the recognition, flipping, and excision of this 
common lesion by wild-type AAG (Figure 4.1C; (8, 9)). AAG uses nonspecific binding and 
facilitated diffusion (10) to search for sites of damage. Stopped-flow experiments indicated that 
once an εA is found, AAG forms an initial recognition complex in which the εA lesion is partially 
unstacked (8). From this intermediate, AAG catalyzes nucleotide flipping to form a more stable 
specific recognition complex in the enzyme active site before N-glycosidic bond hydrolysis.  
The natural fluorescence of εA allowed for the full kinetic characterization of wild-type 
AAG, however, the majority of substrates recognized by AAG are not fluorescent. Currently 
there is no direct method to measure the rate constant of nucleotide flipping for these lesions. 
Tryptophan fluorescence of proteins is often used as a tool to monitor changes in proteins or 
DNA, and a tryptophan reporter in AAG would allow measurement of kflip for any lesion. The 
catalytic domain of AAG contains three tryptophan residues (W243, W270, and W284), raising 
the possibility that the intrinsic tryptophan fluorescence of wild-type could be used to monitor 
conformational changes upon binding DNA. However, since the three tryptophan residues are 
all found near the back surface of the protein, away from the enzyme active site, we predicted 
their environment would not change upon DNA binding (Figure 4.1A). In the crystal structure of 
AAG bound to a flipped-out εA lesion, the DNA is bent away from the protein by about 20°, and 
the intercalating tyrosine-162 is located at the center of the bend (7). The side chain of 
tyrosine-162 projects from a β-hairpin on the surface of AAG and inserts into 
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Figure 4.1. AAG uses nucleotide flipping. (A) Cartoon representation of the AAG (yellow) complex 
with εA-DNA (green) from the PDB (1EWN) was rendered with Pymol (http://www.pymol.org). The 
three native tryptophan residues are shown in space-filling representation (blue). They are all located 
near the surface of the protein far away from the DNA-binding surface of AAG. The εA base is flipped 
into the active site, and the intercalating residue (Y162) is shown in red. (B) Substitution of tyrosine-
162 with tryptophan can be accommodated. Image was rendered with Pymol, and no energy 
minimization or additional modeling was performed, but this suggests that the slightly larger 
tryptophan side chain could be accommodated. (C) AAG (crescent) binds to nonspecific DNA and 
rapidly searches for DNA damage. This searching process is described by the macroscopic rate 
constant kfind. Once a lesion (solid rectangle) is encountered in an initial recognition complex, it can 
be flipped into the enzyme active site to form the specific recognition complex. AAG catalyzes 
hydrolysis of the N-glycosidic bond (kchem) from this complex. As shown by the red ball and stick, the 
intercalating Y162 residue is important throughout all steps of the kinetic mechanism.  
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the minor groove DNA, thus filling the space left by the flipped-out nucleotide. Tyrosine-162 
was substituted with tryptophan and a rotamer was selected that avoided steric clashes with 
both DNA and protein side chains (Figure 4.1B). No energy minimization or additional modeling 
was performed, but this exercise suggests that the slightly larger tryptophan side chain can be 
accommodated without large-scale changes in other AAG residues. In addition, previous work 
with Y162 mutants established that phenylalanine at this position is a conservative mutation, 
and DNA intercalation contributes to specific recognition of DNA damage by acting as a plug to 
stabilize the specific lesion recognition complex (Chapter 3). Therefore, in this study we 
mutated the intercalating residue of AAG to tryptophan (Y162W) to potentially generate a 
fluorescent probe to report on nucleotide flipping.  
 Substitution of the highly conserved tyrosine with tryptophan at position 162 had 
minimal effects on the overall kinetic parameters. The slightly bulkier tryptophan residue did 
not alter the equilibrium constant for flipping, and excision of εA is identical to wild-type. 
Unexpectedly, upon binding damaged or undamaged DNA, the tryptophan fluorescence of 
Y162W AAG is rapidly quenched and does not change throughout the timescale of nucleotide 
flipping. Assignment of Y162W fluorescence was confirmed by characterization of mutation of 
two of the native tryptophan residues, W270A/W284A. This suggests Y162 intercalates early in 
the search for DNA damage, and Y162 is critical throughout all steps of the kinetic mechanism.  
Materials and Methods 
Purification of Wild-type and Mutant AAG Protein. The catalytic domain of human AAG that 
lacks the first 79 amino acids was expressed in E. coli and purified as previously described (11). 
The Y162W mutant was constructed by site-directed mutagenesis and purified using the same 
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protocol. The concentration of AAG was determined by fluorescent titration of εA-DNA, as 
described below, and the concentrations were found to be within 2-fold of the concentration 
determined from the UV absorbance and the calculated extinction coefficient for the wild-type 
or mutant protein.  
Synthesis and Purification of Oligodeoxynucleotides. The 25mer oligonucleotides were 
synthesized by Integrated DNA Technologies or by the W.M. Keck Facility at Yale University. The 
oligonucleotides were desalted using Sephadex G-25 and purified using denaturing 
polyacrylamide gel electrophoresis as previously described. Oligonucleotides for gel-based 
assays were labeled on the lesion containing strand with a 5’-fluorescein (6-fam) label. The 
concentrations of the single stranded oligonucleotides were determined from the absorbance 
at 260 nm, using the calculated extinction coefficients for all oligonucleotides except those 
containing εA. For oligonucleotides containing εA, the extinction coefficient was calculated for 
the same sequence with an A in place of the εA and corrected by subtracting 9400 M-1cm-1 to 
account for the weaker absorbance of εA as compared to A. The lesion-containing 
oligonucleotides were annealed with a 1.2-fold excess of the complement by heating to 90 °C 
and cooling slowly to 4 °C. Two different sequence contexts were used and these are referred 
to by the central three nucleotides (i.e., TEC has a central εA lesion flanked by a 5’T and a 3’C; 
TXC 5’ –CGATAGCATCCTXCCTTCTCTCCAT 
3’ –GCTATCGTAGGATGGAAGAGAGGTA 
 
AXA 5’ –CGATAGCATCAAXAATTCTCTCCAT 
3’ –GCTATCGTAGTTTTTAAGAGAGGTA 
 
X= εA, A, or pyrrolidine  
 
Scheme 4.1 
 
99 
 
Scheme 4.1). Two DNA sequences were used because the fluorescence is different due to 
changes in the εA environment (8). The oligonucleotide sequence TEC gave 4-fold lower 
fluorescence than free εA, consistent with quenching of εA fluorescence even in single-stranded 
DNA. Surprisingly, the AEA sequence yielded much higher fluorescence, essentially identical to 
that of free εA. Upon annealing to complement, the fluorescence decreased 1.7-fold for TEC 
and 1.4-fold for AEA. This is consistent with increased quenching due to base stacking 
interactions in duplex DNA. It is possible that the lack of nearby G nucleotides can account for 
the high fluorescence of the AEA sequence. The addition of AAG resulted in a dramatic 5-fold 
decrease in the fluorescence of the AEA substrate, whereas the TEC substrate only showed 
slight quenching. The two oligonucleotide sequences exhibit almost identical fluorescence 
emission when they are bound to AAG, so this strongly suggests that εA is in a similar 
environment in both complexes (the flipped-out specific recognition complex) (8). 
Steady-State Fluorescence Measurements. Fluorescence emission spectra were collected with 
a PTI QuantaMaster fluorometer controlled by FeliX software. For εA fluorescence, an 
excitation wavelength of 314 nm (6 nm band-pass) was used and the total fluorescence was 
measured at emission wavelengths from 340-480 nm (6 nm band-pass). Samples (300 µL) of 
400 nM εA-containing DNA were prepared in the standard buffer (50 mM NaMES (pH 6.5), 100 
mM NaCl, 1 mM EDTA, 1 mM DTT) and spectra were recorded at 25 °C. To determine the 
steady-state fluorescence of εA-containing DNA bound to AAG, the spectra were recorded 
within one minute. No significant excision of εA occurs during this time. Three independent 
titrations were averaged, and the data were fit to a quadratic equation assuming tight binding 
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by AAG (Equation 4.1), in which Frel is the relative fluorescence, A is the fractional quenching, 
and Kd is the dissociation constant for the εA-DNA. 
2E
DNA)(4EDNA)E(KDNA)EA(K
1F
2
dd
rel

   (4.1) 
Gel-based Glycosylase Assay. We measured single-turnover glycosylase activity with the 
standard glycosylase activity assay that utilizes abasic site cleavage by NaOH followed by DNA 
separation on a denaturing polyacramide gel. Fluorescein-labeled DNA substrates (50 nM) 
containing εA were prepared in the standard buffer. The reactions were initiated with the 
addition of 75 nM – 1200 nM AAG and incubated at 25 °C. At various time points, a sample 
from the reaction was removed and quenched in two volumes of 0.3 M NaOH, giving a final 
hydroxide concentration of 0.2 M. The abasic sites were cleaved by heating at 70 °C for 15 
minutes. Samples were mixed with an equal volume of formamide/EDTA loading buffer before 
loading onto a 15% polyacrylamide gel. Gels were scanned with a Typhoon Imager (GE Trio+ 
Healthcare) to detect the fluorescein label by exciting at 488 nm and measuring emission with a 
520BP40 filter. The gel bands were quantified using ImageQuant TL (GE Healthcare). The data 
was converted to fraction product [Fraction Product = product / (product + substrate)] and then 
fit by a single exponential using nonlinear least squares regression with Kaleidagraph (Synergy 
Software), in which kobs is the rate constant, t is the time, and A is the amplitude (Equation 4.2). 
In all cases, the same rate constant was measured at two different concentrations of AAG.  This 
demonstrates that AAG was saturating and that the maximal single-turnover rate constant was 
determined (see Appendix C). Under these conditions, the observed rate constant is equal to 
the maximal single-turnover rate constant (kobs = kmax).  
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Fraction product = A(1 - e-kobst)    (4.2)  
Stopped-Flow Kinetics. Pre-steady state kinetic experiments were performed on a Hi-Tech SF-
61DSX2, controlled by Kinetic Studio (TgK Scientific). The fluorescence of εA was measured 
using an excitation wavelength of 313 nm and a WG360 long-pass emission filter as previously 
described (8). The fluorescence of tryptophan was measured using an excitation wavelength of 
296 nm and a 330BP20 band-pass emission filter. At least three traces were averaged together 
at each concentration. The traces for Y162W were fit by a double exponential (Equation 4.3) 
where F is the fluorescence as a function of time, C is the fluorescence of free DNA, X and Y are 
the changes in fluorescence of the intermediates, and t is the time.  
 )e-Y(1-)e-X(1-C=F
t-kt-k obs2,obs1,       (4.3) 
Observed rate constants were plotted versus concentration and fit to a straight line. k1,obs 
showed a linear concentration dependence, and the slope is equal to kon (M
-1s-1), and the y-
intercept is equal to koff (s
-1). The value of k2,obs was independent of concentration and is equal 
to kflip + kunflip.  
Pulse-Chase Assay to Measure Substrate Dissociation. The macroscopic rate constant for 
dissociation of wild-type and mutant AAG from εA-containing DNA was measured by pulse-
chase in the standard reaction buffer at 25 °C as previously described for wild-type AAG (8). 
Briefly, in 20 μL reactions, 50 nM fluorescein-labeled TEC DNA was mixed with 75 nM - 1200 nM 
AAG for 20 seconds, and then a chase of 10 μM unlabeled pyrrolidine DNA was added. 
Pyrrolidine binds tightly to AAG as a transition state analogue (12, 13). At various time points, a 
sample from the reaction was removed and analyzed as described for “Gel-based glycosylase 
assay”. Base excision catalyzed by AAG results in fluorescein-labeled product, whereas 
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dissociation releases unreacted fluorescein-labeled substrate. If AAG dissociates from the 
labeled DNA before the chemical cleavage step and then binds to the unlabeled DNA, less of 
the reaction will occur during the single-turnover part of the curve as compared to the same 
experiment without chase. The data was converted to fraction product and fit by a single 
exponential (Equation 4.2).  The observed rate constant was independent of the concentration 
of AAG.   
According to the two step binding mechanism described in Figure 4.1C, two different 
partitioning equations can be written (14). All labeled substrate is initially bound, and therefore 
the fraction of product formed is given by the fraction that goes on to react. This is indicated by 
Equation 4.4, in which A is the burst amplitude (the fraction of product formed in the burst 
phase of the experiment), kmax is the maximal single-turnover rate constant for formation of 
product, and koff,obs is the macroscopic rate constant for dissociation from the flipped-out 
complex. This expression can be rearranged to solve for the desired dissociation rate constant 
(Equation 4.5). Similarly, for branched pathways, the observed rate constant for the burst phase 
of the pulse-chase experiment is given by the sum of the rate constants for the competing 
pathways, formation of product is given by kmax and the macroscopic dissociation of substrate is 
designated koff,obs (Equation 4.6). Solving for koff,obs gives Equation 4.7. 
maxobsoff,
max
kk
k
=A

      (4.4) 
max
max
obsoff, k
A
k
k        (4.5) 
maxobsoff,obs kkk        (4.6) 
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maxobsobsoff, kkk        (4.7) 
Control reactions in which no chase was added provided the single-turnover rate 
constant, kmax, and confirmed that these concentrations of AAG were saturating. From these 
values, the dissociation rate constant, koff, for AAG dissociating from εA-DNA was calculated by 
two different methods (Equations 4.5 and 4.7). Both methods gave similar values for koff,obs and 
we report the results obtained from Equation 4.5. 
Since the εA-DNA binds in two steps, the observed rate constant for dissociation of 
substrate (koff, obs) could be limited by the unflipping rate (kunflip) or dissociation from nonspecific 
DNA (koff). Assuming that the flipped-out complex is stable (i.e., kflip >> kunflip), this observed 
dissociation rate constant can be expressed in terms of the microscopic rate constants 
(Equation 4.8; (14)) Stopped-flow fluorescence suggests that dissociation from the initial 
AAG•DNA complex is rapid, and therefore the observed rate constant for substrate dissociation 
from the εA-DNA•AAG complex is approximately equal to the reverse rate constant for flipping 
(Equation 4.9).  








 flipoff
off
unflipobsoff,
kk
k
k=k      (4.8) 
unflipobsoff, kk 
      (4.9)
 
Results 
Binding and Excision of εA by Y162W 
We used site-directed mutagenesis to create the Y162W variant, and characterized its ability to 
bind and excise εA from synthetic 25mer oligonucleotides containing a central εA·T mismatch. 
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Full characterization of Y162W was necessary to determine whether the tyrosine to tryptophan 
substitution was conservative. To confirm stable binding of active Y162W to the εA lesion, 
steady-state fluorescence titrations were used (Figure 4.2A). It was previously shown that εA-
DNA of the sequence AEA shows a large decrease in fluorescence upon binding to wild-type 
AAG (8). The equivalence point of fluorescence titrations with a fixed concentration of εA-DNA 
and increasing concentrations of protein yields the concentration of active enzyme. The active 
concentration determined by this method was approximately 80% of the value calculated from 
the UV absorbance and extinction coefficient. The corrected concentration was used for all 
experiments described below.  
 
 
 
Figure 4.2. Binding and excision of εA by wile-type and Y162W AAG. (A) Titration of 0.4 µM AEA 
DNA with wild-type and Y162W. Normalized fluorescence was fit by the quadratic equation under 
conditions of tight binding (Equation 4.1). These fits indicate that the number of εA-binding sites is 
86% of the expected value for wild-type and 100% of the expected value for Y162W. Titration also 
shows that both proteins stably bind εA. (B) Single-turnover excision of εA by wild-type and 
mutant AAG with 50 nM TEC DNA and saturating enzyme was fit by a single exponential 
(Equation 4.2) to obtain the rate constants for N-glycosidic bond cleavage (Table 4.1). Data 
points are an average ± SD from three independent experiments. 
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Single-turnover experiments with enzyme in excess over εA-DNA substrate were 
performed to evaluate whether Y162W maintained glycosylase activity (Figure 4.2B). For wild-
type AAG, the maximal single-turnover rate constant is N-glycosidic bond hydrolysis. The rate 
constant for excision of εA by Y162W is identical to the previously reported value for wild-type 
AAG (Chapter 3 and (8)). This provides evidence that the slightly larger tryptophan residue does 
not disrupt the transition state for N-glycosidic bond hydrolysis. However, AAG binds tightly to 
εA-DNA, so it is possible that the Y162W mutation impairs lesion recognition or nucleotide 
flipping and this effect is masked by tight εA binding.  
Stopped-flow Fluorescence to Monitor Binding and Flipping of εA-DNA 
To evaluate whether the Y162W mutant alters the rate constants for DNA binding or nucleotide 
flipping, rapid mixing experiments were performed to monitor transient changes in εA 
fluorescence. When a fixed concentration of TEC εA-DNA was mixed with increasing 
concentrations of Y162W, we observed an initial decrease in fluorescence that was followed by 
an increase in fluorescence (Figure 4.3A). This was unexpected because wild-type AAG shows 
the opposite trend under the same conditions (Figure 4.3A; (8)). The concentration of Y162W 
was varied, and each trace was fit to a double exponential (Figure 4.3B). The first phase is 
linearly dependent on enzyme concentration (Figure 4.3C) and this is assigned to binding and 
formation of the initial recognition complex (Chapter 3 and (8)). This initial step yielded an 
observed rate constant for binding that is nearly identical to wild-type AAG under these 
conditions (Table 4.1). The concentration independent second phase corresponds to the 
nucleotide flipping step and formation of the specific lesion recognition complex (Figure 4.3D). 
The second step is approximately 2-fold faster for the mutant than for wild-type AAG. Since this 
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Table 4.1. Kinetic parameters for flipping and excision of εA by wild-type and Y162W AAGa 
 
 Wild-typeb Y162W 
kon (M
-1s-1) (1.1 ± 0.03) x 109 (1.2 ± 0.6) x 109 
kflip (s
-1) 3.6 ± 0.7 7.9 ± 0.7 
kunflip (s
-1) (1.6 ± 0.3) x 10-3 (5.5 ± 0.2) x 10-3 
Kflip
c 2300 1400 
kmax εA (s
-1) (8.0 ± 0.6) x 10-4 (8.3 ± 0.5) x 10-4 
 
aAll rate constants were determined using the TEC oligonucleotide. The standard conditions 
were 25 °C, 50 mM NaMES (pH 6.5), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT. 
 
bThe values for wild-type AAG were previously reported (Chapter 3).  
 
cThe equilibrium constant for flipping is given by the ratio of the flipping and unflipping rate 
constants (Kflip = kflip/kunflip).  
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Figure 4.3. Stopped-flow fluorescence with excess protein to measure binding and nucleotide 
flipping by Y162W. (A) Opposite changes in εA fluorescence by wild-type and Y162W (400 nM 
protein plus 50 nM or 100 nM TEC DNA). (B) Representative data from experiments in which 100 nM 
TEC DNA was mixed with increasing concentrations of Y162W. Traces are the average of three 
binding reactions and are fit by the sum of exponentials (Equation 4.3). (C) The rate constant for the 
first phase of the binding reaction (k1,obs) is dependent on the concentration of AAG and a linear fit 
yields the bimolecular rate constant for binding (kon) with the values summarized in Table 4.1. (D) The 
rate constants for the second phase of the binding reaction (k2,obs) are independent of the 
concentration of AAG and reflect the sum of the forward and reverse rate constants for nucleotide 
flipping. Rate constants in C and D are from three independent experiments (average ± SD). Results 
for wild-type AAG were previously published (8). 
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observed rate constant for nucleotide flipping is an approach to equilibrium, it is equal to the 
sum of the rate constants for flipping and unflipping. Therefore, dissociation kinetics must also 
be monitored in order to determine the macroscopic rate constants for nucleotide flipping.  
Pulse-chase Experiment to Measure Unflipping and Dissociation of εA-DNA 
We performed a pulse-chase experiment in which wild-type or Y162W AAG are mixed with 
fluorescently labeled εA-DNA and then chased with an excess of pyrrolidine inhibitor DNA. All 
AAG that dissociates is immediately bound by the inhibitor, so the partitioning between 
dissociation and base excision can be directly measured. As previously reported, 70% of wild-
type AAG dissociates from the substrate, while 30% partitions to product (8, 9). Assuming that 
dissociation of AAG from nonspecific DNA is fast, the observed rate constant is simply the rate
 
 
 
Figure 4.4. Pulse-chase experiments to measure dissociation of εA-DNA. Fluorescein (fam)-labeled 
DNA (50 nM) was mixed with excess AAG (75 nM - 1200 nM) for 20 seconds, and then 10 µM 
unlabeled pyrrolidine DNA was added as a chase. The reactions were quenched at the indicated time 
points, and the fraction of abasic DNA product was determined by alkaline hydrolysis and gel 
electrophoresis (see Material and Methods for details). The partitioning between the forward 
reaction (base excision) and substrate dissociation was measured. The commitment for wild-type 
(30%) and Y162W (13%) were used to calculate the rates of unflipping (see Materials and Methods). 
The low commitment for Y162W AAG was reproducible and readily distinguished from the control in 
which chase and substrate are added at the same time (see Appendix C). 
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constant for unflipping. For the Y162W mutant, 87% of the substrate dissociated (Figure 4.4), 
indicating a 3-fold faster value for kunflip compared to wild-type. This small amount of product is 
readily distinguished from the mixing control in which chase and substrate are added together 
(see Appendix C).  
The results from the association and dissociation experiments were used to calculate 
the rate and equilibrium constants for nucleotide flipping (Table 4.1). The microscopic rate 
constant for flipping was calculated from the observed rate constant for formation of the 
extrahelical complex (kflip = k2,obs – kunflip). For both wild-type and Y162W, the unflipping rate 
constants are significantly slower than the observed rate constants for flipping. This indicates 
that the observed rate constant that was assigned to nucleotide flipping (k2,obs) is approximately 
equal to the microscopic rate constant for flipping (kflip). The equilibrium constant for 
nucleotide flipping (Kflip = kflip/kunflip) by Y162W is only 1.6-fold less favorable than wild-type, 
thus confirming that Y162W is a conservative mutation.  
Stopped-flow Fluorescence of Tryptophan 
To determine whether the tryptophan fluorescence of the Y162W protein reports on nucleotide 
flipping, we followed the fluorescence of tryptophan during the rapid mixing experiments. 
Previous control reactions in which the tryptophan fluorescence was recorded for wild-type 
AAG mixed with εA-DNA established that none of the three tryptophan residues present in AAG 
are sensitive to nucleotide flipping (9). Upon mixing a fixed concentration of Y162W with 
increasing concentrations of εA-DNA, a rapid quenching of tryptophan fluorescence was 
observed (Figure 4.5A). Surprisingly, the tryptophan fluorescence of Y162W did not change 
during the timescale of nucleotide flipping. The 20% quenching of tryptophan fluorescence was 
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Figure 4.5. Stopped-flow fluorescence to monitor changes in tryptophan fluorescence. 
Representative data from experiments in which 50 nM Y162W (A and B) or 50 nM 
W270A/W284A/Y162W (C and D) was mixed with increasing concentrations of damaged TEC DNA (A 
and C) or undamaged TAC DNA (B and D). Samples were excited at 296 nm, and emission was 
collected with a 330BP20 band-pass filter. Regardless of DNA type, both Y162W and 
W270A/W284A/Y162W show a rapid 20% decrease in tryptophan fluorescence. The change in 
fluorescence remains constant, and there is no change in fluorescence on the timescale of nucleotide 
flipping. Photobleaching was observed for shots longer than two seconds.  
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highly reproducible and suggests that the environment of Y162W changes rapidly upon binding 
DNA and is not sensitive to the nucleotide flipping step. The experiment was repeated with 
undamaged DNA (Figure 4.5B), and interestingly, we still observed the rapid 20% quenching of 
tryptophan fluorescence. Therefore, the tryptophan fluorescence of Y162W reports on 
nonspecific DNA binding, and Y162W is not sensitive to formation of either the initial 
recognition complex, or the specific recognition complex. However, quenching of the other 
three native tryptophan residues may have masked changes in tryptophan fluorescence from 
Y162W. Therefore we attempted to minimize the background tryptophan fluorescence by 
mutating the native tryptophan residues. 
Assignment of Y162W Tryptophan Fluorescence 
The catalytic domain of AAG contains three tryptophan residues (W243, W270, and W284). All 
three tryptophan residues are located near the back surface of the protein, away from the 
enzyme active site (Figure 4.1A). Nevertheless, changes in tryptophan fluorescence were 
observed upon binding of wild-type AAG to damaged or undamaged DNA in steady-state 
experiments (Figure 4.6). Therefore, tryptophan mutants were made in an attempt to minimize 
the background tryptophan fluorescence. Mutation of all three native tryptophan residues 
resulted in insoluble protein; however both W270 and W284 could be mutated. Two soluble 
mutants were made, W270A/W284A and W270A/W284A/Y162W. Both mutants stably bind εA 
and they excise εA only 2-fold slower than wild-type AAG (see Appendix C). Additional 
experiments showed that W270A/W284A and W270A/W284A/Y162W bind to DNA faster, and 
the unflipping rate constant is faster than wild-type (see Appendix C). It is not clear why 
mutating two tryptophan residues on the back side of the protein alters the kinetic 
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parameters, however understanding why these mutations change kflip and kunflip would require 
mutational analysis which is out of the scope of this work. Nevertheless, we have confidence 
changes in tryptophan fluorescence can be monitored because both mutants stably bind εA 
lesions, and excision of εA is similar to wild-type.  
Based on steady-state titrations with W270A/W284A, no change in tryptophan 
fluorescence was observed upon binding damaged or undamaged DNA (Figure 4.6). Therefore, 
the tryptophan fluorescence of the remaining tryptophan residue, W243, does not change upon 
binding DNA. The triple mutant, W270A/W284A/Y162W, successfully removed the background 
tryptophan fluorescence and was soluble under our reaction conditions. The rapid mixing 
experiment was repeated with a fixed concentration of this mutant and increasing 
 
 
Figure 4.6. Steady-state quenching of AAG tryptophan fluorescence upon binding damaged or 
undamaged DNA. The three native tryptophan residues in wild-type AAG (W243, W270, and W284) 
showed quenching of tryptophan fluorescence upon stable binding of damaged or undamaged DNA. 
Mutation of W270 and W284 to alanine removed all background tryptophan fluorescence. The 
remaining tryptophan, W243, does not report on DNA binding. Therefore, the tryptophan quenching 
observed by W270A/W284A/Y162W is due to changes in Y162W tryptophan fluorescence. 
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concentrations of TEC DNA. A similar 20% quenching of tryptophan fluorescence was observed 
as before (Figure 4.5 C & D). The fast quenching of tryptophan fluorescence was observed for 
both εA-DNA and undamaged DNA, so we know the Y162W tryptophan fluorescence reports on 
nonspecific binding. This suggests that Y162 intercalation occurs early in the search for DNA 
damage. 
Discussion 
Monitoring Nucleotide Flipping 
The rates of DNA binding and nucleotide flipping are critical to understanding how a DNA 
glycosylase recognizes damaged nucleotides. Several previous studies have used the 
incorporation of fluorescent reporter groups into DNA, like 2-aminopurine, to investigate the 
kinetics of DNA binding and nucleotide flipping by other families of DNA glycosylases (15-20). 
Direct measurement of nucleotide flipping of non-fluorescent lesions is needed because 
evidence suggests nucleotide flipping provides a barrier to the excision of damaged bases by 
AAG (5, 21). Knowing the rate of nucleotide flipping for various AAG substrates will help us 
better understand damage recognition and removal. To generate a tryptophan reporter to 
directly monitor structural changes in the protein upon binding DNA, we used site-directed 
mutagenesis to make the Y162W variant. In wild-type AAG, the intercalating residue, Y162, is 
critical for specific recognition of DNA damage. This residue also acts as a plug to stabilize the 
specific lesion recognition complex (Chapter 3). 
Y162W is a Conservative Mutation 
Although tyrosine-162 is highly conserved, the crystal structure raised the possibility that a 
tryptophan substitution might be tolerated. We used the intrinsic fluorescence of the εA lesion 
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to determine the kinetic mechanism for the Y162W mutant. Overall this is a very conservative 
mutation. While both kflip and kunflip are marginally faster for the mutant, the slightly bulkier 
tryptophan residue did not alter the equilibrium constant for flipping, and excision of εA is 
identical to wild-type (Table 4.1). This was surprising because the Y162W variant has never 
been found in nature. Also, extensive mutagenesis of AAG and selection for active site variants 
that conferred resistance to DNA alkylating agents have identified hundreds of allowed 
mutations, but no active variants at position 162. However, our results with εA suggest Y162W 
is similar to wild-type AAG.    
Timing of DNA Intercalation 
Unexpectedly, the Y162W tryptophan fluorescence does not report on nucleotide flipping. 
Upon mixing increasing concentrations of damaged or undamaged DNA with a fixed 
concentration of Y162W, a rapid 20% quenching of tryptophan fluorescence was observed. No 
changes in fluorescence were observed on the timescale of nucleotide flipping. This suggests 
that DNA intercalation occurs early in the search for DNA damage. In structural studies of AAG 
bound to an εC lesion, tyrosine-162 was capable of forming both lower- and higher- affinity 
interactions with the DNA, possibly playing roles in both a lower-affinity searching process, and 
a higher affinity recognition process (22). Using tryptophan mutants, we were able to observe 
changes in fluorescence upon formation of the lower-affinity searching interactions. While this 
rapid quenching of fluorescence was highly reproducible, we wanted to remove the background 
fluorescence from the native tryptophan residues (W243, W270, and/or W284) to confirm the 
result. 
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 Multiple combinations of mutations were tested; however W270A/W284A and 
W270A/W284A/Y162W were the most soluble. Both tryptophan mutants stably bind εA, and 
they retain glycosylase activity (see Appendix C). In rapid mixing experiments, when mixed with 
increasing concentrations of damaged or undamaged DNA, the W270A/W284A/Y162W mutant 
showed a rapid 20% quenching of tryptophan fluorescence that was similar to what was seen 
for Y162W AAG (Figure 4.5 C & D). Therefore, the environment of Y162W changes rapidly upon 
binding DNA, and these results suggest that intercalation occurs early during the search for 
damage. However we cannot rule out the possibility that other conformational changes result 
in changes in fluorescence that are too small to detect.  
This early role of intercalation appears to be common among independently evolved 
enzymes. Using a single Qdot-labeled glycosylase molecule, it was previously shown that Fpg 
glycosylase uses an intercalating phenylalanine residue to test the strength and flexibility of the 
base pairs, and mutation of the phenylalanine to alanine increased the rate of diffusion (23). 
The work was expanded to include three bacterial glycosylases in two structural families: Fpg, 
Nei, and Nth (24). Single molecule studies combined with mutagenesis showed the glycosylases 
diffuse along DNA, and pause momentarily to interrogate random bases. It is only when a 
damaged base is recognized, that the enzyme stops and excises it (24). Consistent with our 
results, this work suggested that the intercalating residue potentially acts as a sensor for DNA 
damage (23, 24).    
Implications 
DNA glycosylases are faced with the task of finding rare DNA damage in a sea of undamaged 
DNA. These enzymes use nonspecific binding and facilitated diffusion to search for sites of 
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damage (10). We now understand that the intercalating residue plays an important role during 
this search for damage. By mutating the intercalating tyrosine in AAG to tryptophan, we 
observed a rapid quenching of tryptophan fluorescence upon binding damaged or undamaged 
DNA. Strikingly, there were no additional changes in tryptophan fluorescence throughout the 
timescale of nucleotide flipping. Previous work established that tyrosine 162 plays a critical role 
in the discrimination between damaged and undamaged nucleotides, and these results suggest 
that DNA intercalation occurs early in the reaction.      
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Appendix C 
Additional data figures and discussion to support Chapter 4 
 
 
 
  
 
 
 
Table C-1. Kinetic parameters for flipping and excision of εA by wild-type and tryptophan 
mutantsa 
 
 Wild-typeb Y162W W270A/W284A W270A/W284A/Y162W 
kon (M
-1s-1) (1.1 ± 0.03) x 109 (1.2 ± 0.6) x 109 (7.5 ± 0.07) x 108 Fastc 
kflip (s
-1) 3.6 ± 0.7 7.9 ± 0.7 9.7 ± 0.3 28.6 ± 0.6 
kmax εA (s
-1) (8.0 ± 0.6) x 10-4 (8.3 ± 0.5) x 10-4 (2.8 ± 0.1) x 10-4 (3.4 ± 0.2) x 10-4 
 
aAll rate constants were determined using the TEC oligonucleotide. The standard conditions 
were 25 oC, 50 mM NaMES (pH 6.5), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT. 
 
bThe values for wild-type AAG were previously reported (Chapter 3).  
 
ckon is too fast to measure for W270A/W284A/Y162W 
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Figure C-1. Binding and excision of εA by tryptophan mutants. (A) Titration of 0.4 µM εA-DNA with 
wild-type and tryptophan mutants. Normalized fluorescence was fit by the quadratic equation under 
conditions of tight binding. Titration shows that all tryptophan mutants stably bind εA, and the 
accurate concentration of protein was determined from the equivalence point. The fits indicate that 
the number of εA-binding sites is 86% of the expected value for wild-type, 100% for Y162W, 80% for 
W270A/W284A, and 31% for W270A/W284A/Y162W. (B) Single-turnover excision of εA by wild-type 
and mutant AAG with 50 nM DNA and saturating (75 nM - 1200 nM) enzyme was fit by a single 
exponential (Equation 4.2) to obtain the rate constants for N-glycosidic bond cleavage (Table C-1). All 
tryptophan mutants retained catalytic activity. Data points are an average ± SD from three 
independent experiments. 
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Figure C-2. Pulse-chase experiment for measuring the partitioning between excision and 
dissociation of εA-DNA for wild-type (A) Y162W (B) W270A/W284A (C) and W270A/W284A/Y162W 
(D) AAG. As a control to test the effectiveness of the unlabeled pyrrolidine-DNA chase, reactions 
were initiated by adding AAG to a mixture of chase and 5’-fam εA-DNA substrate (triangles). The 
reactions in the presence (squares) and absence (circles) of chase for wild-type and Y162W are from 
Figure 4.4 in the text. Comparison of the +chase reaction and the chase control for Y162W supports a 
small, but measurable commitment to excision. Should be noted this control reaction was only 
performed once with the Y162W mutant. However, 100% W270A/W284A and 
W270A/W284A/Y162W dissociated and no product could be detected in the presence of chase. This 
indicates that unflipping is must faster than N-glycosidic bond cleavage. In order to precisely 
measure the rate of unflipping for these mutants, double-mixing stopped-flow experiments are 
required.  
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Figure C-3. Stopped-flow fluorescence with excess protein to measure binding and nucleotide 
flipping by tryptophan mutants. Representative data from experiments in which TEC DNA was mixed 
with wild-type (A; (8)), Y162W (B; from Figure 4.3 in main text), W270A/W284A (C), and  
W270A/W284A/Y162W (D). Traces are the average of three binding reactions. (E) The rate constant 
for the first phase of the binding reaction (k1,obs) is dependent on the concentration of AAG and a 
linear fit yields the bimolecular rate constant for binding (kon). Binding of W270A/W284A/Y162W 
occurs during the dead time of the instrument. (D) The rate constants for the second phase of the 
binding reaction (k2,obs) are independent of the concentration of AAG and reflect the sum of the 
forward and reverse rate constants for nucleotide flipping. Rate constants in C and D are from two 
independent experiments (average ± SD), and the rate constants are summarized in Table C-1. 
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Figure C-4. Single-turnover excision of εA for wild-type and mutant AAG. Essentially identical rate 
constants were obtained for excision of εA from TEC DNA (50 nM) and excess AAG. These data 
indicate that the lowest concentration of enzyme is saturating for all of the AAG variants tested. 
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CHAPTER 5 
 
Structure/Function Analysis of Intercalation and Nucleotide Flipping in Human 
Alkyladenine DNA Glycosylase1 
 
 
 To repair or modify bases embedded in the DNA duplex; enzymes often employ a 
nucleotide flipping strategy in which the target nucleotide is rotated 180° into the active site 
(2). It is proposed that both DNA bending and DNA intercalation are important for nucleotide 
flipping (2, 3). However, the timing of DNA bending is unknown, and the fundamental effects of 
DNA intercalation remain poorly understood. Structural studies have identified intercalating 
amino acid side chains in a wide variety of enzymes, but interestingly the identity of the amino 
acid varies (5). 
DNA glycosylases are one type of enzyme that use nucleotide flipping to engage 
substrates. These enzymes initiate the base excision repair (BER) pathway by locating sites of 
damage in the genome and catalyzing the hydrolysis of the N-glycosidic bond to release the 
damaged base (6). We took advantage of the fluorescence of 1,N6-ethenoadenine (εA), a 
1I planned the experiments and generated mutant plasmids. Karina Kangas purified all the mutant 
proteins (except for Y162A, Y162F, and Y162W). I performed the pulse-chase experiments for Y162H, 
Y162I, and Y162A. All other experiments were performed by Karina. We both analyzed the data and I 
wrote the chapter. 
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Figure 5.1. Nucleotide flipping and DNA intercalation by human AAG. (A) Cartoon representation of 
the AAG (green) complex with εA-DNA (blue) from the PDB (1EWN) was rendered with Pymol 
(http://www.pymol.org). The εA base is flipped into the active site, and the intercalating residue 
(Y162) is shown in red. (B) The intercalating tyrosine fills the space left by the flipped-out nucleotide, 
and stacking interactions are made between the DNA and Y162 after nucleotide flipping. (C) AAG 
(crescent) binds to nonspecific DNA and rapidly searches for DNA damage. This searching process is 
described by the macroscopic rate constant kfind. Once a lesion (solid rectangle) is encountered in an 
initial recognition complex, it can be flipped into the enzyme active site to form the specific 
recognition complex. AAG catalyzes hydrolysis of the N-glycosidic bond (kchem) from this complex. As 
shown by the red ball and stick, the intercalating Y162 residue is important throughout all steps of 
the kinetic mechanism.  
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common form of DNA damage, to monitor binding and flipping by human alkyladenine DNA 
glycosylase (AAG) during DNA repair (7, 8). This monomeric repair protein is responsible for 
removing a diverse set of alkylated and deaminated purine lesions (7, 9-11). The minimal kinetic 
mechanism for multi-step recognition of εA damage has been reported (4, 12). Given the excess 
of undamaged DNA, initial binding of AAG is not at the site of damage (Figure 5.1C). AAG uses 
nonspecific binding (kon) and facilitated diffusion (13) to search for sites of damage (kfind). Once 
an εA is found, AAG forms an initial recognition complex that is accompanied by changes in the 
stacking of the lesion base (4). From this intermediate, AAG catalyzes nucleotide flipping (kflip) 
to form a more stable specific recognition complex that positions the substrate for N-glycosidic 
bond cleavage (kchem; (14)). Multi-step recognition provides multiple opportunities for 
discrimination between damaged and undamaged nucleotides and similar mechanisms have 
been proposed for independently evolved DNA repair glycosylases (15-18). 
In the crystal structure of AAG bound to a flipped-out εA lesion, the DNA is bent away 
from the protein by about 20°, and the intercalating tyrosine-162 is located at the center of the 
bend (Figure 5.1A; (14)). The side chain of tyrosine-162 projects from a β-hairpin on the surface 
of AAG and inserts into the minor groove DNA, thus filling the space left by the flipped-out 
nucleotide (Figure 5.1B). Recently the functional contributes of the intercalating residue to each 
of the steps in the AAG catalytic mechanism were determined (Chapter 3). The intercalating 
tyrosine residue (Y162) was mutated to phenylalanine (Y162F) and alanine (Y162A). 
Surprisingly, the Y162A mutation was well tolerated in vitro and does not appear to greatly 
perturb the structure, because the N-glycosidic bond cleavage is within 2-fold of wild-type (WT) 
AAG. Remarkably, the Y162A mutation increases the rate of nucleotide flipping by 50-fold 
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relative to wild-type AAG. This mutant also exhibits faster unflipping, resulting in a 140-fold 
reduction in the equilibrium constant for formation of the flipped-out complex. In contrast, the 
kinetic parameters for the Y162F and wild-type enzymes are very similar, suggesting that the 
hydroxyl of tyrosine is not necessary for function. These findings establish that DNA 
intercalation contributes to the specific recognition of DNA damage by acting as a plug to 
stabilize the specific recognition complex. Tyrosine 162 plays a critical role in the discrimination 
between damaged and undamaged nucleotides, and DNA intercalation slows the macroscopic 
rate of diffusive searching.  
Most DNA glycosylases use a bulky side chain (Asn, Arg, Gln, Leu, or Tyr) to fill the space 
left by the flipped-out damaged nucleotide, although an exception includes 3-methyladenine 
DNA glycosylase, which has a Gly at this position (19). Unlike AAG, typically when the 
intercalating residue of a DNA glycosylase is mutated to a small amino acid, little to no activity 
is observed (14, 20-25). For example, the intercalating L191 residue in uracil DNA glycosylase 
(UDG) was mutated to either alanine or glycine (23). Both mutants were unable to excise uracil 
from single-stranded or duplex DNA. Using a pyrene nucleotide opposite a uracil base, the weak 
binding affinity and low catalytic activity of L191A and L191G was rescued (26, 27). The pyrene 
in DNA acts as a wedge to “push” the uracil from the base stack in free DNA, and a plug to 
prevent reinsertion after nucleotide flipping. This chemical rescue lead to the conclusion that 
the intercalating residue of UDG plays an early and late role in nucleotide flipping.  
We investigated the structure/function relationship of the intercalating residue to each 
of the steps in the AAG catalytic mechanism by systematically mutating the intercalating 
tyrosine residue to amino acids of various volumes and properties. Tyrosine 162 was mutated 
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to tryptophan (W), phenylalanine (F), leucine (L), isoleucine (I), histidine (H), asparagine (N), and 
alanine (A). The forward and reverse rate constants for nucleotide flipping were measured to 
investigate whether there is a correlation between the size (volume) of the intercalating 
residue and kflip or kunflip. Alternatively, it may be critical that the residue is aromatic. 
Surprisingly, characterization of the seven Y162 AAG mutants resulted in three categories: 
aromatic (Y162, Y162F, and Y162W), non-aromatic (Y162A, Y162N, Y162L, and Y162L), and 
Y162H. The rate constant for nucleotide flipping is much faster for the non-aromatic mutants 
and Y162H compared to wild-type. These mutants are unable to stabilize the initial recognition 
complex and slow nucleotide flipping like wild-type and the aromatic mutants. The rate 
constant for unflipping is also much faster for the non-aromatic mutants. The aromatic mutants 
and Y162H AAG act like a plug, and are able to stabilize the specific recognition complex. 
Overall, only the aromatic Y162 mutants (Y162, Y162H, Y162F, and Y162W) have a favorable 
equilibrium constant for nucleotide flipping. No volume dependence of the intercalating 
residue was observed, as even the bulkier non-aromatic mutants (Y162N, Y162I, and Y162L) 
were unable to prevent the damaged base from flipping back into the DNA. Overall, the 
aromatic residues are less mobile, and are able to form favorable stacking interactions that 
stabilize the initial recognition complex. These larger residues are also able to plug the space 
left by the flipped-out nucleotide, thus stabilizing the specific recognition complex. The results 
establish that AAG requires an aromatic residue at position at 162 for optimal activity and 
specificity.  
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Materials and Methods 
Purification of Wild-type and Mutant AAG Proteins. The catalytic domain of human AAG that 
lacks the first 79 amino acids was expressed in E. coli and purified as previously described (28). 
The Y162 mutants were constructed by site-directed mutagenesis and purified using the same 
protocol. The concentration of protein was determined by fluorescent titration of ɛA-DNA, as 
described below, and the concentrations were found to be within 5-fold of the concentration 
determined from the UV absorbance and calculated extinction coefficient.  
Synthesis and Purification of Oligodeoxynucleotides. The 25mer oligonucleotides were 
synthesized by Integrated DNA Technologies or by the W.M. Keck Facility at Yale University. The 
oligonucleotides were desalted using Sephadex G-25 and purified using denaturing 
polyacrylamide gel electrophoresis as previously described. Oligonucleotides for gel-based 
assays were labeled on the lesion containing strand with a 5’-fluorescein (6-fam) label. The 
concentrations of the single stranded oligonucleotides were determined from the absorbance 
at 260 nm, using the calculated extinction coefficients for all oligonucleotides except those 
containing εA. For the oligonucleotide containing εA, the extinction coefficient was calculated 
for the same sequence with an A in place of the εA and corrected by subtracting 9400 M-1cm-1 
to account for the weaker absorbance of εA as compared to A. The lesion-containing 
oligonucleotide was annealed with a 1.2-fold excess of the complement by heating to 90 °C and 
cooling slowly to 4 °C. One DNA sequence context was used and is referred to by the central 
three nucleotides (i.e., AEA has a central εA lesion flanked by a 5’A and a 3’A; Scheme 5.1). Two 
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different DNA sequences were previously used to determine the minimal kinetic mechanism of 
AAG because the fluorescence was different for the two sequences (TXC and AXA; (4)). All 
previously published results primarily utilized TXC DNA (4, 12); however in this work only AXA 
DNA was used. 
Steady-state Fluorescence Measurements. Fluorescence emission spectra were collected with 
a PTI QuantaMaster fluorometer controlled by FeliX software. For ɛA fluorescence, an 
excitation wavelength of 314 nm (6 nm band-pass) was used and the total fluorescence was 
measured at emission wavelengths from 340-480 nm (6 nm band-pass). Samples (300 µL) of 
400 nM ɛA-containing DNA were prepared in the standard buffer [50 mM NaMES (pH 6.5), 100 
mM NaCl, 1 mM EDTA, 1 mM DTT] and spectra were recorded at 25 °C. To determine the 
steady-state fluorescence of ɛA-containing DNA bound to AAG, the spectra were recorded 
within one minute to ensure that no significant excision of ɛA occurred. Three independent 
titrations were averaged, and the data were fit by a quadratic equation assuming tight binding 
by AAG (Equation 5.1), in with Frel is the relative fluorescence, A is the fractional quenching, and 
Kd is the dissociation constant for the ɛA-DNA.  
2E
DNA)(4EDNA)E(KDNA)EA(K
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
  (5.1) 
Gel-based Glycosylase Assay. Single-turnover glycosylase activity was measured with a 
discontinuous assay that utilizes abasic site cleavage by NaOH followed by DNA separation on a 
AXA 5’ –CGATAGCATCAAXAATTCTCTCCAT 
3’ –GCTATCGTAGTTTTTAAGAGAGGTA 
 
X= εA  
 
Scheme 5.1 
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denaturing polyacrylamide gel (13, 28). Fluorescein-labeled (5'-6-fam) DNA substrates (50 nM) 
containing ɛA were prepared in the standard buffer. Reactions were initiated with the addition 
of 300 nM - 600 nM AAG and incubated at 25 °C. At various time points, a sample from the 
reaction was removed and quenched in two volumes of 0.3 M NaOH, giving a final hydroxide 
concentration of 0.2 M. The abasic sites were cleaved by heating at 70 °C for 15 minutes. 
Samples were mixed with an equal volume of fomamide/EDTA loading buffer before loading 
onto a 15% polyacrylamide gel. Gels were scanned with a Typhoon Imager (GE Trio+ 
Healthcare) to detect the fluorescein label by exciting at 488 nm and measuring emission with a 
520BP40 filter. The gel bands were quantified using ImageQuant TL (GE Healthcare). The data 
were converted to fraction product [Fraction Product = product / (product + substrate)] and 
then fit by a single exponential (Equation 5.2) using Kaleidagraph (Synergy Software). Single-
turnover rates were independent of the concentration of AAG, indicating that the maximal rate 
constant was measured (kobs = kmax; data not shown).  
Fraction product = A(1 - e-kobst)    (5.2) 
Stopped-flow Kinetics. Pre-steady state kinetic experiments were performed on a Hi-Tech SF-
61DSX2, controlled by Kinetic Studio (TgK Scientific). The fluorescence of ɛA was measured 
using an excitation wavelength of 313 nm and a WG360 long-pass emission filter (4). At least 
three traces were averaged together at each concentration. The traces for wild-type, Y162F, 
and Y162W were fit by a double exponential (Equation 5.3) where F is the fluorescence as a 
function of time, C is the fluorescence of free DNA, X and Y are the changes in fluorescence of 
the intermediates, and t is the time. The traces for Y162A, Y162N, Y162H, Y162L, and Y162I 
were fit by a single exponential (Equation 5.2) and kobs is equal to kflip + kunflip.     
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 )e-Y(1-)e-X(1-C=F
t-kt-k obs2,obs1,     (5.3) 
For wild-type, Y162F, and Y162W, the observed rate constants were plotted versus 
concentration and fit by a straight line. k1,obs showed a linear concentration dependence, and 
the slope is equal to kon (M
-1s-1), and the y-intercept is equal to koff (s
-1). The value of k2,obs was 
independent of concentration and is equal to kflip + kunflip.   
Pulse-Chase Assay to Measure Substrate Dissociation. The macroscopic rate constant for 
dissociation of wild-type and mutant AAG from εA-containing DNA was measured by pulse-
chase in the standard reaction buffer at 25 °C as previously described for wild-type AAG (4). 
Briefly, in 20 μL reactions, 50 nM fluorescein-labeled TEC DNA was mixed with 75 nM or 150 
nM AAG for 20 seconds, and then a chase of 10 μM unlabeled TEC DNA was added.  At various 
time points, a sample from the reaction was removed and analyzed as described for “Gel-based 
glycosylase assay”. Base excision catalyzed by AAG results in fluorescein-labeled product, 
whereas dissociation releases unreacted fluorescein-labeled substrate. The partitioning 
between hydrolysis and dissociation can be determined from either the exponential rate 
constant or by the change in burst amplitude. If AAG dissociates from the labeled DNA before 
the chemical cleavage step and then binds to the unlabeled DNA, less of the reaction will occur 
during the single-turnover part of the curve as compared to the same experiment without 
chase. The data was converted to fraction product and fit by a single exponential (Equation 
5.2).  The observed rate constant was independent of the concentration of AAG.   
According to the two step binding mechanism, two different partitioning equations can 
be written (29). All labeled substrate is initially bound, and therefore the fraction of product 
formed is given by the fraction that goes on to react. This is indicated by Equation 5.4, in which 
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A is the burst amplitude (the fraction of product formed in the burst phase of the experiment), 
kmax is the maximal single-turnover rate constant for formation of product, and koff,obs is the 
macroscopic rate constant for dissociation from the flipped-out complex. This expression can 
be rearranged to solve for the desired dissociation rate constant (Equation 5.5). Similarly, for 
branched pathways, the observed rate constant for the burst phase of the pulse-chase 
experiment is given by the sum of the rate constants for the competing pathways, formation of 
product is given by kmax and the macroscopic dissociation of substrate is designated koff,obs 
(Equation 5.6). Solving for koff,obs gives Equation 5.7. 
maxobsoff,
max
kk
k
=A

      (5.4) 
max
max
obsoff, k
A
k
k       (5.5) 
maxobsoff,obs kkk        (5.6) 
maxobsobsoff, kkk        (5.7) 
Control reactions in which no chase was added provided the single-turnover rate 
constant, kmax, and confirmed that these concentrations of AAG were saturating. From these 
values, the dissociation rate constant, koff, for AAG dissociating from εA-DNA was calculated by 
two different methods (Equations 5.5 and 5.7). Both methods gave very similar values for koff,obs 
and we report the results obtained from Equation 5.5. 
Since the εA-DNA binds in two steps, the observed rate constant for dissociation of 
substrate (koff, obs) could be limited by the unflipping rate (kunflip) or dissociation from nonspecific 
DNA (koff). According to Scheme 2.3, and assuming that the flipped-out complex is stable (i.e., 
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kflip >> kunflip), this observed dissociation rate constant can be expressed in terms of the 
microscopic rate constants (Equation 5.8; (29)). Stopped flow fluorescence suggests that 
dissociation from the initial AAG•DNA complex is rapid, and therefore the observed rate 
constant for substrate dissociation from the εA-DNA•AAG complex is approximately equal to 
the reverse rate constant for flipping (Equation 5.9).  








 flipoff
off
unflipobsoff,
kk
k
k=k     (5.8) 
unflipobsoff, kk 
      (5.9)
 
Direct Measurement of Substrate Dissociation. Stopped-flow double mixing experiments were 
performed to measure unflipping and dissociation of ɛA-DNA by Y162A, Y162N, Y162H, Y162L, 
Y162I, Y162F, and Y162W. To rapidly form the flipped-out AAG complex, 2.8 µM DNA was 
mixed with 2 µM AAG. After an aging time of one second, 18 µM or 36 µM pyrrolidine-DNA was 
added as a competitor. The final concentrations after mixing were 700 nM DNA, 500 nM AAG, 
and 9 µM or 18 µM pyrrolidine-DNA. The reaction was followed for 1-300 seconds; no 
significant excision of ɛA occurs during this time. Three traces were averaged together and the 
change in fluorescence was fit by a single exponential (Equation 5.2). As described for the gel-
based pulse-chase assay, the observed rate constant for dissociation is equal to the rate 
constant for unflipping.  
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Results 
Binding and Excision of ɛA by AAG Mutants 
We used site-directed mutagenesis to generate seven Y162 AAG variants to test how the 
volume of the intercalating residue alters nucleotide flipping and excision of εA by AAG. Each 
mutant was first characterized for its ability to bind and excise ɛA from a synthetic 25mer 
oligonucleotide containing a central ɛA•T mismatch. As AAG has a relatively slow rate of base 
excision, steady-state fluorescence titrations could be used to measure binding of active 
enzyme to ɛA-DNA (4). The AEA DNA sequence used has high ɛA-fluorescence, and the stable 
 
 
Figure 5.2. Binding and excision of εA by AAG. (A) Titration of 0.4 µM AEA DNA with wild-type and 
Y162 mutants. Steady-state fluorescence was monitored within one minute, before excision can 
occur. Three independent titrations were performed and the average and standard deviation are 
shown. The normalized fluorescence was fit by the quadratic equation under conditions of tight 
binding (Equation 5.1). These fits indicate that the number of εA-binding sites is 86% the expected 
value for wild-type, 100% for Y162A, 41% for Y162N, 76% for Y162H, 41% for Y162L, 100% for Y162I, 
67% for Y162F, and 100% for Y162W. (B) Single-turnover excision of εA by wild-type and mutant AAG 
with 50 nM DNA and saturating enzyme was fit by a single exponential (Equation 5.2) to obtain the 
rate constants for N-glycosidic bond cleavage (Table 5.1). Data points are an average ± SD from three 
independent experiments. 
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Table 5.1. Kinetic parameters for flipping and excision of εA by wild-type and Y162 
mutantsa 
 
 Wild-typeb Y162F Y162W Y162H 
kflip (s
-1) 7.0 ± 0.2 5.2 ± 0.3 7.0 ± 1.1 46.1 ± 1.8 
kunflip (s
-1) (4.6 ± 0.2) x 10-3 4.6 x 10-2 c 3.9 x 10-2 c 0.20c 
Kflip
d 1520 113 180 231 
kchem εA (s
-1) (6.1 ± 0.8) x 10-4 (4.5 ± 0.5) x 10-4 (6.8 ± 1) x 10-4 (7.0 ± 0.1) x 10-4 
 
 Y162A Y162N Y162L Y162I 
kflip (s
-1) 41.1 ± 8.4 26.0 ± 6.9 56.0 ± 2.7 28.9 ± 4.4 
kunflip (s
-1) 10 ± 0.8 2.5 ± 0.08 8.0 ± 0.5 9.6 ± (7.1 x 10-5) 
Kflip
d 4 10 7 3 
kchem εA (s
-1) (2.8 ± 0.2) x 10-4 (3.5 ± 0.4) x 10-4 (2.6 ± 0.4) x 10-4 (2.1 ± 0.1) x 10-4 
 
aAll rate constants were determined using the AEA oligonucleotide. The standard conditions 
were 25 oC, 50 mM NaMES (pH 6.5), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT. 
 
bThe values for wild-type with AEA DNA (kflip = 7.0 ± 0.2 s
-1 and kchem = (6.1 ± 0.8) x 10
-4 s-1) 
are similar to previously reported values (kflip = 4.3 ± 0.4 s
-1 and kchem = (5.3 ± 0.2) x 10
-4 s-1) 
(4).  
 
cDouble-mixing stopped-flow experiments were only performed once for these mutants. 
 
dThe equilibrium constant for flipping is given by the ratio of the flipping and unflipping rate 
constants (Kflip = kflip/kunflip).  
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binding of the extrahelical ɛA lesion results in a 5-fold quenching of fluorescence for wild-type 
AAG (Figure 5.2A). Titrations of the Y162 mutants showed somewhat less quenching of ɛA-
fluorescence (2-3 fold), but nonetheless indicate tight binding of ɛA-DNA. From these titrations, 
the active concentration of protein was more accurately determined, and this corrected 
concentration was used for the remaining experiments.   
To evaluate whether the mutant proteins retain catalytic activity, single-turnover 
experiments were performed with enzyme in excess over the εA-DNA substrate (Figure 5.2B). 
Previous work established the Y162A mutant retained catalytic activity, which was surprising 
because it had been suggested that this mutant may lack activity (14). Knowing that the mutant 
with the smallest amino acid at position Y162 was active; we predicted that all other Y162 
mutants, regardless of size or polarity would retain catalytic activity. This was found to be the 
case, and the rate constant for excision by all of the mutants is within 2.5-fold that of wild-type 
(Table 5.1). Therefore the transition state for N-glycosidic bond hydrolysis is not disrupted by 
these mutations. This allowed us to measure flipping and unflipping for each mutant.  
Stopped-flow Fluorescence to Monitor Binding and Flipping of ɛA-DNA 
Rapid mixing experiments were used to determine the rate constants for association and 
nucleotide flipping (Figure 5.3). Two phases were observed when excess wild-type AAG was 
mixed with 100 nM AEA DNA. For this substrate, the εA fluorescence is initially high in the free 
DNA, is partially quenched in the first intermediate, and is more strongly quenched in the fully 
flipped-out complex. Similar traces were also observed for Y162F and Y162W, and were fit well 
by a double exponential (Equation 5.3). The first phase is linearly dependent on the enzyme 
concentration, and is assigned to binding and formation of the initial recognition complex. The 
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Figure 5.3. Stopped-flow fluorescence with excess protein to measure binding and nucleotide 
flipping by Y162 mutants. Representative data from experiments in which 100 nM AEA DNA was 
mixed with increasing concentrations of wild-type (A), Y162A (B), Y162N (C), Y162H (D), Y162L (E), 
Y162I (F), Y162F (G), and Y162W (H). Traces are the average of three binding reactions and are fit by 
either a single or double exponential (Equations 5.2 and 5.3). (I) The rate constant for the first phase 
of the binding reaction (k1,obs) is dependent on the concentration of AAG and a linear fit yields the 
bimolecular rate constant for binding (kon) (J) The rate constants for the second phase of the binding 
reaction (k2,obs) are independent of the concentration of AAG and reflect the sum of the forward and 
reverse rate constants for nucleotide flipping. Rate constants in I and J are from three independent 
experiments (average ± SD).  
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second phase is independent of concentration and corresponds to nucleotide flipping to form 
the specific recognition complex. The observed first order rate constant for formation of the 
flipped-out specific recognition complex is nearly identical for Y162F, Y162W, and wild-type 
AAG.  
Association experiments with the other Y162 variants yielded different fluorescence 
traces, and were similar to the previously reported Y162A results (Chapter 3). For Y162A, 
Y162N, Y162H, Y162L, and Y162I, only a single time dependent decrease in fluorescence was 
observed (Figure 5.3). Even at low concentrations of protein, the first phase of the reaction was 
complete in the dead time of the stopped-flow (kon > 10
9 M-1s-1). In each case, the exponential 
decrease in fluorescence, which indicates formation of the flipped-out specific recognition 
complex, was independent of concentration and much faster than wild-type AAG. Overall, 
variants of AAG with a non-aromatic intercalating residue bind nonspecific DNA and search for 
damage significantly faster than the wild-type enzyme.  
Measurement of Unflipping and Dissociation of ɛA-DNA 
To define individual microscopic rate and equilibrium constants it is necessary to measure the 
dissociation kinetics. As previously described, the dissociation of AAG from ɛA-containing DNA 
was investigated using the pulse-chase method, whereby the AAG•ɛA-DNA complex is allowed 
to form and is subsequently chased with an excess of tight binding pyrrolidine-DNA inhibitor 
(12). Any AAG that dissociates is bound to the inhibitor, allowing measurement of the 
partitioning forward (abasic DNA product) and backward (ɛA-DNA substrate). Previously 
reported values for wild-type, Y162F, and Y162W were from experiments with the TEC DNA 
substrate. Using the AEA substrate, wild-type AAG is the only protein committed to excision of 
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ɛA, with 15% of the complex partitioning forward to product and 85% dissociating (Figure 5.4). 
Assuming the dissociation of AAG from nonspecific DNA is fast, these data yield the microscopic 
rate constant for unflipping (Equation 5.5). Since 100% of the other Y162 variants dissociated 
from the DNA, no product could be detected in the presence of chase (Figure 5.4). This 
indicates that unflipping is much faster than N-glycosidic bond cleavage. In order to precisely 
measure the rate of unflipping for these mutants, we next performed a double-mixing 
experiment in the stopped-flow.  
 In the double-mixing experiment, the flipped-out complex of mutant AAG with ɛA-DNA 
was rapidly formed and then challenged with pyrrolidine-DNA competitor. The time-dependent 
 
 
Figure 5.4. Pulse-chase experiments to measure dissociation of εA-DNA. Fluorescein (fam)-labeled 
DNA (50 nM) was mixed with excess AAG (75 nM - 1200 nM) for 20 seconds, and then 10 µM 
unlabeled pyrrolidine TXC DNA was added as a chase. The reactions were quenched at the indicated 
time points, and the fraction of abasic DNA product was determined by alkaline hydrolysis and gel 
electrophoresis (see Material and Methods for details). The partitioning between the forward 
reaction (base excision) and substrate dissociation was measured. The commitment for wild-type 
(15%) was used to calculate the rate of unflipping (see Materials and Methods). 100% of all Y162 
mutants dissociated and the +chase reaction matches the control in which chase and substrate are 
added at the same time (data not shown). Therefore, stopped-flow double-mixing experiments were 
necessary to measure kunflip for the Y162 mutants.  
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Figure 5.5. Direct measurement of εA-DNA dissociation from Y162 mutants. Double-mixing 
experiments were performed using stopped-flow fluorescence to monitor the increase in 
fluorescence upon release of εA-DNA for Y162A (A), Y162N (B), Y162I (C), Y162L (D), Y162F (E), 
Y162W (F), and Y162H (G). The AAG•DNA complex was formed, aged for one second, and then 
chased with an excess of pyrrolidine-DNA as a competitor. The traces reflect the average of three 
separate mixing experiments and the solid lines depict the best fit to a single exponential. Rate 
constants in Table 5.1 are from two independent experiments (average ± SD) unless otherwise 
stated.   
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increase in ɛA fluorescence is fit by a single exponential, which corresponds to the rate-limiting 
unflipping step. This experiment reveals the rate of ɛA unflipping is anywhere between 9 to 
2,000-fold faster than wild-type, depending on the mutation. Overall, the aromatic residues at 
position 162 (phenylalanine, tyrosine, histidine, or tryptophan) had slower rates of unflipping 
compared to the non-aromatic residues (alanine, asparagine, leucine, or isoleucine). This 
observation supports the model that tyrosine intercalation acts as a plug to block the unflipping 
of ɛA.  
After determining the rate constants for unflipping, the rate and equilibrium constants 
for nucleotide flipping could be calculated for wild-type and the Y162 variants (Table 5.1). Even 
though kunflip is faster for the Y162 mutants compared to wild-type AAG, the unflipping rate 
constants are significantly slower than the observed rate constants for flipping. This indicates 
that the observed rate constant that was assigned to nucleotide flipping (k2,obs) is approximately 
equal to the microscopic rate constant for flipping (kflip). The equilibrium constant for 
nucleotide flipping is the ratio of the two values (Kflip = kflip/kunflip). For aromatic residues 
(tyrosine, phenylalanine, histidine, and tryptophan), the equilibrium constant for nucleotide 
flipping is highly favorable. In contrast, the equilibrium constant for flipping is greatly decreased 
for proteins with a non-aromatic amino acid at the position of 162.  
Discussion 
Structures of DNA repair glycosylases in complex with DNA suggest that nucleotide flipping is 
aided by intercalating residues (2, 30-32). The prevalence of nucleotide flipping and the 
dramatic nature of the conformational change that accompanies DNA bending and nucleotide 
flipping have captured the interest of scientists for almost twenty years. However, little is 
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known about the fundamental mechanisms by which nucleotide flipping is accomplished 
because it is difficult to observe rapid conformational changes that occur on the millisecond 
time scale. To understand the contribution of DNA intercalation to the energetic landscape for 
specific recognition and nucleotide flipping, we performed comprehensive kinetic analysis of 
mutant forms of AAG in which the conserved intercalating tyrosine (Y162) was mutated. These 
results provide support for the model that intercalation by an aromatic side chain greatly 
stabilizes the extrahelical conformation of the specific recognition complex. Unexpectedly, we 
further confirm the role for Y162 in slowing the rate of nucleotide flipping, apparently by 
stabilizing the initial recognition complex. This structure/function study supports the model 
that DNA intercalation contributes to the specificity of AAG, but the increased specificity comes 
at the cost of reduced speed (Chapter 3).  
AAG Requires an Aromatic Intercalating Residue 
We focused on the role of the intercalating tyrosine (Y162), which is universally conserved 
among eukaryotic AAG homologs (32, 33). Seven mutations were made at position 162 to 
determine whether nucleotide flipping and excision by AAG depends on the identity of the 
intercalating residue. We predicted a volume dependence of the intercalating residue where 
larger amino acids would serve as a plug and slow kunflip. Instead we found AAG requires an 
aromatic intercalating residue. No systematic change in the rate constants for flipping or 
unflipping were observed regardless of the volume or polarity. All non-aromatic residues have a 
decreased equilibrium constant for nucleotide flipping which may be explained by increased 
mobility of these residues (Table 5.1 and Figure 5.6). Aromatic residues form favorable pi-pi 
stacking interactions with nucleobases of DNA which restrict their mobility. This suggests that 
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Figure 5.6. Volume dependence of the intercalating residue. (A) kflip (B) kunflip or (C) Kflip verses the 
residue volume (Å3). The BL- residue volume calculation was used (1). Mutants with an aromatic 
residue at position 162 have a favorable equilibrium constant for nucleotide flipping because both 
kflip and kunflip are slow. The opposite trend is true for mutants with a non-aromatic residue.   
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aromatic stacking interactions are responsible for the stabilization of the initial recognition 
complex and the specific recognition complex.    
All seven Y162 mutations made by site-directed mutagenesis are well tolerated in vitro 
and do not appear to greatly perturb the structure, because the N-glycosidic bond cleavage 
step is within 3-fold of wild-type AAG. Some prokaryotic homologs of AAG have been identified 
that appear to substitute histidine for tyrosine at the intercalating position (32, 34). Histidine 
could make similar stacking interactions as tyrosine, phenylalanine, and tryptophan. Kinetic 
analysis showed that this was the case. While the rate constant for nucleotide flipping is 7-fold 
faster for the Y162H mutant compared to wild-type, the aromatic Y162H mutant is able to slow 
the rate constant for unflipping and stabilize the specific recognition complex. Thus the overall 
equilibrium constant for nucleotide flipping remains very favorable for this mutant.  
Binding to nonspecific DNA and searching are significantly faster for all non-aromatic 
Y162 mutants, and too fast to measure with stopped-flow assays. Parallels can be drawn with 
recent reports that mutation of intercalating residues to alanine in other DNA glycosylases 
increases the rate of diffusion (20, 21). Thus, a theme emerges that DNA intercalation slows the 
macroscopic rate of diffusive searching. Although the non-aromatic Y162 mutants engage εA 
sites significantly faster than the wild-type enzyme, the destabilization of the specific 
recognition complex greatly reduces the specificity of the enzyme. Previous work reported 
Y162A is not able to effectively find sites of damage when challenged by an excess of 
undamaged bases, leading to the prediction that DNA intercalation is essential for in vivo DNA 
repair (Chapter 3). Consistent with this conclusion, heterologous expression of Y162A AAG fails 
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to fully protect cells against an exogenous DNA alkylating agent (14). We predict the other non-
aromatic Y162 mutants would be deficient for DNA repair in vivo. 
DNA Intercalation by Other DNA Glycosylases 
There are several distinct and evolutionary families of DNA repair glycosylases (35, 36). These 
enzymes differ in their chemical mechanisms and in the identity of the lesions that they 
recognize, however they all recognize damaged bases and catalyze cleavage of the N-glycosidic 
bond. To gain access to damaged bases, DNA glycosylases use nucleotide flipping and DNA 
intercalation. While these enzymes fill the space left by the flipped-out damaged nucleotide 
with one or more intercalating residues, the identity of the intercalating residues varies.  
Fluorescence methods have been used to measure DNA binding and nucleotide flipping 
by many DNA glycosylases, and results from the literature are summarized in Table 5.2 (4, 18, 
37, 38). Since these enzymes belong to different superfamilies and therefore evolved 
independently, it is interesting to compare the equilibrium constant for nucleotide flipping and 
the identity of the intercalating residue. Compared to other DNA glycosylases, the rate 
constants for both forward and reverse flipping are much slower for AAG. AAG has a very 
favorable equilibrium constant for flipping of εA. However, biochemical evidence suggests that 
Table 5.2. Comparison of nucleotide flipping by DNA repair glycosylases.  
 
Enzyme 
 
Superfamily 
Substrate 
Range 
Intercalating 
Residue 
 
Substrate 
kflip 
(s-1) 
kunflip 
 (s-1) 
 
Kflip 
 
Reference 
UDG UDG Narrow L191 2’-
fluoroU·G 
1260 38 33 (38) 
 
OGG1 HhH Narrow N149 8-oxo-G·C 13 1 10 (18) 
 
Fpg Fpg Broad M73 8-oxo-G·C 12 12 1 (39) 
 
AAG AAG Broad Y162 εA·T 7 0.005 1400 This study 
and (4) 
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εA is unique among the well-characterized AAG substrates, because other lesions such as 7-
methylguanosine and inosine appear to have unfavorable equilibrium constants for flipping (10, 
39). Most DNA glycosylases do not use an aromatic intercalating residue (Table 5.2), and overall 
the equilibrium constant for nucleotide flipping is much less favorable than AAG. Interestingly, 
similar Kflip values were obtained for non-aromatic Y162 AAG mutants. It appears that for most 
glycosylases, the identity of the intercalating residue is less important than its steric bulk, which 
serves to plug the hole and prevent reinsertion of the damaged base. Based on our results, the 
aromatic intercalating residue is essential for AAG and increases specificity for εA by stabilizing 
both the initial recognition complex and the stable recognition complex.  
Conclusions 
Structures of AAG bound to εA-DNA (32) raised the possibility that intercalation by Y162 could 
increase the rate constant for flipping by “pushing” or destabilizing the duplex and decrease the 
rate constant for unflipping by “plugging” the hole vacated by the flipped-out nucleobase, as 
has also been suggested for other glycosylases (30, 31). Our study provides a rigorous test of 
these models. The kinetic parameters for small, non-aromatic Y162 mutants support the 
plugging model, with these mutants showing a 2000-fold increase in the rate of unflipping 
relative to wild-type AAG. Surprisingly, none of the smaller Y162 mutants show a reduced rate 
of flipping, but instead all non-aromatic Y162 mutants flip out εA lesions at least 4-fold faster 
than the wild-type enzyme. This argues against the pushing model for Y162 and demonstrates 
that intercalation of Y162 dramatically slows the nucleotide flipping step. The slower rate 
constant for flipping by wild-type AAG is presumably explained by tight binding of εA in an 
initial recognition complex. Overall, the non-aromatic mutations greatly destabilize the specific 
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recognition complex, and we obtain an estimate of 380-fold stabilization for the contribution of 
tyrosine intercalation to the equilibrium constant for flipping. AAG is a particularly attractive 
system to delve into the biophysical and biochemical mechanism of multi-step DNA recognition, 
but it is apparent that many different enzymes must employ similar strategies to discriminate 
between non-specific and specific sites, and the lessons learned from AAG may be more widely 
applicable to other DNA modifying enzymes.  
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CHAPTER 6 
Conclusions and Future Directions 
 
Kinetic Mechanism of AAG 
Human alkyladenine DNA glycosylase (AAG) is a monomeric repair protein responsible for 
removing a diverse set of alkylated and oxidized purine bases (1-4). Crystal structures of AAG 
complexed with damaged DNA revealed the DNA is bent where a tyrosine (Y162) intercalates 
into the space left by the flipped-out damaged nucleotide (5, 6). Previous work established the 
kinetic mechanism for AAG (Scheme 6.1; (7)). Briefly, AAG binds nonspecifically to DNA (kon) 
and uses facilitated diffusion (8) to search for sites of damage. The searching process is 
described by the macroscopic rate constant kfind. This rate constant will depend on the length of 
the DNA and involves many microscopic searching steps. Once a lesion is found, AAG forms an 
initial recognition complex that is accompanied by changes in the stacking of the lesion base 
(7). From this intermediate, AAG catalyzes nucleotide flipping (kflip) to form a more stable 
specific recognition complex that positions the substrate for N-glycosidic bond cleavage (5). In 
this specific complex the DNA is bent and the damaged nucleotide is flipped 180°. After N-
glycosidic bond hydrolysis (kchem), the lesion base is released. Dissociation of AAG from the 
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abasic product requires rotation of the abasic sugar back into the duplex (kunflip). From the less 
tightly bound complex, AAG can translocate along the DNA in search for additional sites of 
damage before ultimately dissociating (koff).   
Direct Measurement of kfind   
In the series of transient kinetic experiments used to dissect the individual steps of binding, 
flipping, and base excision by AAG, conditions of excess protein were used (7, 9). While this 
condition is most commonly employed to monitor labeled DNA, simultaneous searching by 
multiple AAG molecules makes the searching step too fast to detect (7). We modeled searching 
by multiple proteins explicitly to show that an additive model, in which two proteins search 
twice as fast as one protein, is consistent with the experimental data; however we were never 
able to directly measure kfind until recently (see Appendix B). We gained new insight into the 
DNA searching process by directly measuring the rate of searching under conditions of excess 
DNA. Although the fraction of DNA that is bound is much smaller under these conditions, we 
were fortunate because there was sufficient signal to accurately measure protein binding. 
Under these conditions the initial recognition complex is formed with a unimolecular rate 
constant of 120 s-1 for wild-type AAG (Chapter 3). This observed rate constant (kfind) is equal to 
the sum of the rate constants for finding and leaving the site of damage. For wild-type AAG this 
initial recognition complex is significantly populated, indicating that the rate of finding the εA 
Scheme 6.1. 
157 
 
site is faster than the rate of leaving the site. Although multiple AAG molecules can bind to a 
single oligonucleotide, the observed rate constant for nucleotide flipping is identical under 
conditions of excess DNA or excess protein. This indicates that multiple proteins do not affect 
the flipping step and that rate constants obtained in experiments with multiple or single 
proteins bound can be directly compared. This experimental approach can be used with other 
DNA glycosylases to better understand the searching process. 
Functional Insights into Active Site Tyrosines 
Much is known about the removal of the naturally fluorescent lesion 1,N6-ethenoadenine (εA) 
by AAG. However we sought to observe conformational changes in the protein directly. Similar 
approaches have been very informative for other DNA repair glycosylases (10-13). In Chapter 2, 
tryptophan residues were introduced into the binding pocket of AAG with the goal of 
measuring the rate constant for nucleotide flipping of non-fluorescent lesions. The two tyrosine 
residues that sandwich the bound lesion in the crystal structures (5, 6), Y127 or Y159, were 
replaced with tryptophan. While Y127W and Y159W had minimal effects on the excision of εA, 
there were much larger effects on the rate and equilibrium constant for nucleotide flipping. It 
has been suggested that a tyrosine to tryptophan mutation should be relatively conservative 
(14), however both positions are invariantly found to be tyrosine in AAG homologs in organisms 
ranging from bacteria to plants to vertebrates (15). Extensive mutagenesis of AAG and selection 
for active site variants that conferred resistance to DNA alkylating agents has identified 
hundreds of allowed mutations, but no active variants at position 127 have been identified (15, 
16). Only two substitutions were observed at position 159 (N and F) in those experiments. This 
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suggests that these two active site residues are important for AAG to perform its role in DNA 
repair within the cell.  
Therefore, the large effects on the rate and equilibrium constant for nucleotide flipping 
are consistent with the simple model that bulky tryptophan residues in the active site 
destabilize the flipped-out conformation and accelerate the rate constant for unflipping. In 
spite of these differences, stopped-flow fluorescence experiments show that these mutant 
proteins exhibit the same two-state binding model as was observed for wild-type AAG. These 
observations indicate that the εA lesion and tryptophan side chains located in the AAG active 
site both report on the initial recognition complex and on the specific recognition complex. 
Identical rates were observed from time-dependent changes in both εA and tryptophan 
fluorescence, demonstrating that there are already changes in the active site environment prior 
to full nucleotide flipping.  
Role of the Intercalating Residue (Y162) 
The functional contributions of the intercalating residue (Y162) to each of the steps in the AAG 
catalytic mechanism were addressed in Chapter 3. The intercalating tyrosine residue was 
mutated to phenylalanine (Y162F) and alanine (Y162A). Remarkably, the Y162A mutation 
increases the rate of nucleotide flipping by 50-fold relative to wild-type AAG. This mutant also 
exhibits faster unflipping, resulting in a 140-fold reduction in the equilibrium constant for 
formation of the flipped-out complex. In contrast, the kinetic parameters for the Y162F and 
wild-type enzymes are very similar, suggesting that the hydroxyl of tyrosine is not necessary for 
function. These results establish that DNA intercalation contributes to the specific recognition 
of DNA damage by acting as a plug to stabilize the specific recognition complex. Tyrosine 162 
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plays a critical role in the discrimination of damaged and undamaged nucleotides, by increasing 
the amount of the extrahelical lesion recognition complex and enhancing efficient repair of rare 
sites of damage.  
Timing of DNA Intercalation 
In Chapter 4, site-directed mutagenesis and transient kinetic approaches were used to 
determine the timing of tyrosine (Y162) intercalation for human AAG. The intercalating tyrosine 
was mutated to tryptophan since tryptophan fluorescence is an excellent tool to follow 
structural changes in a protein. Even though this mutation is not found in nature, the results 
indicate that Y162W is a conservative mutation. Excision of the naturally fluorescent lesion 
1,N6-enthenoadenine (εA) by Y162W is identical to wild-type, and the equilibrium constant for 
flipping remains highly favorable. Surprisingly, the tryptophan fluorescence of Y162W does not 
report on nucleotide flipping. Instead, the rapid quenching of Y162W tryptophan fluorescence 
upon binding damaged or undamaged DNA suggests that Y162 intercalation occurs early in the 
search for DNA damage. 
Important Properties of the Intercalating Residue 
Almost all DNA glycosylases that use nucleotide flipping have an intercalating residue to fill the 
space left by the flipped-out damaged nucleotide, but the identity of the intercalating amino 
acid varies. Human AAG uses an aromatic tyrosine residue. To investigate how the size (volume) 
of the intercalating side chain affects nucleotide flipping and base excision, seven Y162 variants 
of AAG were made and individual steps of the kinetic mechanism were characterized in Chapter 
5. All seven Y162 mutants retained catalytic activity, measured by single-turnover excision of 
εA. This structure/function study shows that the formation of the initial recognition complex 
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and nucleotide flipping are affected by the size of this residue. Based on the results, the seven 
mutants fell into three categories: aromatic (Y162, Y162F, and Y162W) non-aromatic (Y162A, 
Y162N, Y162I, and Y162L), and Y162H. While Y162H is aromatic, the kinetic characterization of 
this mutant does not fully match the aromatic mutants or the non-aromatic mutants. Like the 
non-aromatic mutants, the rate constant for nucleotide flipping is much faster for Y162H 
compared to wild-type. However, the rate constant for unflipping is slow for Y162H, and more 
similar to the other aromatic mutants. Like the other aromatic mutants, Y162H is able to 
stabilize the specific recognition complex. Overall, all AAG proteins with an aromatic 
intercalating residue (Y162, Y162H, Y162F, and Y162W) have a favorable equilibrium constant 
for flipping. Altering the volume and polarity did not result in a systematic change in the rate 
constants for flipping and unflipping. The bulkier non-aromatic mutants (Y162N, Y162I, and 
Y162L) did not act like a plug, and were unable to prevent the damaged base from flipping back 
into the DNA. Perhaps this is due to increased mobility compared to aromatic side changes, 
which are expected to be able to make favorable pi-pi interactions with nucleobases of DNA. 
Therefore, intercalation of the aromatic residue dramatically slows the nucleotide flipping step, 
and the tyrosine acts as a plug to block the unflipping of εA. 
Overall Conclusions 
Taken together, the kinetic mechanism of human AAG is optimized for specificity rather than 
speed, and the intercalating tyrosine residue plays a role throughout the kinetic mechanism. 
Intercalation occurs early in the search for damage, and tyrosine 162 plays an important role in 
discriminating between damage and undamaged nucleotides. Favorable aromatic stacking 
interactions between tyrosine 162 and nucleobases of DNA stabilize both the initial recognition 
161 
 
complex and the stable recognition complex. AAG has been an attractive model system to learn 
about the biophysical and biochemical mechanism of multi-step DNA recognition, and the 
lessons learned from AAG may be more widely applicable to other DNA modifying enzymes. 
Future Directions 
All enzymes that flip DNA bases are also thought to bend DNA at the target site. Crystal 
structures allow us to observe the final extrahelical state, and we can often determine the 
extent of DNA bending. However, the timing of DNA bending remains unknown. We would like 
to know whether the DNA bends prior to, simultaneous with, or after nucleotide flipping 
(Scheme 6.2). If DNA bending occurs prior to nucleotide flipping, this suggests the ease of 
bending DNA will contribute to the recognition of damage. If DNA bending is late, then bending 
can be excluded from the mechanism of damage recognition. Development of an assay to 
measure DNA bending would be beneficial to address the temporal relationship of bending and 
flipping. Fluorescence resonance energy transfer (FRET) between donor and acceptor 
fluorophores is a very sensitive method for measuring DNA bending induced by proteins (17). 
 
 
Scheme 6.2. 
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To develop a real-time DNA bending assay for AAG, two orthogonal approaches should 
be tried since the extent of DNA bending upon AAG binding remains unknown. One set of FRET 
substrates would contain external fluorophores to observe large bend angles. A second set of 
substrates would contain nucleotide analogs inside the DNA duplex that should allow for 
measurement of smaller bend angles. Both types of DNA substrates would contain a centrally 
located εA lesion. Importantly, the excitation (313 nm) and emission (410 nm) of εA is distinct 
from the other fluorophores that would be used. For each set of FRET substrates, the donor and 
acceptor must first be tested individually to be sure AAG binding does not alter the 
fluorescence.  
Upon addition of AAG to the first set of FRET substrates, the fluorescence emission of 
the acceptor is expected to increase, as DNA bending brings the two DNA ends into closer 
proximity. If AAG induces small DNA bends, this set of DNA substrates is unlikely to work. To 
observe 10-30° bend angles, a double-labeled U-shaped DNA construct should be made, or a 
proximal FRET pair should be used (17). In contrast, internal base analogs will be used in the 
second set of FRET substrates. These analogs are easy to position close to the site of bending, 
and they have negligible influence on the normal secondary structure of DNA (18).  
Stopped-flow fluorescence can be used to correlate the changes in FRET with changes in 
εA fluorescence. Previous work established the transient changes in the fluorescence of εA 
reveal the existence of two distinct complexes that are formed on the millisecond timescale 
prior to hydrolysis (7, 9). An initial recognition complex is characterized by partial disruption of 
εA stacking interactions, followed by a stable extrahelical complex in which the εA lesion is 
strongly quenched by interactions in the AAG active site. Since the excitation and emission of 
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εA is distinct from the FRET fluorophores, we can follow both signals at the same time. If εA is 
flipped into the active site prior to DNA bending, we would predict the FRET signal to occur late 
in the reaction, after the fluorescence of εA is quenched (Scheme 6.2; bottom pathway). 
However, based on the timing of DNA intercalation determined in Chapter 4, we predict that 
DNA bending, and therefore FRET, will precede flipping of the εA base (Scheme 6.2; top 
pathway). Potentially, these experiments may reveal that the AAG-DNA complex is highly 
dynamic and undergoes conformational transitions between many states with different degrees 
of DNA bending. At that point it would be necessary to use single-molecule FRET to study rare 
kinetic or structural changes which are normally lost in the ensemble average. The new 
methods proposed here to study DNA bending will enable us to examine non-fluorescent 
lesions and undamaged DNA to learn more about the earliest steps in locating sites of DNA 
damage. These methods could be widely applicable to the many other proteins that bend DNA.  
NMR Studies to Characterize Changes in Conformation and Dynamics of AAG 
Previously published crystal structures of AAG bound to damaged DNA help us understand the 
static arrangement of residues in the final flipped-out specific recognition complex, however, 
we would like to know the structure and dynamics of AAG free in solution and when bound to 
undamaged DNA (5). Nuclear magnetic resonance (NMR) is an excellent technique that can be 
used to understand the molecular motions that occur as AAG binds to a DNA oligonucleotide. 
Specifically, NMR experiments would allow us to monitor the movement of the intercalating 
residue (Y162) throughout DNA binding and nucleotide flipping. Combining NMR experiments 
with the previous kinetic analysis will help us better understand the timing of DNA intercalation 
and damage recognition by AAG. A protocol for expression of AAG in minimal media was 
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developed to allow for 15N labeling (Wolfe Thesis). The purification protocol was optimized to 
increase the yield of labeled protein, and preliminary HSQC experiments were done to assess 
the spectrum of AAG in solution as well as when bound to DNA. Unfortunately AAG was 
unstable under the experimental NMR conditions used, so optimization is still needed before 
additional NMR experiments can be performed to probe structural changes and differences in 
dynamics.   
Using the Intrinsic Fluorescence of εA to Probe Structure and Dynamics in Different Sequence 
Contexts  
 
Since the altered structure and increased dynamics of damaged DNA may serve as a signal to 
the repair proteins, experiments to study the effects of sequence context on εA fluorescence 
would help us to understand how DNA repair enzymes can identify damaged bases in DNA. We 
predict the structure and dynamics of DNA will change for different εA-DNA sequences, and the 
environment of εA within each sequence will affect the fluorescence. 1,N6-ethenoadenosine 
(εA) is a common form of alkylative damage that can be repaired by several different DNA 
repair pathways (4, 19-21). This lesion is highly mutagenic in mammalian cells, sterically bulky, 
and does not form hydrogen bonds with the opposing thymine (T). The natural fluorescence of 
εA provides a probe of the local environment (22).  
Two different 25 base pair oligonucleotides, TEC and AEA, each containing a central εA 
lesion were previously characterized (names refer to the central three nucleotides i.e., TEC has 
a central εA lesion flanked by a 5’T and a 3’C) (7, 9). While the excitation of both single-
stranded oligonucleotides at 320 nm gave a broad fluorescence emission peak centered at 410 
nm, the TEC oligonucleotide sequence gave 4-fold lower fluorescence than free εA. This was 
consistent with quenching of εA fluorescence even in single-stranded DNA. Surprisingly, the 
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oligonucleotide sequence AEA yielded much higher fluorescence, essentially identical to that of 
free εA. When appropriate complement was annealed to these sequences, then the 
fluorescence emission was decreased by a factor of 1.7-fold for TEC and 1.4-fold for AEA. This 
was consistent with increased quenching due to enhanced base stacking interactions in duplex 
DNA. It was not clear why these two sequence contexts showed such different quenching, but it 
is possible that the lack of nearby guanine nucleotides can account for the high fluorescence of 
the AEA sequence. A previous study of charge transfer between εA and normal bases reported 
that G is the most efficient quencher of εA, with only modest quenching occurring between εA 
and C, T, or A bases (23). Properties of the DNA π-stack can range from insulator- to “wire”-like. 
Therefore, the extent of stacking among εA and the DNA base-pair stack may affect the 
reaction kinetics and distance dependences of charge transfer mediated by the DNA helix.  
Future work is needed to characterize additional DNA sequences to correlate sequence 
context with εA fluorescence in both single-strand and duplex DNA. Initial experiments showed 
that quenching of εA fluorescence is reporting on the conformation and dynamics of the εA. 
Overall, the various sequences tested had large differences in εA fluorescence, but additional 
DNA sequences should be tested to determine the distance dependence of εA quenching by 
guanine. In the future, stopped-flow fluorescence should be used to determine the rate 
constant of nucleotide flipping by AAG for each sequence. The most interesting sequences can 
be studied using NMR to better understand the structure and dynamics of damaged DNA (24). 
Potentially the rate of nucleotide flipping is correlated to the dynamics and or conformation of 
the εA lesion in the different sequence contexts.  
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